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I I IIm:1Il ~a l ,,~, hr"il~1 milk 3nd c ....... , ... al ,,>rcr"',,,,,~ ",01ll3io ~Cl. c rJ I DIlJ» Ill1'IlUIlOlol!iclll 
C')lUron~nl ~ indlJ(lin.~ mucms (Ill\ln ,us $! lyCoJl!l)lein~). wh'ch prolccT Ihe 
g.I'>I!"I .>itllc~ jll1a l and fcmnk r"pm,IIl ~t1 vc lra(' I ~ ami hrca~t I" d inf;lllt> fn'lIl baclcl"lal , 
viml and fUll gal ml" <;lions. In addition to tliCir ""II ~T1own fUllct;'11l in luhri c3lion. 
1l '''II ~ "" .",Iing arKl digestion. "'1.1("\1 , ~lId 'II\IC;", ha,e b"en llwd a, r~I I "'I"!: '( : a l 
mari( ~r> in cli,,:a,~,", ,"ucl! a, a,lh,"a. chm]1 ic bml1"';II~. ",,-l ie lihms; .. , and caI"Cn l\'!Ll\a, 
of Iht) b~;"t lung ;",,:1 001"" . ( nul" .'11 10 ", i~ ;,1' 0 kilO-HI 1(' mloih' l th" m'ltv lly of 
human ou""unoddici::ncy \,lniS (I II V,. Ih" C'"11.a~"' " age '" of aC<j uin..""(j 
IInlll ul " ... ldic,cn",y ~yndrome (/1 IUS), 
'\(·conlin.:; Ii ) lh ~ .loim UniTcd Nari'J!l '> rn"g ra" Ul'~ On IIIViAIU$ (l!NAIDS) 
worldwide an ",(;mated 3~,(O milliulll>C''f'lc were li ving wiTlI!!l V in 2()() ~ " ith 4.1 
TlliJlion newly i"f,eled alld 2,~ milli",) dcalh~ II has been rCpoltn! th,lt ilfl ~s ( "nal~d 
24.5 milli ,,,, o i' Ill" HIV inlCcTrd pc,;.p lc 0 1" " h('"1 tiO'% I<::males 11" " ill "ull -S3h3mn 
,\the" \\'i lll th" Southcm Africall reglun IJa\'I1):( th~ hii:hes( pre",,,,,,,,,,,, ill ,\ frica , 
I'un hcnn"r'e Ih~ 1nCido.'lCC o f OpP'"t lll1l,U,- dl~C;,~':'" such a, '11I I'> al"" r~p<'rlcd ((1 
i l)~~,,~' \\ ,Ih HI V pre'·al""lC"'. Th ,,~ far. dc\pir.: the <.Ii'>('", ,,,,)- of hi$!h ly 3(~ i \"e 
a'lI ircl(O\'iml Ih~ml'ies "h,dl couIll in hOlh prol"""''' and rC\;cr.;;.: Tnlllsni" 'a~'" 
iO)hiblhl1'. HTV remains a~ a l!loly~ l Thr",;,i """". ;ally III Ihe Ihin! ,,, ,rid L~'">llriC\. 
T h ~r~f\lT~ lhcr~ i~ a need for rhe dc, ,, l ... ,,' •• crll (, I" ~a re compollnds \0 r~ du~~ \ "all,)ad~ 
in l!l f(X'I ~d pc"pk and 10 prn cnt tl'e rrJllSOlll , sio n ..,flll" virus Jeom (1!l e illdividu:,1 r<) 
,, " (,'h ~r. T I ,~ ~~areh j(Jr a suiwhk ,", jC~ lll C ; S ,,11t1,)ing, 
Thi '> i, a 1\0\ d !i\ud ~' th,1( "'\ ""li!:l-llcd Ih ~ an ll-H I V I act; v;ly "f hUll"''' <;alh a. br.::" ,( 
milk ... ,,1 r"',!(lIanc~ rl ug mucus all..! 1I1l1CIIl, I,,)m HI\, neg;ni\'e illdh'iduals nnd 
,·olllp.1 rcd I h i~ to th.;: anll -HIV_1 ad" ny (, f tht) "., Ii,-" ry ",ue in,; fron, IYJliclits " .111 
Il IV I1l fC:Cllon " r fu ll blown AIOS in ~ n m ",Im onh,bn ion a'-S3)'. l' un ho:r'lIoro: I h ,~ 
'>t udy m'c\li~3; l.,j Th c wI.;: "f",,"vary Vl lle7 In inhibiTin)! II IV. l ", fo:~ ro [)n ol lh ~ 
j);;ripher.l l bl,~ >d 111.)t)lH)udcar cdl< II'UMCs). re'[lI'c ing ,iral illkct;"n of IhJ III V- 1 
in fcct ~d 1'1"1 M C ~ mid mi n;Llli zin.~ the .'>pn:ad " f H I V· I fn'Lll H IV- I IX, .. i!; '"C I'AMC~ l(' 










in tlk: inhibiIion of ~nvelop..-:d virU8<'S specilically poxvirus activity was also 
invcSligat~d. 
Follo\\ing S~phamsc ('fAR ~d filtmlion and caesIUm chlnrid~ d~nsity-grad~nt 
ullra-rentrifugmion, th~ pl"<'8e"nc.: of M I}C SR ,md ML'C 7 in sali,it. MI I C 1 in breasl 
milk and MI}Cl, MITC2, Ml'C4, ~fUCSAc' ~1l'C513 and MUCti mocins In the 
prcgmmcy plug mucus \\a, <:onli~d by \1,.'eslern blol1ing amI immllllO-
hi'loch~mi>lry analysis, fhe amino acid analysis whkh show~d high amounts of 
serine, threonine, ghuamic a<:id, gly<:ine, <lsparli<: acid and proline was suggestive ofa 
typical mllcin amino acid profile of which 'nine. llk:ronine and proline m<lke up 
20.1 %, 26% and 28% oflh~ MITC I, ML'CSB and MUC7 mucin, r~spccti,dy. 
/"IU<:1n8 of vmous "'Jurc~s w~r~ shown 10 be non-toxic to (EM SS cells. The anti-
mY-1 activity of crude saliva, breasl milk and crude pregnan~y piug muCUS togeth~r 
wilh tm:,ir purified compon~nls (MUC513 and MUC7 in saliva, MUCi in breasl milk 
and MI~'CI, MUC2, .\IUC4. MUC5AC, /l.JlTC5R and MUC6 in prcgnal"K'y plug) from 
HIY n~gative individuals mtd salivary MlJC5B and MlX7 from lilY positive 
patients (with diffef<'nt CD4 ~OImts <200. 200-400 and >400) was oktermin~d by 
incubating Ih~m with H1V-' prior 10 iTlkction oflhe CEM SS c~ lls. Tm:, crude sali\a. 
sal ivary MUC5U wd MUC7. milk mucin (Mlle1) and pregnancy plug mucins 
inhibiloctl IIIY-1 activily by 'l7.5%_ Crude breast milk and pr.:gnancy plug mucus did 
nO! inhibit lhe virus. Ml'C5U wd MUC7, purilied &urn Ilk; nooe saliva of HIV 
positi\~ pali~nts did not inhibil lhe ,irus dlocr irr~spectiv.: of their C04 (llunt'_ 
Agarose gel electrophor~sis show~d th .. ,S<., mllClll', ~"f":'cially MLlC7. to hav.: varying 
rnobiliti~s compar.,u to their llOmllil count~rparts suggesting al\<;e",d gly ... osylalion 
pil1t~rns that ver;. likdy caus~ poor enirapTl\~nl ()fjh~ virus. 
Salivary .\IUC7 did not inhibit HlV-1 infection oftlre PilMCs VI'm:,n M1.T7 was first 
in~ub<lkd with lh~,~ cells r<lther than with tb~ virus ['his suggest.:d that mucin 
inhibition is by physical .:ntrapnli:nt of tm:, virus th<ln by blocking pulalive viral 
binding siks on the sllrillc:e of PRMCs_ M1.T7 had no ctf~ct on rcxiuction of 
intracellular viral loads of infect~d FUMCs. Th~r~ W<l' \'~ry lillk ,iral exchange 










mucins with th~ illli:d~d c~lls pl'~venkd this tr;msmission. the linding nttds 10 be 
further explored. 
Salivm}' :\1UC5I3 and MUC7. milk mucin ('VllJCI) and pregnan<:y 1'1"1> Ill"eills aisu 
inhibil~d the activil)' of \'a<:cinia vir"-S (\'GK-5 strain) which is a lillnily or the 
~ll\"eloP<'d [>Uxvinls in II du~ d~P<',1d~l1t manner up 10 100'%, This sugg~sts that 
IlIucins may also possess II strong udivity uglllllsl Ulher enveloped viruscs. This re~ult 
could pl'Ovid~ vJluable informatiun in the attempt to uSC mucins JS ther<lpelitic agenls 
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ell i\ "T "R I 
LITERA TURF, REVIEW 
1.1 Background 
MUCU8 i8 a 8lim)' visco.:lastic or gelatinous blanket secretion thm coms the surface of 
epi\helial \i88ues of the gastrointestinal, respiratory and r~pmdlll;tiw tracts as well as 
the 8kin ofwme amphibians (Olmsted er ai" 2001; Reid, 1978). Not only docs mucus 
pnlVide pnltt'ction againsl microbial inlections. dehydration, physical or chemical 
injuries. its contrihution 10 lh~ innalt' irmnunt' 8y8\em i8 ~Iw wi'll documenled 
(Robcher 1:/ (11 .• 1999; Bo8Ch. cr (11" 2000: Pcrcz,Vilar and Hill, 1999; Ro>c and 
Vo)'now, 20(6). In reiation8hip8 01 slruc(ur~ and fUllction mUCU8 play8 an import,ml 
role in groy..1h, fetal dt>velopmelll, epithelial ren~y..al and differentiation, epithdial 
integrity, e:ll"cinogenesis and metastasis (r>.loniallx el <I/" 20(1). Its prescn<:e in 
different gland, of the hody and epithelia ,UGh a, the mammary gland, salivary gland, 
oesophageal epithciilUll, stomach. pancreas, hile ducts, lung epithelium, kidney, 
bladuer. liver. U(eIUS. rete testis, prostate. comea and conjunctiva make mucus the 
mosl widely di8lribu\ed bodily ,,;ecretion (Dllwe and C~rianj 1989; Gip80n d (1/.. 
1995; Iiolling,worth and Sy..anson, 2004; Idri, and Carraway, 1m; Patton et al., 
1995; Taylor etal" 1998). 
In addition to its wdl know" function ill luhrica\ion, ti~SI'" mating and dige8tion. 
hllman 8alivary mUCU8 function8 as an anti-viral. bacterial. toxin and fungal agenl b)' 
aggregating and removing thest' pathogenic mkro-organisms from the oral cavity 
(Gururajael ,,1 , 1999; Wei and Rob<'k, 2005). Som~ onht' fllnclion8 ofmucll8 in lh~ 
gl18troiutestinal tract include the aggregation and removal of agents such as cholera 
loxin in lht' stomoch. par.18itic nemalodes inlh~ intestine. regllialing the mOvement of 
hydrogen, gluco8e and other low-nlolecular-weight ions through the giWtnxlUlKienal 
epithelium, pnltt'Ction against acid, p"psin. hilt'. akohol, non-steroidal anti-
inflamlllatory drug8 anu antioxiuant agents. Furthennl>re lIlUCU8 pro\ect~ the ,011 











lInUig~sl":! I(){,d, and fil~C~S through thc gastroinksl inal tmct (Allen. 19~ I). Sali var) 
mucus IS also rcport~d 10 pia} a ~ignificant role in minimLdng th~ d1i;~1 01' or 
inhibition of the human immunoddi~i~n~y "ims (I1fV) infcction through the oral 
~avily 0\agashunmugam el al., 1')97) 
Human b",ast milk i~ known to ~ontain a number of non-immunological compol"M:'nts 
including mucin. "hich is hiologi~ally adive and protects breust fed inf'ants against 
inf~clions from bucteria. vinlses, fungi and toxins (Schrokn e/ a/., 1992; 
Wiede['S~hain and Kewburg, 2001). Cervical mucus also pla}s a signiticant rok in 
~al",guarding th~ femak reproouctivo:- tmct physiology from intcrnal and cxternal 
ladnr~ (Carl~t<Xlt et al.. 1983: Curlsto:-dt el ui., 1982), In addition to its protection 
against microhial coloni~"tion. inJi;,clion and rt'guiation 01' ,;peml tran~port to llre 
upper reproductive tmct (Eriksen el al . 1998: Wolr el al.. 1980; YurcwicL and 
Moghis~i. 1981). it provides lubricution. tissue hydration, cell attacimlo:-nt and anti-
prokolyti~ oclivill' (Gip~on eI at" 1995: ldris and Carraway. 1999; Lagow i'I al" 
1999: Venega~ eI ai, 1995). A~conling to Arglicso eI al (2()()2) abnom-.alit) in 
cervical mucus produclion affects fertility hy blocking spcrm transport to Ihc upper 
reprodudl\'e (roct where fertilization oc~ur~. 
'I he o:-pitheJial surface of the human rcspi ratory Iract is ulso co\'ered by the slimy and 
vis~o~lastic mucu~ st'~r~lion (l1o\'~nh~rg ~I al., 1997). whidl provid~s prol~dion 
ugainst a number of o:-xternul agents such lB chemicul und puthological insult,; 
(Thornton e/ al .. 1997). In addilion to iL, [undion in lh~ prol~ction of th~ airway 
o:-pithdiulll from puthogenic and k thul agents, it participutes in the muco,;al respon><:' 
to inllammation and inJi;,clion (Ros~ et aI., lOO I). 
MllCUS is a crooc hody st'C",tion containing wal~r, gl)COprOleins (mucins), ilpids, 
nu~kic acids. ladokrrin, I yso~,yl11~, immunoglohulins and ions (C"'~th, 1978; (ii pson 
et at.. 201l1: Lcibuf"l al., ?Oll?: Tabak, 1')95). Thc long and heavily O-glycosylmed 
glycOpf()l"in~ call.,:! mu~ins ar~ lh~ major ~OD1pon~nls (··RSO/. 01' the IOlal 
Illucromolcculcs) of tile crude mucus secretion (Argikso "1 ai" 2002). According to 
Moniaus e/ al. (lOOt). mucins a", r~fXJf't"d (0 h~ ~ynthesiLcd and s.ccrcled by 
specialized cdls of the epithelium and in some caso:-s hy the non mucin-secreting cdls 











mucins from human saliva. breast milk an..! c~r .... i~<l1 sc~rel Hln s (If fJJV n~gatiw 
individuHls and eompJre Iheir anli-H1V- I acti .... ity to thc salivary mu~in~ from HIV 
positi,",,' individuals in an in "lira IIIV inhibilion asSfly. 
1.2 l'tIucu~ and mucin~ a~ pathological markcr~ 
lluman mucins h<l"'" be~n ust'd ... , puthologk,d Inark~rs in dist'as",~ such .." 
malignancies of the gastrointestinal and respiratory lI'acts (Holscher c/ at.. 19':l5). rhc 
over-production or expression of Ihcse mllcins is JS5OCi~t",d with pathologic~1 
conditioll5 (Louah~d e/ al .• 20(0). For instanc~, mucus o\'n-pwduction in Ihe 
respirJ.tory trJ.d is aSf;O<;i<lt",d with ~ nutnkr of discases. such a~ <I~\hma. ~hwni~ 
bwnditi s_ cystic fibrosis <lnd lung c<ln;i ~om<l (Lou<lh~d d al., 2000) "hi~h arc known 
to induce obstlU~tion in the <lirways (Figu,"" 1.1) (Rost' ~I 01., 2001). 
In \hl' ti:mak reproductivc traCI, less or (lver-production of mucus or mueins is 
associated with hornlOnal or reproductive st~tl1S, infection. ~nd p<lthology of th~ 
femak r~plOducti\-e tract (Gipson d al._ 1997). ACCllrding to Yurcwl~L '111d Moghissi 
(1981) these abnormalities may cause inl"crtility. SimultJneously the rate and 1c~-e1of 
muCIl~ or mucin production 1Il hllman breast milk is known to be an impoJ1ant marker 
in met~static breast c~nccr progression (Sekine et 0/. , 1985). Hollingsworth and 
Sw~nson (2[)04) ","ported the area sUlTounding the tumour to b~ hypoxic. acidic, and 
nch in proteascs and otocr biologically active matcri~ls. This could support their 
hypoth~sis that tumours Ill<ly use mudm dllring inya~ion, mCla~ta~i~ and growth. One 
example of this is the shift in the n<lture of mucill5 from ncutwl to a~idic in mali ~'11alll 
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Figur., 1.1 O'W I'rodudion "r m"Cl" "nd mud,,, induc", ,inl.; nh",,,,·tioD_ hPOSlL" ~f 
)-,lLm,," "irw"}' "P iTi>e:i um :0 ro\ ,, [onll lC!:l" 1 agc-fl" ,cdl '" l'"' hogcm or ""in , in<it"", i diJm m<lti OIl ~r 
a n jillmlln , r"J'O 'lSe. r h. HlfloIlLH,alOr)' <>, 'LL LlTl ULe rC'P'm s" med]"Lor ,~,ti"al<' , "'-T<l; OI1 ~f nw"ill' 
tr~m , lLrh,. gob l", ,,,li s or gland"lar ' e'ere' Lory (' c'lI , in ,be """ie "0",1'''0,, ,,,x! :!nhlcl cLll llyp"'ri"ia 
" '1<1 glan du],r il)-p<'l'ia,;"."hYI"'''<ophy LlL 1),-, cl\n)[I:C couiili",, _ rim T",,,II, 111 mu pT(}(hLC--i(Ml of 
muc in, in patients wLlh J.< lh""i, eil",,,, [(' ob,lmC Li yc flu im",,",), (h,,;,,,,; _ Dr cy,;" jjbros; , ir.prcxlu"li 
I'" "n ~o,c 'Hili V":>",, ...... 2(~1I,) 
1.3 lld in itiun of nnu:ins 
\llL~ms wll1(:h "r~ the major g lycoprotein CelnlJX'n('nt, of till' crude HlU CU, ,ccreli()n 
IMOlli aux <'I al .. 20()]: Thormson <'I at., 2(02) aIT high ly gl y~osylaled and larg~ m 
,ize wilh Illoke'u h r weiglll r~n gi ng hel\\'~en ~ x 10" to 4 x 10" l).1 (Yur('wicz e/ al .. 
1987 ). Their carhohydrat~ w nwnt which cot)<,1 imte, 50 \cl H5~"', ell the LrlO ll'Cllk i, 
knuwn 10 proll.'C.l lLlLLnns li-()m ~n /ymali c degT;ld,ilion (hgurc 1.4) (L~ikallf N "I .. 
~ (~) 2). 1 he ll1ol1o , aech~rid" COllllX"ition of iLlllcim, is cOlnpri,ed 01 live ,ugar 
re<ldll eS narllc1 y .v-ac~lylgI LlLO s amine. ,V-aCdylgalaetosmn II1C. gnlacll1s~, fuco,c and 
,i ni ie acid I-'Hilb N ul._ 1')97: Petcr,un ('/ ai I')Yl() 
rh~ dclicicncy "fllronic acid alllllhe mml l all lounh "rll13nno s~ « 1 %) arc among the 
rac1l1 rs which dl stingu lsll~ s mucin glycopro te in, Ifcllll the gl ycuptolcins () r semll. and 
cOnneLll\ e lisstIes or pro leogl ycans (I< eid. I <) 7~). I' unhcnm,re t ll~ ir vn ri ab k numocr 











mnino acids (which make up 80% of the total amino acid) are otflcr distinguish ing 
faclor~ (Ml'Llkr et al_ , 1997: I'ere/-Vilar and Hill. 1999; I'et~rson <'I aI, 199~ 1- or lhe 
Ii,,~ sugar residu~~, tn.: sulphat~ residues are known to bind to N~aectyl!'.lucosam ill~ 
or galactooc while th~ N~acetylgalactosamine_ usu~lIy at \h~ reducing ends of the 
ehain is O-linked to s~rine or threonine lhrough an oxygen ~lom (Allen. 1981). In N-
IlTlktd sugars such as in proleoglyeans the attachmcnt of ,V-acctylgluw>anmlc 10 
asparagine is through a nitrogen alom iilld the link is an ;V-!'.lycosidie onc (Reid, 
I 97S1. The sugar rcsidues atlhe nOll rcdueill!'. lcrmini are usually (.(-lin k~d fucose or 
siali~ ~ciJ. with \h~ir amounl inveTs~l)- proporlional to each other, with the exc~ption 
of the ;V-acetylgalaetosamine. which i, ~t\ao::r.:,d to th~ pn,tcin core. jhe terminal 
sugms are gcnemll y ~-l inked (fib'llJ"e 1.2) (Gipson eI a/.. 1995; \1,/ i g!'.ins c/ al_ , 200 11. 
According to Reid (19781 therefore mllCins are tkscri~d as polypcptide chain with 
th~ oligo>i1cehmide emits attached to e,-ery thim amino ao::id ami projccted 10 gh-e the 
mucin:; a bmp bmsh or a le st-lU~ brush lik~ SIruCI",r~, 
C. ,.Lp'" 
, , 
o I<-.. ,-.i"",,,,.,~< e,,-,,-': 
• f' ."'.....,. "',""' " .. . ~~., . 
• O' K'''' 
Fi~n"e 1_2 [)i.gram m~li< rc~r<.cnt"lioll5 "f {~. fil e ,uga,- uroit, or ~ ",,,,,;n. jll ,moe'", 'h e 
N_,"c'y lg, lach"a"';ne i, ""ually anaciled or ().linked 10 ,cri"e or ,hrw,, ;r .. "hid, i, ol oo",,,.d hy the 
oddi,i,," "r ~aj""",,,, or ,\' -oc tt) tgluco ",,~ in._ FLJrt"er term i"al ~lyco'Y~lIi<)n (}CCll" hy 'he aJ.:j ;t ion or 
fue"'c. ,ialic ac id or " ,Ifate "nd hlood_grOLJP dclcrminarll'_ LOll." " alld d rep"' '''"'' lun g muein_ b 
porc ine ,ubmaxillary mucin, C o.-""i," cyst fluid mucin ",ilh 1",0 Le' blood g'oor determinants anJ" 











1.'1 Bio ... ynthcsis ofmucins 
'vlu~il1S bi05ymhc~b i~ r~)X'nt"d to stan in the nucleu5 where the mudn or MliC gene 
exprt"ssion is activalt'{i by 111~ transcription ra~[ors ilnd transl8ted 10 MUC prOkins ill 
th~ riboS0me~ (Phdps. l'n8; Rose <Uld VO;>110"'. 2006). Subseqllent to the ,V-link~d 
g:ly~osyl8lion in the endoplasmic r~ticulurn (P;1Il(>Jl d ai .. 1'195). 0- glycosybtion of 
the MliC protein bad.hol1e (><:"u r~ in ihe ~is-Goigi apPJfatus (Liddl cr ai" 2006; 
Za!cwsb. ('f ai, ZOllO), A'-acelyl gaLiclo~alllille addition is ~tep one in the ~;>nthl'si~ or 
(I-glycilns ami pr~<:~des elongatioll (J ,eikaur ('/ at" 2002; I idell d af. . 201l_,)_ The 
t[,~Jl~f~f of N-;1<:dylgala<:L<.>".ulline i" rcpwled 10 lmliate th~ wbsc'lucnt additio~ ,,( 
hexo,es and/or hC)«(>slltnl~es to I.'ach gl}(.'Osylatil>1l site (O-glycan) by a 'CrIC'S of 
g:ly~0 8y ltn!ll Srerascs ill a ,t~pwjs~ marlllLT, Finally thc I-LIlly glycosylated or mH/mal 
mucin is 111>red in secretor} grmlliles until mucin 8~ncti('n i~ trigg~r~d by d1l1C'f 
internal Of ~xtcmal Jitck>,s (l'erez,V,]Il' Qnd Hill. 19'-19; RoS<.' and V'oynow. 200A) or 
trallspon~d to the plasma memhrdllC (Iigml.' 1 3) (Palloll d al_, I 'N5 ). 
"-"'"'I"'''''''' 
Figure I.J f)ia~""mroalic ,ep""<nl~lio" or ","ci" bio'yntb •• i •. TIw mucin or IdUe gene 
.~ pre"i()n i, inili:>!cu in II," nucleu, "nd T"n,I"led 10 MUC pmtcin, in ,i0080[""" SubsequenI1o'v. 
lin kod gl)co'yknion in 'he enoop lasmic Teliou l,." "nJ IJ- gl}"ocyJmion in The ci,.(;olgl app"':>!u,. 
furthe' glycosyJmion i, in iliated hy glyon,yh"'n, fo,,,,e ,_ Ribo","nes. emk'pl a,mic reticulum "Id 
glyco,ylr",nsfe ' '''.s "TO rcp, o"nl«l by (.)_ (Ut) 000 (GTl respecTi"ly (r<['f,xlucoJ from Rose "nd 










1.5 I'hp ica 1 properti'" of In udns 
BilSt:d on its sensitivity to cnzymatil' digc'stion a rnl1<:in is divided into 1\\0 rcgi"n~ 
namcly. th~ gl}"o s} J~Ie\j ~nd nongl y,'os)' l~kd (mk:edl rt'gions (R~id, 1978: Sellers el 
"f., ]9gR). Whik toc g/yn>s)'lalc'd rq;i<m is ~haracterized h)' a numocr of t;mdt:m 
r~r<:'Jls rlch in socrioc, threonine and prolint:. Ih~ n~ked region is rkh in ostci ne and 
l'ontains low amounts 0rthrt'!min~, seri' "",, and pm l i n~ amino adds (Creeth. 197);; 
Wickstrom ('I ai" 19(8), The amioo acids 0r the protdn hal'koonc in th~ gly"osylaled 
region is protecttx! from enzymatic digestion by the carbohydrate units whcreas the 
nuktx! region is very susceplibk 10 a variety of enzymt:s such !IS pt:p~in, IT}'p~in. 
papain. and pronase (Figure 1.4) (Credh. 1978; Godl et al.. 2002; Liddl el al, 2006: 
Tabak. 1995; Wickstrom e/ al., 19\1);: Wiggins el "'-, 200]). In toc prt:senct: of 
reducing agents slich as mt:r~aplodhanoL dithiolhr~itol , and ,V-acct}lcysteint: the size 
or mUl,ins is rcportex\ to de\'-Te~St". which led [() thc suggcstion that the dis"liide 
bridges located hct,\-,et:n the mktx! regions or mu"ins may maintain m""ins m 
multimcril' form (Allen, 1981: Pere/-Vilar and Hil L 1999: Tabak el al., 1982), 
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1.6 Mucin purification 
A~corJing to Crceth (197S) mucin, can be separated irom non-mucin emnponent, of' 
the cmue mucus seer~tion, either hy degnKlativ~ Or non-de""",,dative methods. Vihilc 
methods such a~ proteolysis, thiol rcdU(:tion. 'olllcation and extmdion wilh chilotropic 
reagents arc degraJative one~. ,ol-gcl sepmmion ilnd homogenization, \I~l filtrmion. 
ion-exchange duumlltography, affinity chromatography and equilibrium den,ity 
b'HIUient ultra-centrifugation rcpresent the non-degmuilti,e methods. Of th~se methods 
gd filtration, ~quilibrium density gradient ultra-ccntnCligation and i()n-ex~hllDge 
chromatogl1lphy are found to be the most 5uitabk methods in muein isolation and 
purification (Allen, 19~1). These lDethods can s~parat~ mucins from non-mU(:in 
~omponen(s ,mch iL' protein" lipid~, nudek a~ id, and ~nzymes bast'd on their siz~. 
den,ity, and ~h.arg~ di ITeren~e, re><pcctively (Allen, I 9S I ). 
According to Alkn (J981) gel lil!ration or siz~ ~xclu sion ~hromiltography ~an 
partially pLlrify mucin' hy dLlting th~ larbocr lDokcular wdght mucins in the excluded 
v()lume and the smallcr molecular weight wmponenl, in th~ includ~d volume. 
Cae,ium ~hlOlide J.:nsity b'l'adicnt centrifugation which i, a \,idely lli<CU purification 
method " ~apable of ,cparating lD\lCins at a density of p - 1.45-1 55 fwm lower-
densit> malelial (lipid and protein) and high~r-den,ity miltenal (nudek acids). Ion-
cxchange chromatography C11D also separate mucin~ according to eharb>e. Furth~nnore 
sodium dlKle~yl sulfilte polYilo)lamide-gd ~kctmphorc,i, (SDS-PAGE), whi~h 
separates high molecular 'weight mucin, ii-om smaller size protcin, according to th~ir 
eledrophorelic m()hility, i, a),o a routinely used method in mocin purilkatiun (Pa!lon 
cr at.. 1995). Illlwev~r, their larger size, hlgh glyco,y lmion and viscoeiastk nature of 
nlll(: ins make their purification very difficult (Ros~ lmd Voynow, ~(){)6). 
\,7 :Vluciu genes and classification 
Uased on thdr amino ilcid seqllen~e, duuITlOsmnal localization and form. hurnan 
mucins are classified into lhree da,:;es namely: gel limning ('VfUC2, MUC5AC. 
MUC5Fl. "lUCri, and M1JCI9), 'oluhle ('VfUC7, MUCII. lmd .'vIUC9) and memhmn~ 











MUCI7. "Old MU(20). 0" the " tllo:, 11.111d I1mci rL' su.:h as MUC I4. M IJ('IS and 
M ile II( do flot h,I\"O: tanocm repeals ami rr:m ni n unclassified (Godin til .• 2002~ Lidell 
1'1 Df. 201)3; \ll>'lillU.~ el ,)/ . 2001. Rose lind Voyn"w.1OO6). Wi th tht' t'x~qlt ion (If 
MUCI ~. "hid , r~ localized on chmllll>'-,{)1l1t' I2q l2.toc l!cJ formin~ nn-.: il"lS \MtlC2. 
MU('SAC, MUC5U. and M1IC6) "rc l ocllli~t(t "11 chrmn,.,sllmc llpl5S Th.: s..,lllble 
'lIur.;ins MU("7. )o..1UC8. and .\IUC9 an; I<'!.::.li/cd on ~hromos01nt' 4ql ).y2 1, 12y24 ..1 
:1Ix!1 p 1 J r;;sp<·ctlvdy. Of thc mC111hn.llIC hmmJ nru<.:1l1 s . .'viI 1("3/\. M I TCJU, .\IUC J 1 
or MOel 2 ,,00 Ml .'C 17 arc l(lCali7cd on ~hnlmo"'-'m~ 7q22: Ml )C" and MU('20 on 
chn.'mo""m~ 3'12'1. MUC I Oil chrom(lso' n~ Iq2 1--q2.f ; MUC IJ on c-hrO'I\O""mt' 
JqJ 3.3 and \IU("16 on c hromosome 19'113.2 (Ros.: and VO}lIO\~ . 2()O6). 
I. 7. 1 s..~rccnlllnd gd rurmiflt: mud,,,, 
The sec 'e!eil lind gd fimnin g rnucins (MUC2, ~UC5AC. MU('5U. MU(" b. ;,nl.! 
MUC"J9) urI: lhe largest in sizc Jnd luove \"is~·""lastic propcrtie-s (lioliingsw<.lI lh ~nd 
Swnnsoll. 2004; I.agow «I aI . IQ9Y: VlIn S~uni"i,(en ~i a/., 20(0). Th~ir protein 
bad;I\i.'11I: IS ch:ll":Jctcri7cd by a m,mixr 01 umdcm repeats Of O-gIY~"Q<~'l al i()n sire! 
sccpara!N b~' C)"Sk inc-ri<."h domains .. \1 the- mmther of l3J1ocm re-pe-au ~I!d O· 
glyn>:;ylut inn ~ it"--~ arc directly pruponi(mal . ~ithcr (If them ma y inf1uc:nc~ thl: .~i7" " ," 
lh~ . .e mucin_ (RO>.!.' and V~·no,,". 2006), Thc c)",>leinC"S in tho: C-I<'TlTlin, ,)f lhese 
llllldn! a,"", chouJ; ht 10 inducc pnl)rTl("1iz."l!ion via lho: disulfioc hoods (Lagow ('I (1/ .. 
19?9; Van s.,uningen e/ al . . lUOO). whj(:.h ~onCribul~s to locir larJ.:t' sil:(' unl.! gcl-
forming f0l111S (Figun: 1.5) (I cikauf «I (1/., 2002 ~ RoS<' ('/ al .. 20ll l). However. th~ si~c 
und tIl<: ~I) c"sylation pattern ofth~so: mild". is tissoc specific or I.!iff~r from li ~~ ue t" 
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Figur. 1.5 Dia~,.,."'mati< r<pre,eNt. lioN OfK .,udN ,trlJomr. (r<pr{Kluc<rl frOln Ro .. "",I 
Vo~·" OW, 2(06). 
1.7.2 Mcmbran~-b"und mueins 
The membranc-bound mudns (M1.X I. \'IUC3A. "v1 UC3 B, \.11 )(:4, .'vIl JCll. Ml:C12. 
MUC13. MUClli. MUCI7, and MI:(,20). which contain short c)1oplasmic rails in 
il~s , ><:ialion with the ~)·to~keklal ,md c)1osolic adaplOf proteins arc bound to c ~lls b)' 
an imq.'Tal t ransmcmbmn~ domain (llollingswD rth und Swanwn. 2004; I.eikauf el al.. 
2002; Kose and VoynDw. 2()()(ij. Th~y arc normally pr~s~nl in lillLr di~tinct fonns 
numdy; m~mhran~-imehored, <;Olllhk, scereled and th~ tandem f~pcat array. Whilc 
lhc wlublc form is asslUlled to be Ih~ fragillent of th~ mcmbrune-bollnd linm as a 
rcsult of prol("olysis. hoth lhe ~crctcd and the tamkm J'ep.:at array ar~ r~)XJrt~d 10 b~ 
lh~ alkmaliv~ spl i ~~s Dr variunts (\10niilux d <11., 2(01). Varialion in environm<:ntal 
iactDrs su~h as pi!. iDni~ cDncentratiDn and hydraliDn ure r~p<Jrted 10 ac;tivale the 
reka~c of 11K, ~xtraccllular domains from Ih~ edl surface which might help in thc 
ckilrimc~ or slLTfa~~-ass<><.:ialed mok~ules llnd~r dimcull environmental conditions 
(Holl ingsworth and Swanson, 20(4). Furthermore, like the epidermal gro\,1h fadDI' 
(FGF), lh~ir J ux la-m~mbfilne dDmuin may pby a signiliciml rD le in reguLlling the 
n)(:ehani~ms of g]'(",1h. motility. differentiation. inflammat ion, tUlllOW' cdl in\'a::;ion 
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~igurc 1.6 Tht' rok of m<.,br~n< bound mucin, In d.{rr!in~ ... d r.~.I"';n~ env;,owm.n{a l 
fa<tOl",_ A} I" ",Idil ion 10 li>cir mi. as ",ccplo," f,,,- bio~)gical [)x)1<ocLLb such .. -;. leai''', sigl"" •. 
",Iec lin" iKMw,i()n rnolccub_ and b.c{.ri a. ","mb.-an" boLJlld muci", coo als.<> ()-,le<t <h'I"~<S in pi !. 
hyJrmil>n C>r oxygen"lion. B) 'Ih"" bil>logicol ",>;:I "n ,ironmenT.l fact"'" induce uJoI11<>rTll., itH," 1 
d l""g< i" the mernb,on<_Tdh er. d '''bOlni' , pl>:),ph"'ylao;i,,., "rille cylop l .. "" ic <l<~na,". cxpo;;"'" of 
,c(iv< (Iorn"i,,, ""d r<cruirmefll or ,igllal.jTaIk-;dll ci ng m<,t<'GlJb_ ~pidermal growth fuetor and 
ep;u.:rmal growth rac~,,- 'CC~P'O,,"n.: Tcprc"'llL~d by EGF mid ~f(UIJ "";peeli,o l)- (roproo"cod from 











1.7.3 SNn'led and nOn gel forming (soluble) mucins 
Compare'd to Ihe mcmbrml<' bound and gd limning mlK:in" th~ '~nded and nOn gcl 
rnnnillg mncins (MU7. MUC8, and MLl(9) arc smalltr in siz~ and possess simpler 
structural orga"lz~lioll (Moniaux <'I a/., 200T; Rose ~nd Vuynow, 2()06). l ,' nlikt the 
gel forming mu~ills. 1 hey also lad: c, Sl~ i nc-rich dom~illS, Ilowe\'er. I ik~ thc sccr~l~d 
and gel lonmng mocins, they arc px~ed inlO llILKOU5 granules ~nd ,ecreted to th,' 
surface to t,mn a mucus la)-'~r lhat proL~~ls the epithelium tissues from hath physical 
and llIe~hani~al ra~Lors (I ,in el al.. 20(1), 
1.8 Human .aliva 
Saliva is a dilut~ secretion of the oml CIIvity pnxlu~etI b)' Lhree major glands, th~ 
parolid, sllhmandihullll', and sublingual. induding Ihe smal k r gland, such a~ the 
palatal and labial exon1nes (Pmkobpl1ol e/ aI., 200S; Thornton er al., 1999), Dai Iy, up 
Lo IS00ml orhu""'n saliva (Zalcwska et al" 2(00) containing ~yslatin;;, prolin~-rich 
prokins, prolme-rich gl)'coprotcin" carbonic anhydrases. fl<'roxidascs , stmiK:rins, 
hi,tatins, lactofcrrin. lysozyme. secretory immunoglobulin A (s IgAl and mucins is 
r~ported to be soocreted by these glanJ~ (Prdkohplml e/ a/., 200S; lZamasuhbu er <11, 
I ()91), Th", muo::ins. \\' hidl ",mlStituie 26% of lh~ tOTal sa lival)' seneliun, aT<: jJrodu~ed 
by llILKOU;; ~dls in Ih", gland;; (Boischer er al.. 1<)95: Klein e/ at" 1992, Mchrnlm d 
ai., 1998: Zalewska fI <1/., 2(00). In ~dJltion 10 lh~ high concentration of nmcins, the 
'Ilhmandihubr ~nd suhlingual glands ~ontain higb levels oflyso/)'llIc and 9'stalin S 
At the sam~ lilll~. lh~ palatin,'. ".hieh is anOlhcr .>Ourc,' of mucin. is repon""l to 
COnTain high amounts of amylJse, \Vhereas the raroliJ whkh ~onlains high atnounts 
or amylase, proline-rid, prokLrI hand~. q ', tatin, and lysozyme. it l a~h muo::ins 
(Ve<,mmn cI <1/., 1996). 
1.9 Salivary mucins 
Human saliva j, known to conTain, amongsT many other ~omporlenLs, two 
carbohydraTe rich mucin r"puiaLiorl s, r1~mel}' 'v1(il and \1(;2 (Thornton e/ al. 1999). 










g.:n<.' {J h","WII ,,/ "I .. J9<lQj. J h,., 1I111,"tl is ", .... o f ti l("" mo~t wi,ld\' distriOOled "1I "' 1I1~ 
rb Ul ld 111 Ih" ,>!,li'<I. respira,ory and .h" ("'M !.: n.'1ItO"ucl'~" 'me.s lAf~Uo..'S" ('I <If •• 
~(lO2; Thoms-'un n lIf .• :?002j. \ 102. which i~ :, 10" lIIo J.,..·lIlar weight llIuem I~ J , -
J 2(1. ()()IJ) is CllciJ<ktl hy ,h" 1..1 LCi ;;CIlC (Thormon ,,/ .,1. 19(9). Unl i k" .\1 UC~ II . ;1 is 
101.111\1 ,lilly ill "il i .. a (T~ '~nS '<l 1l ,'I "I .. 21>021. !3mh 1Il1lClll' arc '''poned IU cl iffer 
~ lrl,c!lIrr. II )· ,Illd ftl ncti()n,lIly (Thurn!" i' III III.. I\I<I \!; Tl"O:dcr ("I al. . 19951 ~!\d :"U"" 
'y lllh ~,izcd by differcl11 ccll ~ of the sa livary g l .l n d~ (Z:ilcw~ka ('/ al. . 20(0 ). 
Sah'ary .\1 [;("5ll,s 011" o f the <.CC~R'd llludllS with p.:pti<Jt, suhunits l",le,1 through 
Ih~ ,hsu tlidc b,)",1:; to fonn J evmpkx ">!ntc!trr~ lH"lIll1g.~worth and Sw.m;;uu. 20(~). 
S~"\:rt:l"tl h) all th~ 'ailvilry !! I "nd~ eHepl .h" parolid •. \ILCStl is IUWWll t" c"lll"in 
19"" pmtein and 81 % r;lrboh y"r~l~ (Tholll ~S" Il .:1 " I., 20()2; '1 roxlcr N lIl .. 19':15). 'I"!tc 
I'r",,,," ,o of mure than o"e char/;cd ~ LLh roPlll at i o!l i , " ~'0c ,ated wilh ti ll: pr~~~ncc of 
Ml :C: 511 glycufunl1' (RolsdICI' ('I al .. Iq\!5: I'rakobphol ("/ al .. 2iJ05). Th~ 
ca,bohr-tnt te ",oidi" , o f thi, mlldn ar,' !\'po "' ~d to phy J ell/cial 11.) 1 ~ in the 
a~grcl!" 4;"n ami ckarann" of b"r' ~rt:. 1. fUTI;!,!1 and tu~k p.uho!!"lls frum the ,mil 
ca' ny (Kle,n "~I af .. t <)')2; Tho",." " /!f ,II . I 'f'}iJ: Vet.' TllaJ1 n al 1991). FUr1h~nnorc 
ML'C5R is al", .... purted 10 aggrcgatl' or 'J'''~l il ' '' lc \ 11U"" ..... ~I!eh a.~ 1 Il V II ho.ns~. '11 '" 
11/ .. 2002). 
1.!oI.2 SaliVllry MlIC7 
pt:I'Tldc ~hain ~ Ild Ie" h~lCr(og~l1":I,)l,, 1 y gl )"~""y ll(~'d (tI"{SdK~' e( a/. . (9<19. I.U):!,, " '" 
al .. I Y')9: Si,,, "lid A<.lbek. 2000). S<"Ctl:t('(1 by WOm'" 1diimlar. ~,th l i"gu:l1 all" l)1liaUll<' 
~"II\·"r) gh!,lds. ML'Ci is rcpon~'d tu c, 'lIt an) '>0";' prutc-ill aOO (,go" \·~rt-;,h)dr:uc 
(Th"'ll~~11 n <II .• !OO:?; Tm.~ l"r (" ,t! . 1 \1'95). Thm f~r two !!Iymf"nn' Qr MU<."7 
Ilamely .\oIU/a a,lIl MUCTh wilh simiillr ,11l1"''' ac,d hilI diflcr..:llt sialir "rid ,,, ,,I 
lilCIl>C "l1Illlh)l:il;,JllS are reponed to ~" lS l III hun"'l l "1liy:t {Holscher ('/ " I .. 1999: Lu, 











Despite its smaller size and simple >trtlerurc, 'VILle7 is reponcd to pos~e~s a strong 
activity against a number of roetemll, lungal and viral ~!rains (GururaJa er a/, J9'f9; 
Soares «/ al., 2003). S()ffi~ of tilt' ~x"mples includ~ inhihition oj' Streptococci. 
PSO'lIdomonas aaug;no.m, Slaphy/ococ'<'!Js aureus, Streptococcus gordonii, Likenella 
corrodens. Streptococcus mutanl.)', PorphYl'Omonas "in"ivalis, Candida alhicans, 
Candida glahrara, Candida krU.I'ei, AclinohaCilius aclinomycetemcolllilanl', 
Saccharomyces cerevisiae, and Crypt()i'O"cus neojormans (Bobek and Situ, 2003: 
loomis e/ aI., 191-:7; Situ and Bohek, 2()()O: W~i and Rohek, 20(5), It abo pby> a 
~ru~ial rok in the inillbitioll nr HIV tral1>mi~siol1 thrOl.lgb sali"a (Monial.lx el ai, 
2()(11 ). 
1,10 An li-H I V acti>ity "f crude human saliva 
Most IIIV inj"~ted il1dividuah arc reported to be susceptible to mal infectio ns such as 
mu~o>al and gingival Icsion~ which might cause blood sl~dding il1to the orill cavity 
and opporll.lnistic diseascs such as gingivitis and ~andidia'iis (Shine e/ al" 19%). 
Hown'~r. despite the pm.sibility 01 blood shedding and vimses into the oral cavity, 
",s~ar~hcrs arc yet to provide credible niden~e amm! oral tran\mi>sion of IIIV 
through kissing. <.lemallreal"...l1\. biting, and aerosolization (Bmol1 et aL 19<)9: 
Bergey et a'-- I ')94; Fox el a/, 1988; ( joto et al.. 1991; Il-lalalll1.1d eI aI., 1493; ,,<asar 
Qme~hi eI al., 19<)5: Shine et ai" 1907: Y~h et af" I ')9~il, 19<J~b: Ycung et al. , 1993). 
I' urthermore. despil." the rn,1."clion of "i ral proteins or sequences hy polyn.,.,ms~ chain 
reaction (peR) in saliva. severul resear~hel> haw i(mnd thc vims 10 be non infectiol.l> 
(Bobd\~r el ai, 2002; ~agashUlmll1gam e/ aI" 1997: Phillips d al __ I 'f94: Wahl et al.. 
1<)-,)7, Yeh el ai, 19<J2b). These reports have led to lilt' ils>umplion lha! saliva may 
contain a ractor or factors lbill inblhit HIV infedivity (Archihald and Cole, 19'Xl; 
Shine et ai, 1996). 
Sevcral ~llIdic~ have continued the iindings ofFulU (19)(6), whi~h demonstrated the 
inhibition or JIIV-I activity hy hl.lman crude :>:lliva in an in --.-ifro inhibition a>say 
(llergey e/ aI., 1994; Kennedy el aI , I99R; ~lom'c e/ aL 1993), In illl tl~,., sludie>, 
IIIV-l was treated or incuhated \vith human crude >aliva at diflerent lime points. At 











n 0.45,[[11 pon: size ceUulo.1.e a~elak filter pap.:r (25mm di~mcter) and hoth th~ 
untiltered and Illler~d sampks Were added 10 Ih~ CD4+ cells al1d incubnt~d for 
ditT~rem lel1gths. SubS<'quem 10 wa~hil1g lhree tim~s with PBS. !he cells were cultur~d 
in RPMI 1641l for S<'veml days nnd yirul rcpli~aliOI1 wus mensured or monitored hy u 
rnunhcr of ussays. These C1SSilYS include: lranscriptal.C a~livily. p24 unligen lev-cis nnd 
monilOring inhIbition of syncytiu rorm~tion via TCiD,,, (\1alamud d at" 1997), 
Thus Illr most of these sllldi~s h~\-e dcmonSlraled!he preI.CTlce of highest anli-HIV-I 
nctivity in subm3lldibular and whole sali,a compared 10 the sali>-a from thc parotid 
glnnd (Arehibnld ~nd Cole. 1990; l30lscher er at" 2002: Mulumud er at" 1993; 
N~gushunmugum e/ al._ 1997: Wu el at., 20m j, llowner, the <;peeilicity orlhese anti-
IIlV-I ~genls is ~mong lhe debaling poinl.l_ Ac~ording to Fox er af. (1988) ~nd 
N~gushunmugum e/ at. (1997) human .\aliva :X,S.<i<::SS very low activity uguinsi virus~s 
such us h~rves simplex nrus (HSV), HIV-2, simian immuno:xlcfidency virus. Ep,tein-
Burr virus. cytomegalovirus, hepatitis B virus and ndenovirus, This hus kd to lhe 
sugge~lion thm the aTlti-HIV-I agents mny possess some ~pe~Jlicit] against the virus 
(Cromhie e/ ai., 1998: Kenn~dy e/ al. . 1998; Nagushunmugam et aI., 1998: ,\\-'u el al. . 
2003), 
V,'hile Berg~y e/ al. (1(94) demonstruted a mnximum unti-HIV-I activity of the 
humun submandibular saliva spccific~lJy th~ mudn ri~h rr""tions. Rohinovitch e/ al. 
(1')<J3) and \1c~eely er al. (1995 und 19'11) reported the ami-lIIV-l m;li,ilies or 
proline-rich proteins and s~'C]'ctory Icuko~yte J1rot~a.'" inhibitoTs (SLPI) resjX'Ctivdy. 
In wntmst. Turpin eI ai, (19%) dcmonstrutC{j the failur~ of the secr~tory leukocj!e 
proteu~ inhibitor to inhibit or aggregaloe HI\, -I particles Bolscher et al. (2002) also 
demonstrmed the failure of 1I1V,I inhibition or aggTegmi(~l h]!he parotid sccr~tion 
which lucks mucins. Meanwhile th~ pres.;,l1<;e of ami-HIV factors in suliva of mv 
negative und positive i ndi vidunls ulso ~xdude the pos~ibl~ role 0 f anti-HI V antihodi~s 
(M~lwnud e/ "I .. 1997). All these lindings mooe!he macromolcculur ~ompon~nts or 











Ilulllan ,.a ll,,, I ~ reponcd 10 phy.a ~ i gnlli~"'"1 ml ~ in th e aggrcgd lioll a[l(l .. kimll1<:~ of 
pilt~' gell i r Lllirro- orgJl11'111 ~ InciLLding HIV frOll1 The oral ravlly hy s,,'allowil1g ell 
apt'domlioll, \l'hi"h may r" , ult in docr~"sillg orJI tr.all~ rni '.\ ion or HIV (~,jJIJmlld CI 
"I.. 1,)~.1; Yeh N "I., 1,/<)2a ), rhollgh the allli- I ll\' ;~<:ll \' ily ()f snhva is I"giles l 111 
hUll laTl slLbll1Jl1(hbul.n"sublingual (HSr>.lSL) ' '''T~Ti()l1 s. their fil(ration pnor t() 
i,,~ub"(lO" \l'lIh I.h c v"u~ l ~ ~p~)rt",1 m reduce Ihl'" a~(I\' l l ,' ~ i g l1ifkimtly (Archibald 
and Cok, 1 9(~l; Clll lnb l ~ <'I al .• I~')a: Ma lallLud 0'1 al .. 199.1: "lagashulllnugam cI cd 
199N. Shin~ ,'1 ill., 19%), This hilS "'d to tile id".a th.at Ihe virll~ Lllay bil1d to ~h e high-
rnole<:u lar \I"'ight sa l"al}' cOlllp~lnell1.\ and form.a m.aCt'(Hllo leuLi.ar ~olllp(lsite whi~h 
IS nc ludibk by filtratloll thmLLgh 0 45~!m pore size tlit,'r paper (Archibald .and Cole. 
I U'XI: "agaSllUll lllUgam <'I ai, 1'/<)7: Sllllgars and Wall I. I ()()8 : Shugars CI u/., l~()<)), 
I herefo rc 011~ OfTh~ ObJ ~(Tl\~~ ol'(h~ pre",Tl! s ~lLdy IS j() purify .'a ln 'Jrl ' nlm: iTl ., Ii-olll 
I llV n~g J~ive and p(h l (i,'~ 1I1di, ,dual, and delemlLlI~ the ,r all il -HIV - I .al'l l"ily. 
1. 12 Hyp otonic nature of ~a lj\,lI and I~ 's is of III V inkrll'd m unuTlll cknr 
Il' " ko,'ytn 
As stated in til~ pre\'iou~ ~~(t i on (Sec tam 1, J 01. desplle I.he po.'sible ., hedllmg () I' H IV 
lI1fe<:l~d hl()od iTllo (he mal cavHy e,pedally dlLring muc()sal and ging ival lc~ion~ or 
dentill treatlllem (Sh inc e/ aI., I ~%), thus fm' the presence 0[' mfoctiou., \'iL'Us~s i~ 110l 
c()nl i l111~d (Bo I 'ch~r e / ,iI., ~OO~). ,\ccording 10 Bal'On eI ai. ( I \l9,)). unlike the YJg.i nJI 
JIllI seminJI flu ids whIch ((llHain >~Ir};' in ['e~(ioHs "ll1~.,e." sali"a IS deiici~lH Ln or 
~()n l.aills very Ill\\, amOlLlH « I',,;,) or infectiom vilUs~s, r\ll'lhermor~ Llamn <'t ai, 
( I <)~<)). dCl11011s:ramd Ilw lysIS of H IV in leLled ~ell sand ",I"bi( i()" 0 I' vmLl ~Lli VI (y by 
so lullOns which con(.ain tile ,ame <,;lit or ion conc~lHration a, s.a iiva, ThiS finding has 
led 10 the hyp()lhl"Sis tl\;ll lhe hypo(oni~ na(Llre oflhe sa li,'a may Iy.,e m Hla~li"a(e lhe 
Il1le~1 e.:1 1I1()llOnuLieM leu kocyle, whic h sh~d into the oral ca, ity (\,i II el ,,/ __ .2003 1 and 
prevelH HI V transmiosion (i3Jl'On <'I al,. 1 9<)<)). 
j\~~mdillg 10 B.amn eI al. (1999). I ys i ~ of the HIV int~Clcd mononuclear leukocytes 











'rilhdi~l ,elk On Ihe ,'Ihn hal ML 111 lli~ ,-a l.';",al ~)I \"roJ m'cn l whidl i~ IM'Wn,,- '" 
nalure. tlw IlIV infected monollud~ar l~ukoc}le~ C'OntlIlll~S 10 h~ mla,'l wllh the 
abll'Iy 10 attach 10 and infcci the HIV rl:sj~t'11l1 ("04 n"gal'v~ ~r' lhdlal ~L·lls. Thl > 
re,uit;; 1)1 pe l1('TraTiol1 of The cpithelial layer ~nd infcctiml of thc s ub-~ plIheila l HIV 
>Cl1s iti\ c ("Tl4 I}I)"II\ C cel l,. t herefofe v iable IIIV inf~ctcd Illononllde~r ieukO,}kS 
ar" req'lIrcd Ixoth tor the 11l1acbn.h~nT and penctfaricln of the cpnhdial celb al lhl' 
mH""al , urf",es prior to il1 tedion ofth~ sub cpilhd ial CD4 pc1Sitiyc cdls. 
l3 ~ro n el ",i. ( ISlSl9) aho reported lhe abi llty oi" l,olml1, ilwus su<:h a, blood. >cmlnal 
fluid ~nd brc~sT milk, to chanf!c Th~ hypoLOnLC nature ofsali\'a and prncil l Iy'" or lh~ 
IlIV infected nwnonllckar leukocyte;; by s~ liva. 1'01" ex~mplc scminal t1uid ~nd blo(Jd. 
at 'oI Lune~ >J,~ll1 1 anu 4,5111 L are reporteu 10 hc sufficicnl to mlldif1' the hypotonic 
mlLlre of' >ali\·" and prole<:t the pos>lblc l1'si~ of the H1V 'nfe,ted rmwwnudcar 
lelLko,'yl~', C,""e'lu~Iltly the HIV 111re<:led ll1onoIlu,lear leukoc}ie, 111 lll<e '~mmal 
fl uid and blo"d may bind lO a",i p"nelral~ lh~ epllbt,hull1 of ' 1 he moulh , pharynx , and 
oe",lpimgm during clml sex and dental tfcatnl<:ill . l'unhefmorc th(' "j;;,ou;; nature: Of 
thickness of tile scminal tluiu 1ll"1' pn.lt('ct the infe cted monOl1uclcar kuhKyt C> fi'om 
any p'h,ibk ~onl ad " ilh sali,a "hich c(lLL ld rC"LLII. 111 h:-l1(Homc lysi" OIl lhe olhcr 
h~n(L Ihe sn,ail volumc "flhe ,-asinal thlld is rcp0ried nOI tCI be cIlough to dl~ngc thc 
hypolonlC' 1 1 Jtur~ of I he s:<I i\.:, (Llaron e/ a/. I 'i~!')). 
Furthermore, l~ar> and ,." ,,1 ,~(:l'l1'OIlS wh ich an: "ot"mc ill nature' ar~ k1l<",n \(' 
I'wlcet dIG IIIV inkcred IDOt)()l1ucka r leuko,')1('S fro111 lY SIS thll s may ,allSC l 11V 
in fi:,t.ioLL' I 13 ~ron el al .. 19S1'l). Al the samc timc a ,'olull1c of ~ppro\im,lldy 2 ~5m l of 
hr(,<1,1 mi lk" l"CIXl[1<'U to ,'ha)1g:, Ihe hypo\Onl<; nalLlr~ or lh ~ hahln' sa liva duri n!; 
bn;a, l fecdHlg and eaU"e I ['~ n'lllis, i c')1 of III V inkdcd monon' Le i c~[' lell k lIC)1 CS from 
1I1V inti:,t ('u 1ll<.l1hc" to infaIlt> (l, lfson and RO!!cr8, 19x(,: Tlmy d <d, . f9~5: Vall de 
Pefre clal .. 1\.1\.13: Zicgkrel df.. 1 9~5). 
I.IJ Human hreas l mill.. 
~JumaJ1 brca>t milk i~ kl10wn to COl1 lam ~ number o f' l"",- immunoic-,gi,a l componenls 










1':J'J2: Wieder,clmin ,md I\e\\bllrg. 200 1). la~toferrin . (l-laClalhullIin. Iy.w/.Yllle. ~­
~a>Cln. secl"clOry leukocyle proI C,I ,e ,nh ibi t<>r>. lanodifucotetra( ,.,c , la~l(,-l\' ­
fu copcntao;;c 1. II and III and l11ono iil~o,y jjnno-l'\ -hexaosc III (1\ aareli ng e/ aI. , ~()O'i 1 
I'hese componcn ts aj'~ bioll'gica lly adl\e and lhe lr abi li ty to p]"()t~cl hreast fed inl;1 Lll, 
again>! l11l(TOOC,. \ 'irll ;; e;; . anci toxin;; " wcll d()(;lIrnenled (S~hrO'cn cl al .. 1':J'J2: 
\V leder,c hain ;mu "\lcv. hurg, 200 I 1_ 
I he protenivc funclion of t llese wLIlI",nenl, m~ lucic:; , he In hI bit ion of rota\'iru;; and 
S-fimhnn tcd E. coli by milk mllcin , inhibil ion " f' ~holera and lahile to~in, of 
Fw,'hcrich ia coli by milk glycol ipid, (Yolkcn d aI., 19'f2) ",,,I lTlh ib lilOn of 
Sli'<plO{ 'O('('1IS pnel(mOnlae, HafrllOphiill5 influ"n:ae and entcropat hogcnic E coli 
adherence by )lllrnan lJIi lk olig",.ac~handes (l\'c\\,hllrg "I aI., 1':J'J4), 13 rc ,l ;;t milk 
COlnpOI1Cllts nre ,llso reportcd to lIlhibil palhogeTls ,u~h as hcpalit" C. Fholii. 
c;tollleg,lIol'im>, Dengll c vinl'i, ;\Jycohaclaiwn, L"i"hmania, C"",lid(1 (11hiC<1ns, and 
H".'licohac/('I' py lori C>laarding "I ai"~ ~()05), lillithermorc, the lIlilk lI1llC in is also 
kn"\\'ll lo be u,cu ,I, p,llhologicn l mnrk er OCC ,Ill,C of its im'olvemcnt in mcta., talic 
p['ogrc,,;oll (OLl\\C and Cenam, 19H9: Hanisch N aI., I ~ 8 ~) , 
Despitc its protcdivc ['(,lc again.,t bactcriaL rungal and \mil palh('gen,. breaSl f~ed lllg 
i;; rcponed to bc respon,iblc I-or about 40% ,,1-lllC HI\' traTl.<m"sion Ii-om mother-io-
chi ld (Nmmling 0'1 "d, ~0051 Largc "'11(' lLnl "f fi-e~ ami ~ell-a,sociat ~ d \'irus~s. such 
ns infeded leukc K"tcs, ma(Tophngcs, lll,mml<ll)' epithelia l cclls ~nd CD4~ T 
lymphocyte, are ['cponccilo oc present III brca,t milk ,,[HIV ,nlcned lJlolhcrs (Ban'll 
0'1 aI., 19'19: Lepagc N aI., 19H7: l\aanl111!/ N aI., 2005_ limy er "/" 1~ 85; V,111 de 
Pen'c eI at" I (N3), /I., a rcslllt, childrcn arc most hkcly 1O oc expo,cd lo lhc,c free 
vinL,e, "r the in feLled cells wh,(:h arc ~apablc ofno"ing the mm:o,,11 barrier during 
b['ca.,t l'ccdlng (Ban m ('/ al 1\19'11_ .-'l.c ~ ordi ng lo "\laardill g er al. (~()O'il, ~-~ase1l] lTl 
the hrc,l,t mIlk i, known to f,l(: ilitatc the infection of CD4~ T lymp hocytc, by IlIV. 
Furlhcrmore a;; HIV has ocen 1.",bICd hum Iymphocylcs WlllCh ~an ['ca~h lhe' felu., 
vi,1 transplnCClll.a , HIV tr,111,m iS>l on from the mothcr to the (:hild ncro ,s the plnccnta 










HUlllim brCiisl Illl ik is knuwlllO ~Olliinn /I.'lUel '''hich i, Ihc m,ljor compon~Jl{ uf Ih~ 
lTIJ lk lill globule lllcmbnmc (\lFG.\1) (flll illn rr ill .. 1982: Kcen,m e/ iI/" 1970; 
Pclcr".Jn el a/ .. 19Q8; S~hrolell el a/" 1992: Shimizu ,l[ld Y,ll llaudll, 1982). Ull i ik~ 
Iho,e scneled and gcl lunTIlllg ur llOll gel lunnmg ll1ucms 01' lhc gil\l roiulesill"lL 
re'p, rmory and r~rnldll~li \'e lcads. lh ~ mlik mu~iu (ldLC I) IS a m~mbrau~ boulld 
mudn (PallO!l e/ fll._ 1 ~~5) ILl spi te "fth~ r~pnrl thm the mllJ.. Lllucin is pres~nt i nlh~ 
tilt glohule Lm'mhrarJ~ Ii-action (creaLll fraClio!lj, somc mClllhrane nssoc i m~d mucins 
are also reponcd to be pr~sent ill the ,kim fraction of the milk (Imam, er ,,/ .. 1')8 1: 
Pn ilesen el "/,, 2001: Patton. 10'l~: Shimizu el "I.. 1(86). 
1.IS.1 .\I UC I 
~'lUCI WhlCh l ~ loc,lled Oll chr<ll m)'Olll~ 1<)21 -<)24 (Rose ami Vnyrw\\, 20(6), is the 
mnst ""Idy di s lrib u t ~d humall mlLc ill "h i ~h is apr~ssc cl in many organ, or glnnds 
sueil as ill the LllQllllllary giwl<.l, lungs. pancreas. ga,trointestinal lrad, kidncy. bl,l(lder, 
~nd 'lmetrium, ovary and te,tc, (Lc ikauf el "I., 2002: Pcterson <'I ,,/.. J (98), In splle U f 
their idcntical protein eompoSilioll' or bilCk b(\ll c, ~11JCI iI] din"rcnllissucs possess 
differcnl glyco lllnl1S wilh tandem rep~als ranging hemceu 25 to 125 all<.l a nwlcculnr 
\\eighl h~1I'i'~cn 250-1000 kDn (Lago".; el ai"~ I ~'l9: Leikiluf rl 01 .. 2()()2: \10llhllLX el 
"I.. 200t: P,d k sL'll Clal" 20(1). It is also known lu ,onlilln :ill% carhohydntle (Patton 
('/ ai, 19'15)_ 
I . I 5.2 Bloch~r" leal com pu,; liun or .\'ILIC 1 
Lik~ nil the mcmbr,ll1 c :Js,ociiilcd 111 Ll C]I1S. an~r ,'" aJ ~l O-glyc< 'sylatiPLls in th~ 
cndoplas Lll i~ reli~lL l urn amI (in lgi apparaluS r~spccti\Tly, .\-lLCI i, tr,lll sporicd lo lhe 
plasma membrane viii tile mCmbrilllC' of the scn elory v~si dcs (/\ ltschukr ",I,,/. , 
2000: P,J] lOll rl aI.. 1995) M1 JC I is kLl'''' Ll by its high Plllymorphie chiimeteristi~s in 
Wlll ~h g~lI ~ll ~ \'ari ahi liti~s nre reported to ocellr on tile lllllllbcr ul' land~m r~p"al s_ 
SlLhs~'lu"ntl :, ] he two nlldcs illil~ ritcd from eiICh piirclll are rcp (\rt~ d In l", responsih l ~ 










lllore lhall one muc'ou bilnd I, reported (u prcscJl{ on (he' SDS-P AGE ([':Il lon e/ al" 
1995, PLlUOIl, 1999)_ 
"\e~ordi ll,..- 10 Pde"'"11 ,'I ,,/. \ I 'N~), thrC<.lninc, ,nine_ anu prolllle Llre reponed tu 
con<,litute 1\0'-";' or the (Lllldem repe:1l unils. Whi lc thrconine and <,crine provide 0-
glycu,yiation ,ile<" proli ne L,< (houghl lO ~ re,pon, ible fOI tl'le fo nnal iun 0 1- Lln 
cXlended rud-likc UL" fi laJlICTltouS ,(ruc'lLlre \dlidl n,e, illxl\e (he cc!l ,urfacc (l :igure 
1 7) , 1 hi, rod-l ike or filamcLltulIi< ,t L"lLctLlre" kn""'n (0 pldy il aUCli11 role III Ule anti· 
ddhe>l \ e rropeny of _\1 U C I during nW L'pho,~cne'i>. [[Llnour progre,Sl elll or me (<l,tdsis 
(M OIll ilU x er ai" 2(0 1), However. de,p irc thc pre,clJC.e 0 I' eysleine r~,idll~' [he ,i~~ of 
'vIUel on ::;OS-PAGE relllilins to be the sam~ both IInd~r rcdLLc' ing Lllld 1l01l-red LL elllg 
c'OIHl itio ns _ Thi<, exc'lLLdes the p<.">lb le bindlLlg of _\IL'C1 to u(hcr prol~ i n , via 
d" LLll ide hond (Pall"" e/ 01., 19951. 
1.16 Ilumull('(T\ icu1 mucus 
Cen,xal muc'us " kllowll to pl ay,~ cnK'i,~1 rule ;11 hum~n rcprod""live phy> wlogy hy 
pro\' iding prorcc(iun agaLll,t microbial cOIO l1L/a[lOn, Il lml 10', ilnd comrol llllg ,p~rm 
sut-,,'iviil and migratiun tu Ihc upper rcproduct[\,c ImC,1 (J\ rglie<,o d a/" ~O()2: ('LlriSledl 
,,/ aI., 19R2; CilrlS(~dt N ,Ii .. 1993: l. ilgow e/ a/" 1999), Thi, is reponed to be a('h ic\'Cd 
by prot~c't oug the >J"'l1n 1i-0111 the ilcidic ell\'irQll111~lll of (h~ vilglllil ilild filul itiili ng the 
tran,port of the normal and act ivdy mubile , pcnn cell> illio llic uppe.- reprudllcIl\'e 
(rae'! e'p"'t:ial ly dLL rillg Ihe pro l i l~mtiv~ phLl>e or Lllld~r lile illfluell('C of o e~ lrogen by 
,electively screening Ihelll from the abnormal and pourly [nubile spc,rm ccll s. Cer\'ical 
mucu<, i, LlI<;(, reponcd 10 prolec't ll", ,penn cel l, li-mn p l"' goeylo,;, (EI 'l~i" , 1971\)_ 
l- urthermore it, dilily ,c('[etioll of 20"60111g is al,o reponed tu prondc lubril'atiun, 
mhancc wc[ne"" p'-~\'l'lIl' dC:'<lccallon, inhib il> and pmmn te<, ce ll altac,hmelll, and 
minimize, enzj1lliltic degradiltion (Gipson cr ai" 1995: Idr is illld Carraway, IY9'-J: 
L,go,," ('/ a'-- 1999. Venegas ('/ al __ 19951_ De<,pl (~ Ih~ c'ontillLloLl> eh~l1ge 111 1llLleLl, 
vi,cusily thruu,~hout I h~ I11c,llstmal cyC-ic wh ic,h may a llu" pathugcn Clllmnce a1 (;rllc" 
,uch '" dLln l1g ll", pro illemti ve ph a,<\ mli llO ll<' of mino-orgill" ,m~ d:lll y are r~po r(ed 
























()· Iinked carb"hydraL~ 
"_ Ii r.ked carbohydrale 
Glycoli r id 
\lem~rar" 
d"nllel, 
( i I yo ,,<:al yx 
I,ip id R; :laycr 
Fi~Il'-< 1.7 Di,,~,-"mmali<' r<p,-<><"lalion of '\ILI.:I. lilL' n~Llj' ' ilo" , tl;" long and hi::hl ) 
gly'-O,}'IaL~d c,"a",llcdar wJ 11l",,(~L u lar "'~IT"'llts uf ML C I I '"1'J'o<lllC.d fr~m P,1"Otl ,'1 "r, I 995) 
1.17 _'lucin npression, in (he [I-male rcp"odudin' 1"ud 
Thus r" r elglll ",u~in 'i 'Lll'h '" \H JCL MIT4. MUC5AL. MUC513. /l- IUC6. -'lUC8. 
MLCY (Lagow ('/ al. 19\.19). atld .'vIULl (Gip>01l CI (1/" 1')97) a r~ reponed 10 b~ 
expl'c>sed by' the female repmd Ul'li \'~ lral'l (Lag'''' ('I aI. , IY99) , Oflhcsc \lUCI lS 











utem,. c,tr\'ix, and v~gi l\a. III addition to MUCI. Ihc hll m'lll ,'er\'ix exr r~ s,; ~s MCC4. 
\lLC'iAC. MllCSR, \ll }Oi, ~ll;Cg (I."!!ov,, cr "I, 1<)9')), "nd ~ IUC2 (Gip,on <', "I, 
I f)97), Th~ oVl(h lC'li fal lop iu1 ' 11 Lh~ a1 " I ""gil ,,, ~x rr~~'~~ M UC9 (I ."gow ('I (d" I 9f)9) 
and \ILC4 (W]ggn,<, d ai, ~ ()O l ) re"l'~,·tl\t1y III addilioll LO ~ ll }CI the ll l ~rw; also 
0 jl1'C'<'<'C<' \fUel> alld \ HJCR ( I,a!,:,)w CI ai, 19<)9) 
1.111 Thf dffc1 "r mcnslrll:l1 q-clf 0" th r fx prrs,io" or mucjn~ 
The qllailly alLd qmlll ily oflhe ('~rvi ea l lll ue in<, ~,'rrc,,~~d by th~ fema lc rcrIOd\lCliv~ 
trlKI i, r~pon~d to Sigll ifk'ln t1 y ~hatlgc dUl'Ing the J ,fkrc nt ph'JSl'S ofth~ lll t'n,rn"ll 
,'yd~ esp,,~i,1I I y ,h ll-;ng Ihe lll i d'l'rolif<:r'lti\'~ (n(lJH~~erl1\'''1 " ,,,1 [\ ",1·1111<:,11 
(rc~~l'ti \ d pi",,,,:,; (E],;t~i ll. 19n. Idri , and ( ana"a). 1m), DunlLf-\ lhe,e J iffcTCIlI 
rhases the I'hY""' I()gy and mucin '>ccrclio ll eapa,'ilY of the Jil1CICLl I regions of the 
f"male rcproJu('ti\"e Iran is knowll to bc inf1l1ellc~ d by or r~s r ond 10 src l'0 1<l honnon ~' 
diflercLltly, As ~ rcm lt these d i ff~r~nt reg,ons nJ el y ~'p ress the S Ulll~ mlL(:in,; 
d ifl<:r~ n tl y I I ,el gem ('I Ill.. I f)99). The glyc'o'yiuli 011 pat l~m. cSI"~Lall y I h~ a.ldl1 LOll or 
<'lIgar.; <'lIdl as L·tllcosc alLd <, iall e ~c id 1O ccrv;"a l mudns is rcported to be dctermin~d 
by the kvcl of gly~osyl tr'111st<: ra 'C a~ll\ 11 y which ," I'ha,~ dej)<'l1dclll. For ilL , lam'c I h~ 
pwlifcr;Jtivc r h~,e is c'harad~riz~d hy lh~ h1 g;hc<,t fllc'o"yl lramfera<,c a,'li,ity f()lIow~d 
by the oVlIlalor) rha<,~ and very low activity dlll'ing the lut~a l p has ~ , These challges 
may an"':,'1 lh~ compos ilion and flilKlion oftllC ~cnfical nlll~US du ring th~ "I CIl"l.ru~1 
cyck (Wiggins <'I al" 200 11, 
1. 19 Th~ role of C~1'\ in,1 ",ueu, in hirth c"nlrol 
An'ording to Yur~wia alld Mng;hi <'<;i ( 19H I), c~rvi"a l l1lU<:llS is rq lOrtcd to regub l ~ 
fenil iza1lOn by con tro ll ing sperm tral1Sp()t1.'llion IO Ihe Lipper rcrmdll~li\e [fac!. J\S ~ 
[~suh. abllorl1l,11 iti es ill the I'h y"~o~helllint1 c'()1 'Ipo, itio] L~ 01' lh i, <,ecrdioll throughout 
lhe menstrual l'yck may cau'>~ infcn il ity ( Arg il~so N al" 20021, For CXa1r1r!e, 111 
respo Ll ,c to i n<:r~ased levels of estrogens prior 10 l)\·u iallOll . the rn U~lI<' ~hallgc<, li'()m 
it's \";s<:ou, or j ~ l1 y mllllr~ to a W3l~ ry Il ll iJ anJ lil i, r~'li it ill milxim1ll11 s r ~rm 
pel1 ~trJ.bliL ly t() t!J.,; "rr~r r~rroduc li \c tITKt (Ldw,mb. I'ns: Gip'oll eI ai., 1997: 










e'''n tra''~pti \'e st~ro'(h, the hig:he r s~cretion of PWs~q"gcns ,ndllen vcry lb i,k mucus 
" l1i"h blo"ks 'P<'nll ''''gmli()n via the , crvi~ compic te ly (E,-ihcn c/ ai. , 19%, 
Y l1rn"o and MoShi",i, I 9R I; Yurew":7 i!I "t., 19),:7)_ 
The changc in q l1al i l Y and lj l1an l ity oj' tbc "~ n'lCal mucus dur ing th ~ d i fkrellt stages of 
the l1,cn,trl1al e'Ycic i, \Try h,gh For 1l1>lancC thc rate of c~rvica l mucus s~crc(ion 
in" reascs ii-om the approx n11"( el ',' 40mgiday in th~ ~arl ',' stagc of th~ pro Ii ferati \'~ and 
lat~ slage 01' til<' 11l(e,, 1 pb";;es lo (he approx ,,,,,,td.,- (iOOmg:iday at 111Id-'JTk (P"rk~, 
1975), Accordins (0 lh,s "'Llhor mal contr""c ptlv~ dnLg:> such "S chlom1ad l non~ 
acelat~ _ nocgcstrel , norc!M1l1drl)IlC and mege;;(rol acctat~ l)f lilc synlhdic pwgcslogen, 
arc r~ported to induc~ lhc production l)f viscOl1S l)f thick ccn'ical mucus which is 
rcsismm W sperm pcnetration , huthennore th~ lu tcal phas ~ i~ chara"tcri7~d by (he 
prcs enc~ of a l arg~ mucus plug in th~ mouth of the eerv ix c>pccially dml ng pr~g:nancy 
(( 'arlstcdt <'I ai" 1983: Lrihen ('/ rd_. 1')<)8). 
S~\era l rc ports ha\'c also rc\'~alc(! that cel".ica l mu,us. sP<'",li"ally 111ue',ns. may 
prc\'cnt ectopH' pregn'm"y by eov~ring the cpithelial cells (Lagow el ai" 1999). 
A",ording: l" lbe' report of Lag'''' el ai., (1'19'1), during (h~ phas~ of cmbryo 
nnpbnla(ion the prodl1c(ion of M LT I in ihc luminal epi(hd ial is known (0 be d"wn 
rcg llla(.:d. suggcst ing \ 111 C I may inhi b ii (he attachme nt of e]11 bry,,_ 
1.211 fhe hurden or HIV-AIDS in .ub-Saharan ,\frka 
Human illlllllLllOuclicicncy vIl11s (111\-'). th~ ,,,u~ati,,-c "g~n l ,, 1- ae'lj 111rcd 
immunodcfkicncy >yndrome (AmS) (S, el ,,/ , 21104: Wyatt and S()(ll'Oski , 1998) is 
replmcd (0 he responsible for the death of too re than 20 ,mlilon pe"p l ~ ,,,,,Id,vide 
(Uuellci el al .. 20(5) of wl11(:h the sub-Saharan Ali- Ica is (he ll~"t atfec(cd region 
(Shmkh d ,,/. , 2000). ha\'ing abnut 25 mill ion adult> and rbi ldr~n Il,mg wilh 
HIV/!\l llS (L,,,ina d "I" 200(,) , n ,,: SoulIl<'Ol part oj' Alii"a is rep,mcd W ha \'e (he 
hi g:h~>l pr~vu l ellce eOll'parcd ll) East and WeSl Afr ica (Shaikh <'I rd_, 2011(,)_ 
According lO Stc\ens (' I ai, (2006) th is ~pidcmic i, expcckd t" cost Soulh Aii-lea 17% 











1. 2 1 111\/ Va,Tim' 
[)e<.pite Ihe JI,co"cry or lllghly acti"e an ti r~lrov iral th~rar'~> "h,cb ~l\llt~1I1 both 
proICJ,C ~nd rCver,e t .. ,IIl,Cnpla<,c ill ilibit",.> to Jmvu r~gHlak 11iV )ll1i:~l1on n~c('l'~s 
'"' "I .. ~1l(5). 11iV .. enl~lm, a tilre~( w"rld wide ~p~c ,ricall y ill third world c(\\)llincs. 
I'hus F'r a llumlX"t of am irctrol"lra l drug, which t~lgd tl lc ,iw, elltry il ~v~ b~~ I ' 
tlncloped. with 1110S1 of I[WIn 1<1 rgcl ing enhc, thc HI V envelope g I ycoplOtelil gl,120 
or the CLl4 and chcmokillc rcceptor family such as CCR5 or CXCR4 jl 'igure I ~) 
(MllOrc and DOlDS, 200.». Onc cxamp[c of an cntry inhibitor dn'g i, entlwirtidc 
(E"t\"f') which IS madc up of the 'ml ll1ll ac id SCqllCnCC llf gp41 slLbuui t of thc Ill \, 
~llv~ lope prOleiu to rrcv~ut membrauc llisiou and virllS cutry lnw thc cytoplasm of 
lile ho,l ~ell (R~~'e, ('f al.. ~11(5). H"w~'er, in aJditioulo t h~ h'gh~,t vanabl~ ualllr~ 
of (he viral cm dope protcin,. tbe "peed and efficiency or the ii.L:iion rate ,igllllicamly 
aifccts thc activity of thcsc d11lgs. I'or instance, thc fastcr thc ratc of fus ion :md clltry 
Ih~ k~~ a~tivity/ pokIH:y 01' (h~ drugs. Mor~over, the pokucy or lhese dnlg>. lUdudiug 
th~ n"Htrali/lng au tib"di ~" '''''' abo be lollHcn~ed by th~ d~usity aud gly"o,ylation 
Ie,el orlbe viral emclope proteins (\1oorc anJ [)onA 2003; Recl'es e/ al .. 20()4. 
Pgolini (·t al. (997) . 
Whilst thc scarch for a vacciue agaillst IIIV is lM1g0lllg in ll1'my cemres ofth~ world. 
th~ n~~d to l onllul~k 11~W (h crap~"t l c ag~nts lil a( could aCI by r~ Ju cillg " ,ra l load, in 
lIl rcd~d ind iVlduab Or IraJ1SlILi",iou ti-mIL inlcckJ to non-in lcctcJ individua ls IS a 
pril)rity. \Vh ilst saliva i> known t.l) pr~v~nt \Jra llran,misslOu orth~ ,irus Ihrough il> 
muCu, component. thc indi, idual LILlicin, lbat compose the llluCUS havc not be cn 
TCSTC,I agaillst th~ virus . Il " also imriglllllg lhat th~ (WO well kno"n arCa, o( 
IntrNn""ion o l'tilc ,iJUs. nanlcly the breast and cefnx, have 111UCllS aud 'Ducins, the 
broad slrU~Ujr~> 01'"hid1 are >ll11Jiar to those in sa liva, allJ yet thcy secm to have no 
anli-H I V act 1 "il y Abo any Illhi b itory ctIcct 0 r sal iva in III V pl)siti vc ill di vidHal S has 
also. to lK<r knlmkdge.1Wllxen iuvestigaled 












• Viral bind ing pl'Olein 
RCCcplO L' 
Receptor illli ibitor dl'llgs 
Vira l bindi ng inhibi tor Mugs 
Fi~"l'O t,8 lJio gl'olllllloli(o t"·oscnl. ti"n, of the prindplc . of , il'ol ,'nll') inhihitol' (I ... ,~, in 
inhil>ilio n Or i~"ckill" or ,i",1 inl('cliuJI>. I be,o dru~> i""gel Oili,o, lire ,ind bindH\~ pH""i ,,, ~r 
' """rl~'> t,ep,,,,lcll'd [[D in Leni,:, 1<1<)00) 
In addit ion w IlIV, cm-eloped v iruse> such as hep:il itis Hand illtl ucnn are among th~ 
m:Jjor SLar~s to hUll1a~ lIfe wllh lhree ofl hell1 r~roned 10 infeLl m(\r~ Ihall one bil l,on 
lJj lli e "oriel pupulatie>ll (Kulwal el ,,/ .. 2llll5), R~ce ntl y. due to thei r ine lm'ie> " in the 
Ii 51 0 i' b i(\lem)flSll1. P'" VlnIS~'. sr e~i fLcal ly Sll1:lI II')(lx. is also altmcling gr~al atWllt ,on 
glohall y (JO))('/ y (·t al. . 20llO). Accord lllg 10 Komal c/ <II (lll05), the re,cnt 











a, Iknlocral lC R~pljhlLe of Congo, til,' spr~ad ofthl' 'c\'c, aCu lC rc,pLralory >}TldnJlllC 
(S .• \RS). \<)gdl,n " 'ilh ll,~ f" , l llr~ tll pm\';elc efti:divc "Ild lnng la'ling "aceillc, 
,,!;alll,1 th ~,~ ~ll\dop~d VLnISCS. mak.' dlC I'odd V~l'.l 'lbC~pl,I )le [0 lhe po"ibk 
~lllcrg~n('C' of ~ny n,'w stra ins. 'I hC I\' loI\' lhc searc h for safe. cffcnivc and a i'l,mlabic 
,mIl ,,; r;oI ag~nts has to be amollg the pl'i,)]'] ti es. 
I . B n hj ,·.,t i\'Ps or thi, ,(" fly 
TI", Illain objc ~l lVC;; or lhi, 'iludy w~re [() i'i()ia lc alld punfy hlLUlall ,ali,'al). hrca;;l 
nllik alld pregnanc y pllLg IlllLClIl, Ii-om HIV Llcgmi"c mdividual, and w dct~rmin~ 
lh" ,r anll-H IV- I acti\'l[ic <; in an in "ifro Il IV inlllbilicl!l assay. \Vc also a{m~cl IO pmify 
sali vary mUClns f!'OUl IllV patients and compare their ~nti-H I V-l ilC tiv itics to lhe 
sa li \'~rv tnll"H1, fWnl III\-, ll~gil1 i \'~ ll](I,, ·](llj~i>. F )l[lh~nll 0r~ \V~ wL,hed [0 "olalC 
pcnphera l blood lll()nollucl~ar cdl, (PFlr-ICs) fwm HIV p,)s it i\'c and n~gatiw 
i ndi \' idlLal 'i and dLlcml inc thc !'O le of sa I i\'ar), tnll('i ns spcl'ific;J.l1y ,,1 L C7 ill inhibi t ing 
11IV- ] tn!~CtiOlll)f th~ PinKs. reduci ng vir~ l infc" li l)lI o rlh~ HTV- ! pO;;llivc I'Rvt(\ 
Jild mini{niz ing the >pr~"d of IIlV- 1 from HIV- l po"ti"" 1'H\'I(\ In HIV- I negal Lvc 
I'R\l (' ,_ L,I,lI y 10 dcknllm~ il' ll le'~ lIlucin, I',,>se, lh ~ ,amc I'ot~ncy agJinst ,)lhc{ 











i\fAT[~nLS A~D METHODS 
2.1 Fthi," 
The l ; In ver~' l y ()r Cape T (),,·n Resear~h and Flhi~~ Committee apprm'ed tillS study 
(elhi~s appwval nll" ,l:><r RFC R FF: 283/20(4). 
rhis Chapwr desndxs all toc mat~ri als and IDeth,,,ls Ilscd du ring tI1C ~ourse of this 
re~e ar~h proJ ecl The~e llIalen"l~ were purd,a~ed Ir()m Kimix. Santa Cmz. 
l\lIV()~aSlra. Sam Ho. Dak"~ylornal'''n. AIDS R e,ear~h and Rereren~~ R~agenl 
Pro"raLllme, C! ioco, Roche-. BiomcriC"Ux. Hlghvcld Bio lo !1;icaL Coslar. I\lcrck and 
Signla .lIld "~rc of the highest purity avail'lbk. The LCl'-'! Westeln blotting 
dcte~lion kit ''<is from Amersh,nn Ri"sci~n~es (AllI"rshalll UKl. \jilnl<:~ I1il l o~~ 
membrane and (lia ly, is lubing were- Ii-om Klllll~ (Chemical and Laboratory Suppl iers. 
SA). Poh-clonal rabbit antl-.\IlIC2, anri-I\IUCSAC. allli_ML'CSB and goat anti-rabbit 
horsc radish pernx i dis~ (IiRI'O) lin k~d s~~ondary 'llllil1·Oliles ,,~~ kl11 dly proI'i(kd by 
S" I" K i rkh",,, r \'1a11~he<t~r, I TK) Polydona l g' KII an li -~,,j] }C7 and rahb ll an ll -!,;oal and 
g'''lt anti-mouse 111<1'0 1 1l1k~d "e,:ondary alllibodi"s were IrOl Il Santa Cru/ 
Bioledmology, Inc (Sania Cmz, Caillorn ia). Mo nodon.iI mousc 'Illti --"llT 7 (LU-
\lUC7a) wa, kindly provideJ by Dalla~ Swalh",s (Univer,ity College london. L'K) . 
.\lonoc-ional mou,c anli-MLCI .Illd anti-:'1LC6 'Illtlbodi~s "ere If"''' r-.(l\'ocaslra 
(N~wcas lle. UK) Env i~lOll--:)f' system lab,;lled polymer-HRP <lnri-monse, anti-rabbit 
and 3.3'-dimninobcnzicl inc (DAB) suhsmlte chr"mog~n we~ from Daktl<:jl.onlatjon 
(USA). Habbit alll i -~ lUC-t p"lydonal an lib()dy was iro", (Sam Ho, USA). The- human 
T Iy"'phubla'\()l(l ~c11 line (CE~ l SS ~dl s) ,\"as from /\IDS Research .wei Rcferenc~ 
R~agent Programme (Germantown, USA ). RP MI 1640. L-G lli lamine and hem-
inadivated Felal Call S~IlIT" "ere Ii-OlD e, l",o (~la'l.,ach uselt,. LSA). 1l-2 and p24 











lit. Rion.ericux (France) respectively_ African green nlllTlkey kiJney cells (SSC-I) 
and Eilrl e '~ BJse Minimum Essential Medium contilin ing L_glullirm)le. non-e><>ent iid 
amino Jcids, ~allCOl and Fetal CalfSa um "ere fmm Highveld BiologiL~1. Culture 
pl~t es Jnd Crystal Violet Dye Were from Co,tar and M~r~k «( jenmill)') r~,>pcCli\'cly , 
Sepharose CL-4B, guanidinium ~hloride «(iul ICI). cutsium chloride «('sCI). Schifrs 
rcab'Cnt. 3-(3-cho lilml dopropyl )-dimet hy I-~mmollio )- I-propane-sulfollute (CHAPS). 
,Ignrose, r..'-ethylmaleimide (N[\IJ, 2-mcrcaptoethanol, 7-Amino-actinomycin D 
(7AAD), Hi,>lopag"",.;'·I077 and .. 'v: ,""-melhylenebisaLrylimlide W~m from Sigma 
(LK), I'hen)' lm~lhyhulfonylnlloride (PMSF). N, ,"~ ,\', N'-tetramelhylethylenediaminc 
(TEMED), LOoma<'sie brilliant blue R-250. ethylenediaminewlra-acetic acid di<'()dium 
salt (Na, -FDTAl. 3,3'S,S'·Telrarnelhylhellzidine (TMB). di-methylsulphoxide 
(DMSO) imd ]X1I)'ox)'eth)'I~n" sorbitan monolaurate (Twe~n 20) were from \lcrck, 
:\TL-M!JCl (201607) and '1CL-MUC6 are rnou<,e monoclonal antibodies raised 
agJinst a carbohydrate epilope or the humilll MLJCI-glyLoprot~in and synthetic 
peptide or lhe MUC6 tandem repeal seq""n~e re<,pective ly (data sheet from 
}," ,,'(;><;aslra Lilbowtories Ltd), LUM2-3, LUMS-I i11)d UIMSB-2 are rabbit anti-
sc:-rurn,> raiocd agirin~l s)'nlhctic' peplide;; of r..'Ci] ,QI'V R V EDI'DGC (11~rrmalln e/ al., 
1999), RNQDQ<iPKFMC (Hmenbcrg eI "I, 19(6) and RNIUi OGKfKMC 
(WiLhtrorn d "I., 1999) which corl'e<,pond<, 10 the t~ndcm repeats of hUmJll Ml~C2, 
MUCSAC and MUC513 mucins res pec tively, Rubbit polycloml anti-/l.1UC4 antib<><l)' 
W,IS r~ised againsl a synthdic peptide ISSi\STGIIATPI,PVTD ~orre'f><)))ding 10 the 
t~dcm repeJt SCql"'llCC of MUC4 (Lo~z-Ferl'er <:1 <1/" 2()OO). liU--"'lliC7J, is J 
mou<,e unti-<,Crum raised against a <,yuihetic pcptid~ E G R E R ]) ] 1 E L R ] 1 R R j II] 
II () locakd in the N-h:nnillul part ofliJe MUC7 prolein within lhe Hi'lalin-like 
domain (klrldl)' provid~d by Dalla,> Swallm" , \Jn i v~r<,i ly Coll~ge London, UK) ~nd 
~-1 691 8, J gOJt anti -serum WJS mised JgJinst JmiTJ() ,Icids in tl"" rdge of 1 OO-I,'iO or 











2.3 Sample l'l.lIedion 
2.J.! C"llecti"n " r . al inl from ,~ mpt"m rree group 
Jluman saliva was ~oJlect~d lrom twenty healthy 's}·mptom Ir~e' I"emale and male 
volul\leer~ ("·00 dedar<:J a risk -Jre~ lil"eslyle) who ab~wined from ealing and Jrinking 
Ji;r al least 2h prior to colledi llll. The produdion 0 I" sali va was ~ti mulated h)· ~heWll\g 
on paral ilm and collected into 51111 of 6/vl (il.lHCi containing a cockta il of protease 
i nhibitnr~ slLch as IOml\.! ED 1A, Sm.M :-.JE.v! and l m~1 P.vISI-' pH 6.5. Samples \\er~ 
colkcted into cook<.l containers on ic~ aoo stor<:d at -20"e until pl1Tlli ~alion. 
To lx, used as a cnld~ sample for IlIV inhibi tion a.>say. whole -;al i va "as colkcted 
into Sm.l of cold O.lM Tris-IIC!. 2% (wlv) F DTA and SmM PI\. !SF pH 7.5. Th,' 
sam.ple was centrililged at 10 OOOg lOT IOmin at 4'·C to remove th,' insoluble debris. 
dialyscd agai nst thre~ changes of <.Iistilled water ov~rnight at 4 "c and Ir",cze-dricd. 
2 . .1.2 C"llec t i"n "f . "I;\">1 rrom HIV pat ients 
Saliva was collected from H IV positive !emak volunteers from the din; ~ "I" infectiolLs 
diseases in Groot" Sehl.lur Hospital (Cape Town. South Africa). The prodlLct ion of 
s"Jiva wa.' slillll.lJmed by chewing on parafilm and collected into 1 Oml 0 1" 6M (rl.lHCi 
containlng a cocktai l of prot,'as,' inhibitors such as 10m\'! I",DTA, 5111~ 1 :-.II",M. and 
l mM P:\1SF pi I 6.5. ~amp l e~ were colled",d imo ~onlcd comaincrs on ice and stored 
at -2(fC. Sampks Ih'r,' grol.lpcd into lhr~e categories ac~of(ling to the CD4 counts of 
the palients. less lhan 200. between lOO and 400 and greater than 400. The pal;ent~ 










T.bl~ 2.1 Sa"'pl., fro", II I V p.li.·lIh "r dill""'lIl 1." 114 WUIIl> and rdaled inf""li,,", 
Case number A , CU4 count Related infection 
, I 2B I ' I TIl 
2 ~6 14' TIl 
3 32 159 lU 
" ~6 170 Diarrhoea & skin rash 5 31 ISS (jasiriiis & rcspirator} inkction , 38 21 1 Or,,1 intcelion 
7 28 244 10 
• 2. ~52 10 , 2~ 266 Genital infcCiioll 
10 20 288 NA 
Il 30 303 TI3 
12 28 307 TIl 
!3 JO 323 Conillllctivitis 
!4 " "' 356 Dl IS 18 .,88 (fi;,(km3 
16 ~5 ](}I) l\ .\ 
17 '7 4~6 Oral infection 
18 " 433 ,\clLte diarrhO<.'a !9 ]] 476 " '"~ J2 57J TIJ '! 4! 618 III 
" ~ " " ,'" 707 1\;\ 
'J 24 <)35 TR 
I 24 4I 1070 " 
2.3.3 Prcgna n9' plug mucus anti ct"n'ical scrapings 
Cervi~al se~rdions w~r~ c()lk~kd from 1",cniy HIV negative tcmak volunteers from 
th~ Depm1men! of GYll3ecolo!,'y 3nd pregnmK)' plug mllClJS tmm 'viakmity Divisions 
or Groole Schuur HospitaL Vaginal mucU'; specimcns were colleded by gentl} 
s~mping th~ vaginal mllCosa "ith a wooden paddle and the pregnanc), plugs were 
extracted prior to delivery by a gynae~ologist. S3mpks w~r~ colk,.-kd inlo 6\1 
GuHCl containing a coektail of protease inhibitors such as 10mM EDTA. 5mM 1\F.M 
3nd l m\1 PMSF pJJ 6,5 and ~!ort:d ~t _20°C until rurlkr analysis. 
Clo be used as ~ crud~ S3mpk for mv inhibition assay. pregnancy plug mucus and 
~~nical sccrClions were collected into Sml of cold 0.1/1.1 Iris-TlCI, 2";;, (wiv) EDTA 
aml5mM PMSF pll 7.5, Siunpks v;~re soluhilis~d hy g~nlk stirring fol' ISh at4"C 











at 4°C Th~ Sllp<'f1lilkml wa, dialysed again,t three ehllngcs of distilled water 
overnight at 4°C and rr~~/~-dried. 
2 . .'1.4 Collcctioll of human breast milk 
IIuman breast milk smnples were collected from twenty jjlV negative lactating 
mothers from the Virology and Microbiology laooratory of the r>.latt:rnity Division in 
Groote Schnur I [ospital. Afkr collection, milk sampks wert: immediately frozt:n and 
stored at -20"C. To Ix: ust:d as a crud~ sampk. fre,h milk in O.2.\-! NaCl. O.02%NaKJ 
conlaining a co~ktail of prokase inhibitors, 101ll.\'! rDTA. SIll.\·! I'MSF and SIll\1 
NEM. was dialysed againsl thr~~ ~hanges Ilf distilled wakr (wernight al 4°C and 
Ji"ee,.e-dried. 
Human breast milk ~amplcs rrom HIV positive lactati ng mOlhers were also collectt:d 
fi"nrn the Di\' i~i()n ()flh~ \leonale Maternity Hospital in GT()ole Schuur. 
2.3.5 C()IIt'rti()1l ()f human blood 
RJood sample> Ii"nrn HIV po~itiv~ patients were C<lllected Ji"om th~ Divisions oftoc 
Neonate and Paediatric Medicine in (,wore Schuur Hospital and IlIV negative bloud 
samples from volunteers in toc laboratory (Departmelll of Surgery. ReseW"~h 
Laboratory. Univep,ity of Cape Town, South Africa). Viral load of both the IIlV 
positive and negative hlood ,amples was determined prior ll> any analysis (",e Tabk 
g.l in Chapter g). 
2.4 Preparation of saliv>!r} and pregnancy plug samples prior to purificatioll 
()f murill" 
Salivary sampks were solnhilised b} overnighl mixing ilt 4"C on a revolving rotor 
and [he in~ol",ble dehris was separaled from toc soluble mucns hy ccmrifugatiol.l at 
44()O.': for jOmin at 4"C, in the casc of prq,'lliln~y plugs ilnd ~ervkal scrapes. samples 
were soluhilised by gentle stirring for ISh at 4"C and toc insoluble Illmerial was 











2.S Prcpllnltion of milk samplr prior to mucin puri(icu ti"n 
Sam pie prep"ra(i on was pcrf01IDed oc~ord ing to the mcthOt! of S<:hroten eI al ( I ')',12). 
Frozen mi lk samples "ere lhawed a! morn iemper,,(ur~ (RT) in the pre~enee 0[' InL\·j 
PM SF and defatted by eenirifugation "t 3 OOOg (i)]" Ih at 4"C. The Cream (i-dclion on 
lhe top (~ee Figure 4.1 in Chapler 4) wa~ collected and ~u~pended in "Suil"hle volume 
of IJ ,2'vt l\aCl, IJ,Ol%Na 1\, eOnlaining a cocktai I of protca~e in tlL hitnrs. I Om ~ 1 FIn A 
and 5mM NFM. and kept at -I"C for Ih. Th~ suspcnsioo was shak~n on a laoomtory 
8haker at RT until butter v.as funncd and the membrane "'''1l8 rdea8ed hy in<:uhation 0[' 
th i~ mixlure al 40"C (or 30min. Following <:entn['ug"tion al -,5 OOOg ('or 30min al -l('C 
the membranc8 WL'J'e recov~reu as a } ~ l1ov,· pell~L The p<:lk( was th<:n suspcnd~u in 
O.2M ~aCI, O,02%NaN; comaining a cocktail of protease inhibitors and subjected to 
homogeni~.alion with a J unkel and Kunkel [ lllra·T lItrax II min, <)500revimin at RTj to 
disaggregate and in<:rcase its solubility. Aftcr sonication insoluble materiab were 
removed by <:ena ifugation at 4 4IXJg for I IJmin at 4"C. 
2.6 Si",c or molecular cxdu~ion chr"matograph~' 
Size exclusion chromatography v.hich separates biological matcnal8 <l<:<:ording 10 
their size bctv.cen a continuom phase and thc interior pores of the gel (Flmoks e/ al.. 
2000; Porath anu Flodin, 1959; Whilaker, 1(50) "a~ u~ed 10 separate human salival)' 
and brcast milk mucins from thc non·mucin comjXltJ("nts of these ~ccre( ion~ ~uch,,~ 
prOlcllls. 
In this study aliquots of the supernatant (20m!) wel'e duom"togr"phed on a Sephamse 
CL·4U gel filtration <:olumn e'1uilihraled and elut~d wi th .. M (iuHCl cnmainlllg a 
cocktail of prot case inhibitors, IOmM ED1A and 51l1v( NFM, and O.05%CHAPS pH 
6.5 al a flow rale 0[' 48ml/h al RT Following a periodic acid schiff's (PAS) and 
protein (A2W) assa}s. the void volu1l1e (Vo) fra~tion~ and inclooeu volcnne (V,) 
fr<lClions w~r~ pooleu separately, dialysed against three changes of distilled watcr 
owrnight at 4"C anu frceLc·dricu. In tbe ~ase of mi lk (he cnlunlll was equil ihrated and 











2.7 J)jal~s is or S :lml,lc~ 
Prior to any anal)'sis or assay, (iuHCI and <:a~silLm <:h l orid~ w~r~ r~mo, ~d Irom 
sampks by dialysis against thm: ("hang", of di ~ti lkd water ()v~rnighi at 4"e by 
constant sti rring. 
To dctennine lh~ amount (<:(m<:entration) of ,amples us~d in ~ad\ analysis Or a~say. 
dialyscd ~arnpk, w~ r~ fre~z~- dri ed b)' a Chnsl ALPHA 1-5 Irca.~ dri~r from Lasct 
l.ahoTatory and Sdenti Ii~ eq lLiprn~nl. 
2.9 ;\11~l}· tic~l dctcrm i ll~tioll., 
Glycoprotein was estimaTed by the PAS proccdul"C of /l.bntk and Alkn (197)\) and 
protcin according to the mcthod of Lowry <'I al. (1951). 
2. 10 1'.1ucill purificatioll 
Sali,ary. breast mi ll.. anJ pregnancy plug nwcln '> wcre purifi cd IlccoHJing 10 t b~ 
method of Crecth and V<cnoorollgh. (1 970). Oriefly nllldn, w~r~ rr~par~d in 4\1 
(;uHCI containing a cockta il of prokase inhih itors, 10mM L[)TA ami 5m\1 1\·F. \I . 
and 0,05% CliAPS at pH 0,5 and adjusktl I() a d,nsil)' of 1.39 to l.40g/IllI ",ith s<,lid 
caesium chlorid~. Dcnsi ty gradi ~nt c~!lt rifllgBti(\Jl wa, perfnnned in a R,eJ...man 1.45 
ll11ra-<:enllifllg~ tor 4Rh I\\,ie" al a \05 (~)Og al 4°e. r>.luein ro~ i li,e fraction , with 
som~ contaminating pTl,tcin were IXX,kd and pr~pared for th~ s~mnd c<:nlri ['ugalion 
>tep. Finally lIlucin rich fractions were pooled, diaiy '>cd against th r~c <:hange~ 01 











f o detennin~ their purity aIld s i z~ salivary. breast ,H ili- and pregnancy plug m",: ;", 
(3()>lg eaeh) were prep~red in rcducing gel loading hulkr cOIlta iniIlg 2'% s,xill.lm 
dodcey! su lll,le (SDS1, 10'/" glycero l. OJ1I % brom<l pbenol blue and 5°,'" 
mcrcaploc thanol and boiled l'or 2miIll'rior to loaJing. E l ectrophore~i ~ was pcrformed 
according to the mctbod of Laemmli ( I <no , iIl ~ 10% (wl \) runn ing gd and a 4% 
(" .Iv) stackiIlg gel ming lh~ Hoctfer Mighty Sm~1l m ini-clectf()phor~sis sy>t~m. The 
gel waS run a120mllp LLlllillhe brolllophenol blue Jye reached the bottom Oflh~ gd , 
2.12 Cradient gel 
I'or bctl~ r reso lutioll milk 'n u ~ in (\fl..C 1) !lnd "li ;yary MI}(,SB alld 'vILe7 Iro," 
111\'-1 rx»itiw illlilvidu<lls w,th dlifereTlt Cf)4 COUIlts «20(), 2(~)-4()O anJ > 4(0) 
(JOjlg ca<:h) were prepared Lll reducillg ge l loading butT~r as abovc and subje<:tcd to a 
3-5% and 4-20% gradient gels respect ively. flli , gel is prepJred by lll1Xing tW() 
,0I Lll ;01ll of dilkrcnt ac rylallliJe concentrations 1<> form <I gr~ di C li l wnh dc~r~<lS;Tlg 
cOTl cemrarions of ac rylamide (pierc~ 1'n l!l'lllli<:S ) (w\\'w , ri cr<:en~ l, <:01 ll, Proleon I ic,). 
2.13 CuO)m",~i" hrillian t bille R-2S0 gel stainin~ 
Gels were 'lil1l1(,d ,,;1.11 O .2~,{. Coomas,;e flnl ham Flit..:: R-2S0 in SO'Y;, ethanol alld 
10%, acel;c acid and dCS1~ illGd in 25'~,'o ethallol ,md 10°'0 il~ L1;c acid t() \',eW the prmein 
bands. 
2. t 4 I'uiudic acid ,chi IT" s gel stai IIi IIg 
Gels were f ixed m 7,5% aCeLic 'Kid. then , tained wi th PAS and dcstaillcd ill 25% 











Z. IS Ag.aro<e gel ciccI rop II u n',i, 
Salinry. br~a<'1 n lLl k aLl d p ["~gnanc.y plug lllu .. :m, (-lO!lg e a~h) wcr~ prepRnxl In a 
,atllpl~ luadmg bund C()nlammg -10% gl y(:~ml. 0.01 % brotn()ph~nol blue and S'Y;' 
I n~["c.aplllClhan,,1 III I x Tris-acdal~ bulkr (TAF.) and bmled lilr 2nnn pn or 10 
loadill[ .. F.kdrophorc>i, wa, ( arried Olll a~,ord illg 10 the method of ThorlltlHl <'I ai. 
(1<)<)9). ill a 1% (wiv) agam" gd (15 x 15, tn 'l pr~par~d m rlJnllillgbuffc r <: Ol11 illlllng 
40rnM TAE. Imr.1 FUTA . and 0 I'Y" SUS pi T 8,0. Bn ~tl y. agamse (I.(>g In l60ml of 
nlll lllng bllffer) was b< llbl III U ml<:mwa\'~ 11l11i l ~olllpld~ l y ,hs",lved alld , o('led 
down TO appr()xirnawly 50"C bd'urc f",uri ll g in(o the Rw-Rad Dl\A ,uh ,cil gel 
apparalu ,. Upon P"IYlllt:rinllull Ih e "ppara(u, ,,'a, li llcd Wllh nllllling butTcr and 
d~droph",e>is waS perl imll~d at IO()V li)[ 2.5h al [Oun] tCIl1( ICra tlll'c . 
2.16 Weslerll hlol1illg 
Afler SUS-P/\( iE aLl d agaros~ gel elec trophoresis 1\-1UCI. MUC2. MUC5AC • 
. \lUCS13 and I\- IUC7 from IIiV negaTive mc! ,Ylc!uaJ.; and sailvar)" MUC5R and \llT7 
from IIiV p uti enl~ wll h CD4 ~OUl'l> «200. 200-400 ami >4001 w~rc transfcrrcd onw 
Ililrucdlulus~ mcmbranes (Nilrocellulosc, O.22Micron) using a setlll-dl)' ele,lro-
blotling unit at O.kmA/c lll" or by vaC llUIll bloniLlg for Ih aT a 'U~1I011 prc><ure o( 
40mb~r accord ing to the JlJ l1 h()(1 of Thomloll e/ "I. (1999), In Ihc CaSe uf SUS-P,ViE 
lhe lralls fer bldTer \l sed conmincd I \l2 m\1 glycine. 2Sm.\1 Tris. I ,3mM SDS and 20%, 
(y/,,) methallul wher~as m agamse gel lh~ tmnsl'er huffer nsed was 4 x SSC (0,6.\1 
Nan. 60m'v1ll'i-sodiulll citmT~, I' ll 7,0), After cle,tm-bloi1m g. lloll-\I'~cific b llld ings 
were bllIChd by i ll~ubalin g thc mcmbrancs overnighT ill Y% (m/v) low fat mllk 
jlo"der in TI3S, 0,05'% Twecll-21J ( 111ST) ut4"C. The lllemhmllcs ,,~re then w~shcd 
WIth TRST 3 x 5mill ~[]d Il1cubaT~d for 2h with lllOUSC ami-l\-lUCI nlOllo<:lonal. rahb ll 
anl l-MUC1, rabbil ami-MIlCS/\C, rabbi! ~ll1i·.\lUC513 polyciollUI and mOl1,e ami-
MUC7 llwllo<:lonal allllb<,die, dliu lc c! m 5°,'0 (m.'\ ',l luw fal milk po",der in TBS' I aT I 
ill 100 (moll,e ami-'vl UCI), j ill 5000 (rahbit ami-\l LC2 ~nd anti ·MCCSAC). I III 
l ()()O (rahbil ~nti -.\lUC5il) and I ill lOOO (mousc un ll-\lU(7). The memhmlle, Wer~ 











aillibOtlies (goal anli-mouse a11d goa! al1!j-mhbi t) dilmed in 5",'(' (m/v ) 10'" hl! milk 
powdel' in TBST al dilul ion" nC I III 1500 (goa! anll-IllOUSe) ~nd I in ~1I011 (goat ami-
rahhit)_ Afler anolher TFlST "a,h n x ';mi11). ha11ds were de!ectcd us ing an LCl 
dClection kit. 
2.17 Enzyrnr linkl.'d irnrnuno,orbl.'nt as<;~y. 
Sa!J\ary M UC 5 Band r.l LTC 7 mucins from III V' ncgati vc and I] I V POSili ve indi vidlla Is 
with di fferel1l CtH count, «20Cl, lOO- '!()O and _"!()O) were comed (lCl~!g/mj) in PlJS 
(1'5°111 pc r "elL ovemlghl at ,ret "011-Spe~ liic bi11d mg of tbe an tihodi es wa, 
prevL>J1 led hy bllK:kmg Ihe wells with 0_'5% HSA-PHS (200], 1. Ih al J7'C) and the 
plak' w~re wa,hed lhl'ee li",es with PBS-Twec:n_ Seriallwo-fold di lutio n" ol"primary 
a11libodie, "Ian ing h-mn S,llg/",I (goal anti-MCCS8) and I~ f!g llli (goat anl i- \1\IC71 
"ere added 10 lhc plale in 1I,5 ~,'; , I3S,\ -P 8S and incuhalcd (1011,,1. 211 at 37"C), Tile 
platc, \\Cl'C w~,hed three timcs \\i lh PBS Twcen and rabb it ami-goat IIRPO-linked 
secondary ant iblxly (1 111 5000 In Cl_5 %, HS A-PIlS) '''is added 10 ead well and 
'nc llbal ed (120!,L III al 17°C), Following thr~~ wa~he" Wilh PBS-Tweell , ISO.ul oflll<e 
sllhSlfak s"llll ion (TMB in Ol5M cilrmc-phosphate buffer. pi] 5.0) was ~dde d 10 
each well and lhe colour was allowed to develop in thc dnrk agail1s11hc hackground of 
the controls (lCl - 15min) and lhe14o; of ea(;h "ell "as measured I II a Tilenek ELISA 
plale reader, A\ a conlrol . well, " ere ~oald wlih PBS 
2.1 S 1m itlli n ,,-h i,lHch"mistry 
Immuno-hi'lt><:heHitcal ana l ysi~ was med 10 identity mucins cxpressed by' the fem ale 
reproductive tract , lIuman endom"triuln and cervix !i", u~, wer~ !ix~d In b"llered 
fomlali11 prrl<:~,,,,d m alcohol< and xylol a,m embeddcd in parafJin w~x uSIng the 
,tandard rHdhod, befol'c being dcwaxed in xylol for 15mil1 and reby'drated by 
~b,ol U1 e. 96% al1d 70% a lcobols l(lr 1m in ~ach_ Alkr a wakr ri n,c, li ,~ue ,eclions 
were m~ubmed wllh ii-,-",h 3~,';, hydl'Ogen pCl'Oxidc in mClhal10l for ](Imin a11d then 
\"ashed in nllllling lap water for I ~m i n fo llowed hy PBS, Anligen r~ lrie\al was 
carried out by' ll1(;uballOn o( Ihe sP"~llne", III ~ilrme blif(~ r pH 6_11 "sing preS\urc 











5min PUS wash~s, sections ",ere b i(><:ked with nonlla l goat s~nlln (It I in 20 In PUS 
for 20min. Afkr removal of serum (drain I, scction" were in~uhaled wilh mouse (lmi-
l\IUCI and imti -]l.1UC(, monoclonal ami boillcs al I m iOO I'ur -,O lll in and mbbll (111 11 -
l\lUC4 polyclon(ll antibody at I in 400 diiutillns in PBS for Ih. A ller 2 ~ 5mln PBS 
wash sCGtions were itlCubated with Lnvision anti-llll)USC (Dakocytomalilln Envi"OlL':j<") 
sy'tem labelled polymer-IIRI' an ti -mouse) and i.!ll\ision (Inti-rabbi t (Lnvision:i!:' 
'y<;tem labell ~d pll lymn-HRP all Ii -rabbit) I(lr .10mm, Sub,L"Lluel1l to 2 _, 5mlll PRS 
\Vasilc" <,cctillns \verc rk\'ei()ped us ing chr()mogen (I drop ll f DAR In in,1 of 
q 1omati()Ll substrate buffcr) for I (lmin. Prior tll colour cLlhanccment with I % Cop~l<,;r 
Sulphmc for IOmin se~t ions were rinsed with PUS and wmer. rh~ scoions were 
counter stained with hCIll(ltmylin and Swtf s water for 1-2mill and debydnned by 
70%,. ')(i~--o and (lbsollile alcohols Il)r 5s~c ~acb bel'ure l><emg lel'l in xylo l F,nal ly slides 
wn~ n\\~r , lipped u,ing ~nldlan mal \'ie,,~ d under thc light JIl lcro,cope. 
Z. I'l Amino "d<l "n "lysis 
Tile arHnlO acid contents of , ali vary \MUC5U and \1l;('7) (Iud milk ().1 CCI) mU~lns 
wcre analyocd m ing il bigb pressure li'lLlHl ~h r0111al()grapby (HPLC) sy,tcJll accord ing 
lo II", methods () I' CoileL1 ami St rydllHI (InS) and Klapper (19~2). In tilis mct!wd 
,amples wcrc n(llUm-drkd and pl(l ced Itl a hydro l)·,is vessel ~Ol1tamlng >lImc 
<:011,ta11l boi ilL1 g Hel and 1'/(, (v/vi phcnol bet,)re ilydrolysing in the gas phase at 
11(l"C for 2411, The vessel was ~bll1ed Wilh ll ltrogen ga, ami s~ al ed under vacuum 
he li.>re usc. SlLbs~quen t l() co()llIlg and \'a~lLUm drying to removc th~ res idual IICl, 
samples w~re red issolved 111 Cltrate buller pH 2.2 atl<1 L mroduc~d illl() a HPLC colulllu 
l\'ll 111 Walcr, f\>s ll cimc.'. M~dford , \ 1A .. fillcd with a ~(lt iOll ~~<:hange r~,i lL 
(su ltollated polystyrcnc no>s-Imh d " ,th di \'iny l bcnL~n~) and eluted with a number 
lli' bllfJer, ranging fnlln a low {O.25]1.1 u'i~o d i um citrate. pH ,HI5} to high (O.25M 
sodilLm nitrate. pl l 9.5) pH, [)d~cti ()l1 0 1' 'UH mo aC1(b wa, rcrform~d lLsing pust 
mlumn derivatiLati()n wi th O-phthalaldehydc (OPA). a fluore,cent reagelll wh ich 
interacts with all but not prolill ~ amino a~i d. For pn llll1~ detecl loLl treatmcnt llf 
s(l mp Ie, "'1fb slldiulll hyp<.>~h hm Ie ahead () I' po,t Cll I1. Ll II n derivatizatiol1 with 0 P A W(lS 
re'-luir~ d. The rckuivc ral ios ()I' thc individual amino adds for ~(lch s:nn pl e was 











2.20 To~ic ity ofhnman , alh'ary, breas t milk and pregnanc} plug mums lI"d 
mucins from HIV n~l!ative and sath'a l)' mucins fmm IIIV pflsiti.,c 
individnal , to the huma n T lymphoblaslOid celliinc. 
Prior lCI IOC HIV ][lhibitir,n assay Ihe Inxi~il)' " I' ~rU(.k sah va, br~ast mlik. pregn,mc} 
rl ug muCLlS, I' urifi~d MLC5B and MLC7 Irom ~al i v a. IvH JC I fmm mi lk anu 
pregn;;mcy pl ug mllC iliS (containing MUCI. Ml :C2. MUC4. MUC5AC, MUC5l:l ;;md 
/l.11;C6) from IIIV n~g"tiw indi\'iduuls and puri ii~d saliv" ry Ml,C5 11 and M1;C? 
fwm illY positiyI:' indi\'iduals wi th difft,r~nt CD-I counts « 200. ]00-400, und >4(0) 
to thl:' phj10h~maggl uti n in (PllA) stimulatl:'d human T lympho~ l astoid celil inc (C FM 
S5) was d~t~l'm in~d bytk toxicity assay. llridly 500,,1 oftk CEM SS cdls ill RPMI 
comp l ct~ cont~ining I 0% F~wl Calf SI:'rum. 1 % P~ni c i ll i n/S l reptom)'ci n untihiolic, 10 
"mol Fungin ,md 50pmol]-m.:rc"pro, __ th'lllol (I inul ~onceTltmt ion 2.5 x 10(' c~lls/ml) 
"'ere inc ubat~d ",i dl 2S0,tI of IL-2 and 2S0~il (O.9mg) of ~~ch S,llllpk in " CO2 
i n~ lIhawr fi)r 24h. As controls. cells iJlc ubat~d with lL-2 only or lL-] ",ithold cdl~ 
(b lank) were used. After spinni ng at IOO{}g for Smin cells \\~r~ re- s\lspcnd~d in 5001,1 
of RPMI and live and d~,>d cdl~ \\er~ counled using Trypan blile exclusioTi cri te ria. 
l'l~ JXrcentage ofviJhk cdls WJS c~lcll IJtl:'d as li, 'I:' c~II~/total cd Is x 100, 
2.2 1 Toxicity of :V1UC7 to whitr blood ern, 
The toxici ty 01' salivflry MUC7 In ",hi te blnoJ cd Is (WUC) "as d e t~ rmi"",d by th~ 
c)lo-toxicity :c;~ay, Fllo"d was l"hn Ii-mn IwO vo lunteers (20ml each) in UDTA lUbc 
ar>d dilutcd tn 35ml "ith PUS, Tn separat ~ WUC from red blooJ c~ l l s ( IWC) and 
plusmu, the hlonu "as layercu O\'er Hislopag ueOC'-1 077 snlUlion by inclining the til be, 
lifter centrifugmion (300g. IO tnin. 4<'C) wit h u slow hn:ak to avoid disruplion or Ih" 
l~yers. thc wue fanning ~ whitl:' band ut th~ mkrfucl:' \\er~ ~olkded, Alk r PBS 
wa~h hy celllriiugation (IOOg, 10min, 4°q cells "ere r,'covered ~s pr~cipituk ,mu 
r~suspenckd In RPMI conl.uinillg 10% Fetal Calf Serum ~nd 1% 
Penicil li lli Sl repiOmyclH all l ihi oti ~, Cel ls (1 ,5ml Or 6,4 - 16,2 x 10(' exlls) w~r~ tb.:n 
mixed with salivuI) MUC7 ut di l f~rl:'nt C()nc~nt r<Jtion (lmg. O,5m;! ,md O.2Smg) and 
ill(;ubatl:'d in " CO, incuh"tor lin 4Rh, As ~o nlm l. ~ell s wi tho lLl Ml:C7 were incubakd 











with PUS by centri fugation (lOOg. 5min. 4"C) and rcco\w~d as precipitate. After 
r~~u~p~nding in 250etl of PUS. cells were incubated with 7-Amino-acti nomycin U 
(70'..0'..])) anr.! cell viabi lit)· was monitored by flow Cj10metry. 7AAD whi<:h 
intercalates into dOllh k-~lrand~d nucleic acid8 and can rendral~ cdl memhrane, Dr 
dead ~ells j, Il""d to disting ui sh bd\\~en l iv~ amI d~ad cells. 
2,22 To'icit)' ofl\11.T7 to red blood lOCUS 
The toxicity of sali\' ary MIT7 to RHC was also determined prior to inhi bition assay. 
Ulood was taken from a volunteer (IOml) in l'DTA tube and placed into four EDTA 
lub~s (2.5ml or 10.5 - 14.7 x 10Q cell s ~ u<:h ). TI", nrst three tllk, w~re inclltmted wilh 
lmg, 0.5mg and 0.25mg o{"MUe7 1<.)r 60min at mom l~mreralllre r~spcctivcl }. As a 
conlmllhe lourlh tllhe wa, i ncllhm~d wilh PBS. i\llhc end of the incubation period 
lhe blood wa, cemrifuged (900g, 15min. 4"C) and cell lysis (ha~molysis) was 
determined by observation. 
2.23 l'reparation of peripheral blood mononuclear cclls 
iiuman blood (10ml) wilh in 6h ofcol l~c!ion "as <.I illlted in 10mi ofqerik I >< PUS 
with .1 or 4 limes g~ntk i ny~ r~ ion of Ihe luOC. Th~ diluted blood (9ml) was then 
~Iowlv by~red onto 3m! or Ficoll and centtifuged (300g. 30 min, RT). Ah~r 
discarding the supernatant fluid (SNF). periphera l blood mononuckar <:dl~ (T'RMCs) 
rmdion~ rookd from dift<::r~nt tubes (20ml) was resuspended in 30ml of PRS and 
~entri I"ug<:d ( I OOg, 1 0 min, R T). The flt'lld wu~ lhen rc,"s)J<."Tld~d in 20ml of PUS. 'j 0 
confirm cells viability 20~!1 01" the <:dl susp~nsion wus mix~d wilh 20,.,1 of 0.4% 
lrypan hlu~ and incllbm~d for 3 to 5min at RT prior to cell ~ounting Ilsing a binocular 
mi<:ros<:oflt'. Th~ susp~n ~ion was cenlril"uged ( IO Og, 10 min. RTJ and the pellet was 
re~u~r~nded in Freezing medium/])'VISO at I >< IO"cells/ml by addition 0 1" Fre~~.in g 
mediumlU\ISO drop wi"". wilh con~tanl mixing, Over I 10 2min with samples placed 
on ice. i\ liq lM'" (I. )ml) in ampoules were stored in cryorr~ser\'ati on Ilni Is in th~ 1 iDF 
1'.1 Rc\co in R80.>1 I<)r ~4h, hdillT trans]<::rring to thc li~llid nitrogen units (R8 120) 











2.H Ph~·to hael1l aggl ul.illill stimulation of p er iphcr ul b luod mononuclear cell, 
An ampoule (1 .. 51111) (\i" l'B:>ICs was rc'mo'ed 1[(\111 hl] \lld nITrogen un it (RH I ~O Unil 
2) and tram,ICn-cd 10 Ihe P:, IH lXlralory on ICe. The """pie " 'US diluted in 10ml of 
steri le PBS drop W1,e by g~nllJ mixing Ihe tLlbe and eenlri filged (IO(lg, I llmin. RT1. 
'I he pdkt wa, re'Ll,pended m ilbum 7ml of pre-wanned R I' VIT l11ediil t W II hout I L- ~) 
and tran,ICrn?d lO a 2'i~m l fla,k prior to the add ili(\n of rh~ phytohaemagglLltinin 
(J' lIA) to a tina l conccnlr"lion 0 1 (l.5~!g/ml (1I )()fll i IOml). The cel!> were ilKllbalcd al 
37'C ill a CO2 incubalor ('i% CO, and Y5% hULll idity) tor J6h (to promote blast 
fllllWlllOn and repllcat ion ofT-cel!» ",ilh ,he flilSk positioned upri ght ami th~ ':;11' 
,lightly loo,encd, Ce ll s in a 15ml cenlriflLge lube was ('eIHrifllgcd (1IKlg, IOmm, RT) 
and the pelle! '-~'ll,pellded in pre-warmcd RPMI ~olIl pl ete m~d lll Lll (contaming 2u .. , 
IL-2) ami lnlld;'rred to the 25('m' fl w,k . 
2.2S HI \, inhihiliun a;sa) 
The anli_T1IV _I activi ti es o j cruoc imh\'u, brea'imilk, pregnancy plug m\l CUS, punficd 
"'!Lle'iB and MUC7 ii'om saliva, )"l lJCI lrom mill, and pregmm~y plug mucinl 
(contQin ing MUCI, \ I I:C2 , 'I, Il JC-l \ fl.'C5AC. MUC5B and MU(6) from HlV 
negative individLml, and PLlI'ifkd " llivary MUC5B mlll \ IUC7 I, '()m HIV P(\,ill\'C 
mdivHlu,Jls with ddTe retlt CD4 count, « 200. 200-400, and >-I(l0) was tesr~ d 1Il an 
1nhibili(\n ,,<say a~c0rding to th~ rocthod of NagalhlltlmligaLll et al. ( 1 ~'l7). Each 
,ample wa., diswlved ill (l25% PBS and ('i IKl ", 1 or () . 'lm.~ each) wa, mixed witb 4ml 
of the SUlltype D HI V-I 'LljX'malam fl uid ISIo,-r} and Incubarcd fo r 60min at 31"C. A,< 
c()l1troh, heal inact ivakd IllV-1 and 1I1V- 1 plus med ia (RPVII IMO ", ilh 10% fel,iI 
calf,cfllLn and IL-2) were "",d. Ttt" ,--m)s ,",,1~ fi rst i,o lat~d from an AIIlS pmient by 
lhe Depam netll of 1>-IedicaI Vim logy. T ygcrberg He>:<pLtal (Cape To" n. S()uth A fi'i~a) . 
in Fcbruary I'lRR, and Il wilS fu lly charanerised and sequcnced (TrcurlllClll et aI. , 
2(l(l2). At the end of lhc itl('uba ti on period Ihe rni ~tlLres (HTV-I p lu, ('nHic saliva), 
(HIV - 1 pi '" brea,l 111 11 k ). till V' - I plus pr~gtlancy pl ug HIUCLl,), (H I V- I pi llS \ ILle'iE), 
(H IV-I 1'1111 \lUC7l. (/-IIV- I pillS MlJCI), (HIV- I pi ll' pregn,m~y p lug IJlU~1I1S), 
(H IV- I pi u, 'vI L 'C 58 !Tom III V patktlts with CD-I count <201l1, (HIV -I P lu;; /1,1 ue 58 











I IIV patients with C D4 ",,,,,1 ' 400 J. (I IIV - I pi us M L'C7 Ij-om HI V' 1',11 i<:ll(, " . ith C 114 
"0"111 ").00). (J IIV I pllt< MLC7 Ii'()]n HIV p" t l~rltS WiTh CD .. ("(>LHn bel\H'~1l 200 and 
4(0), (lJlV- I plu' \ IUC7 Ih>m 11 1V pati~nts with CD4 Coolll ' 400) ,,,,d llL~ c'omrols 
(lIlV I plus media) and heal ma(:l iv,l1ed IIIV I wne liltefed throlLgh 0.4511nl po re 
size cc lilLio:'<e acda[e Ii It er (2 .'i mm di'lmcter) ~ nd holh Ih .. · ' ''' tilt~ r~ d and fl l tcr~ d 
S<1I11J'le, were i!Kuhated wilh Ihe I' IIA stilllu l ~trd CEM SS (' d l ~ al TrC al " 
collccntmtioil or 0.5 x I 0' c'e1 I ~/m l fl>r .Wlllin. Ih ~nd 3h C~ I I, wne th~n washtd 
Ihree t ime, wi th P13S [0 rctl)(,,~ Ii"~e VJnI ~ ;md cultured. Supern~lalll lluLd wa, 
harv~,I~d on 1);1,' 4 ;Ind vira l repli('alwn "a~ llleas u r~d by ,1 qlwlit,ltive p24 antigen 
a"'av. Eudpoill t, were cak\1 l ~tcd h, the R t'ed-lvl U~Il(:h flmnu liJ ;lIld the SO% t issuc 
cullure ;nfe(:ti"e dl>'~ (TCIll;,)] \Vas e,>;prcsscd as lh~ hIgheST d il ull01l Ih;lt produced a 
p(>~iti 'e qlh,lil<lIive 1-'24 ;Intigen result . j\11 samples "a~ done III Lripi ic";lle ,mel the 
,,,,ti -HIV- I ~cli vity l>feac"h ll ll lC"l)1 W,l~ le,ted in ~ sc rial tentold dil lLli(>n I 10 1(> I If' ). 
'10 lkt~nnine if .vll}C7 Can mhihi l HlV-I ml;'dilln hy bllK"kll1g the rllliltive " ira l 
bi ll cilng ,ites (receptor», the PHA slim ll ia(cu CE\-1 SS ce ll , aml I' fl MC, from ll lV 
ll ~g ,ll i v~ lllllividll,Ji, were incubated with difJdeJl{ er>ncelllrmi(>llS or ,al ivary \ ,1 I;C7 
(1 mg. O.Smg. 0.25 mg alld IU 25 Illg) 1(,,- f,(Jlllln at ~ T C. As ,1 r l>~i1l\'~ c"lllltro l the cells 
"'ert in,,, h,,ted with PUS ~nd ~> a negat iv;: cOlllrol IUltrcakd Or cell , oll ly w~r~ u~~d 
Al the ~Jl(l of the lllcuh,nion period llJV- 1 Subtype II ~nd :'Uhlypc C were added 1(> 
thc mIxtures (CF't1 SS c~ l1s p ill' .vlI;C7) cmd (Pfl'vlC, ph lS \flT7) res l:>e(th'e1y 
exc"ept tl> th~ neg,nive control. To ched; ir MI.'C7 ('ou ld rcd"c;: vi ra l inli?clwn r>f lhe 
HIV- I int'Xled PBr,ws. HIV- I f>0, ili,e PH'tfCs "er~ lI1cllbaltd with differem 
c"lHlC"elllr,111 011S of M lIC7 ( 1 mg, O. Smg. 0.25 mg ~nd O.125mg) and (·ultured. Illh i hi 1 "'" 
as,ay waS perJ(lnfl;:d as ahov~ 
The mle " f \I\1C7 in minim;/. Ing lhe" ,pr~ad of HI V- I li'mn HIV- I rXIsi ll ve Pfl MC, tl> 
HIV- I lleg"ti\'e l' fl MC\ Ins ,lI so determined hy the illhibition ~ssay. 13riet1y the PHil 
,Iinlllialed HIV-I P"Si li vc PRvl C~ '1L"r~ mcubaled \\"1I h differenl cOllC"emnll lOnS of 
'vIlIC! ([mg, 0.5mg, 0.2Smg and O. 125mg) I,ll' 60min ~nd lh en added to PBMCs 
IhHfl rrrv-I neg;llive individwi ls. As mntml tile Irr V-I posltl ve PU.\1Cs were 
illcllh~ l ed wllh lhc PB'vl C ~ limn HIV-I negmi"e lll di v idu ,lI ~. Cell~ "cr~ th~ll cultu red 











1'0 ,h~,k if Ih.:r.: are di rkr~11 ces 111 the degre~ ()f i nkel i "Jl Y or ,'irulcn~c of the viruses 
illth~ .Ialiva. breil;;lll1 li k. e~r\'ic'al secretion and pia,,,,,, () f'HIV-! positive individuals 
th~w ~~CL"~liollS \wre ill~ubated with CEr.l SS c~l i.I. A~ il <:onlrollhe CEM SS cell, 
,,~r~ 1I1cuball"(i with lllV-1 Subtype D. Ccll, w~r~ Ih~n cultured ,md viral infectio ll 
W,J> deknnlll~d ,JS "bove, 
2.26 I o\il'ily of human ~aljvar~' . hre,,\1 ",ilk il"d l'l'nk~1 mul'in<, to Ilw 
Al'ric~n gr~en IlIonk9' kidn~.I' cdl,. 
Pnor 10 th~ il1h1bilion :llsay Ihe toxid lyoflhc purified salivary MIK'5R and \ 11)C7, 
hrea.11 nnlk mucin (MI,TC I) ,m el prcg;Il,IIl"Y plug mlldns (~011tain1ng _\llJCI. \IUC2, 
\fl JC4. \1UC5AC', MliC5B alld r. IL'C(l) 10 A ff1~,Jl) gn:ell monkey kldl1~y ~dls (USC-
I) ",'a, d~teL'r\lined by th~ tmicity a,.lay. Bridly A fi'ic,Hl g;re~11 ll1()nk ey kidney cells ill 
a llL()Il()lay.:r on 96-\\dl eonflucnt plaLes were Ir~ated with 50fd tn. 1ll1g;) oj' ~ach 
nlul'ill and Ihm .Itaillcd with ,ry<,tal violelto detcrmine ccll cytow,~icily a,jlldg~d by 
the integrilY ofth~ mono l ~FI'. 
2.27 Vaccinia ,iru, inhihition ,,,,a~' 
Th~ anti-vGK-5 (va~dnia vims str;J in. which is a fmn il ., of the poXl'ims) a~tivity of 
purified s;Jlivar)" breast milk and pregn~n~y plug mudns was lkwrmined by an 
in1uliLlion assa.,. 1n lhis ass~y Alfican )!fecn monkey kidney epithelia l cell, (BSC-I). 
l11ilinlilin~d 111 Farlc'.l B;l~e MillimUl11 F,,~uti;JI \kdilll11 ~ouLiulling l.-gI1lIa1l1 n '~, 11011-
~ssenti,Ji ilmino ,,,,ids. l'<a1ICO.\ and F~ta! C;Jlf Serum ~t a l()'~'-o fin~1 ~OlKenLr.Jtion 
,,~r~ growll 10 10()".-;' con fl ll"nc~ 111 wel l, of' a 96-wel l clLlture piar". Well;; were 
il1o<:ulmed wilh seri,Ji dilutionl of lunre:lkd \GK-5 or \'CK-5 tr~il led with 50,111 
(0. 1 g;m) or puri ii~d ;;alr vary \-IUC5B ,md \HiC7, bre~SI mTi k l11UClll (\HiC I) and 
prq~nancy plu~ mucins (containing \llJCI. MlJC2. \llJC4. !l.HJC5AC. MJ.lC5B alld 
MUC6) illld tlWIl ilKubmed at 37°C in il CO2 in~llbator (5'Y, CO2) for 48h to ,lilow for 
the l;mll31i()ll o(viral rlaljlW;; wtlL eh are c1rcular ' i1 r"ak<,' m lhe cdl m()nolayer c~u.led 
by illf~ctious vims p,mides entering ~d ! s ~nd subsequcntly killing them, Jia~h plaque 










,\1cdia was rcmoved fium each well and cell monolayer:<. were ~ta;ned with a Cry~tal 
Violet Llyc soluti 0l1 (lcrlo Crystal Violet. 20% ethanol, 70% dJbO) in order to 
distinglllsh viral plaqllt's Jnd ,ell deatlt. PI»ql1es in each well were count~d amI the 
ant l-vGK-5 activity of th~ mucin~ was quantified by <:alculaling the pt:rwntage 












I'URIFICA TlOl'\ AND C HARACTERISATlO:"l or H(J~1A:"I SALIVARV 
\HTCIl...-S 
.~ . I Inlmdu,·li"n 
The objective 01' lhe ~l\id} ri'porled in Ihi , chapl~r wa, to purilY and charaderize 
hlllmm silli VilT} mu~in, and to later eXimli ne their imli· HIV·I i1<;li vily (<;ee C hapkr 6 J-
Human crud~ saliva was s.c parat~d by Scpharos.c CL·411 gel filtration and puriJi~d by 
a two-step is.opycnic density gradient c~ntrifugation in ca~sium chloride, TIle pUllly 
imd idenlit) or the>e mu~ins Wi~\ assessed by SnS-PAGF and W~skm hlolling 
respectively. The amino ilCid COnlp<lSl lion 01' th~ nlucins wa~ also dclermin~d by 
llPl .C anal )~is_ 
3.2 Results 
3.2.1 Sellharosl' CL·4B gel tillnHion of human saliva'1"' Ulucins 
S,'pbarose CL-4L3 gd fillCillion chromal"~raplly was perfilmlcd In <;epaml,' human 
",Ii,ar: HllLcin ~oll1pnnel\ls ,wcording to size. As showtl in Figure 3,1 the eiUli ,.ll1 
profile d~monstmkd th~ pr~S~l1<; ~ ol' two mucin rich macrOl1lnkculcs in humJn sali,-a 
which arc ddectabk hy Ih~ PAS JSo.1Y JJld distinguish'lb le hy their d ifrererk.'~ 10 ~i/,c. 
The \1(,1 ~ lukd In the "oid ,olum~ (V,,) "hi 1st Ih~ M(j2 in th~ incJud~d ,-oh,me (V,) 
of Ihe column. Protein dcl~(_tiol1 WJS by ab,orbarl<;e at 2~Onrn_ The \1Ci I containing 
fraction has low 280lUli absorbanco:, unlike Ih~ MG2 containing ITi1<; lion which is 
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F i ~ur . 3.1 S,·ph. 1'0'" CL-4 U ~<I lilt r" t ioll d""",a"' ~I 'ap hl' "f human cl'ud" sol;" •. So ill bl e 
( I Oml) "nH\e h'U"" Ll ,,, :: ,' " ew oc te d in 6,\1 ( i uH CI C(H llU' "" '~ IIhl1 M FJH ,\ . . \ OJ \1 "[\J, I 1l1~ 1 I '/>l Sf 
and O,I ~' Cl IA I' S )'11 6, 5 'I", chn:Jlr.1logrol'hd on " :-:.cph''''''" ClAR CQ lu111n ( 100 x I.i>cm. ,,,lull,. 
200m!) . I '" ,,,IUIII Il "'".> clll tc d wilh 4~1 (iuHU conlailling 1001\1 F f)TA, 5llL\1 "<[\1 <lnel 0 U~% 
Cl I A ~S . pH 6. 5 '" " Il ow r.He 0 1' 4~mV11 ,,' room ,eml"''''' ''''., F" ,,'tions (2,O mll were oLla lysed f" , 
co,hoilyJclLtc wi:h PA'i ,, ' 55511m (+) al1 d 10' ), ro" in by A.~, i_ I. \ JG I I",d MG2 c0r. ,o i Ll i n~ f,a" i,,,,, 
" ere p00h l ,"po'OLc l), " ,,,I (hly 'cJ "ga in" Ihree chang., or disti lld """ '"' (), en': ~ iH ": 4'(: O!lel 
f" ' c.<.:-ci riNi 
], 2.2 SUS-I',\ (;E analys is oft he '1(;1 containing rra~lillns 
To J~teml ine the effickncy of th~ s~pamtion b) S('phawse CL-4B gel fi llralion anJ 
Ibe cxt~nt of plIrity ufth~ materi :11 tbat eluted ll[},kr Ihe \1(il p~ak (\'"j, I rccz(' -dn~d 
MG I material u[] d ~r t h~ V,,, r~ak " as sLL;;]X'nded 11'1 gel loading nu Der n mlail1 il1 g 5% 
~ - lller('arweth~l1,, 1 and >lIbj ected to 10% SDS-PAGE (hgur~ 3.2). Follo"ing 
electrl>p hor,,,, is. gds were st:lill~d with LOc)lllaS;; ic Blill ,ant Bluc R-150 (F,gure 3.2/\) 
and PAS (Fif! l1rc 3.2R) to detennme the r resen~e o r prolein nmtamil1ants :Ind mud n> 
























l'i~lI rc3.1 :'>J)S- r ,\ (;L "naj~,i, (Or Ih . ~!( ; I mat. l"ial. Fr<e7e-dr iod ><1IHpl ., (JG!l~J ,,[ 1"" 
MGI lJO'le,,,,1 h,m L ,,, donor' "~r~ p,ep",ed in ,,"durillg H. i h1,jillg b"tl.r "'xl s. poro;o,j an .m', 
SJ)S-P.·\(,L. ( ,~l, ww' '· .• incd ", i,h (""""",-,, ic Tk lli"nt Blu. R_2.'O (M ""d r.\s l,m Lon.s ore 
nUlL Lh,'red lin li Le "' I' "I ,'.ch g~' aL"I,I,,' molcc"I", weiHht 11""ko" "xlic"t. ,j hy \lw, Th., O(IOW' Ln 
h l.,e lrld",ale, (i,,- ""llip",."in bunlh 01 lh~ \1(" lnalc"Ti aI IA( allU :h"" '11 ,cd irLdicat~ :he InLH.ill' 011 
1"1' of ,h~ '1'~' ~j L1 ~ and I~1 l~p lIi'lh~ runnmg g,l If) ) Tile' " lack an "V,", ale at llle ,'al'l oj mnn II1g g.l<. 
The C("'ma,,,~ Bri lliulll Blue R - ~.'il) stained gel ( I--igure 3,2A) dcnwnstratecl the 
rall~m" \11 , , ,ize 30-GOkDa ib luc ,lfIl""Sj 
suggesting tilat nlrthcL' purill cal]()Jl 01' lIl Ll C11l wa, not T~qu'r~d for v"id v()lume 
mater inl. Wilcn the Same gel was , ra incd wLth PAS (Fig\l r~ 3 . ~R) Ingh nwkcular 
"dglll ]ll " ~Lll bamh wl lh a "'L:~ gr~dte r thall 220kDa were "een ('n wp "fllle 'tacking 
and runmng gd (rcd arrmnl. 
To dck nniM thoe ~Xknl or purity () r lh~ IT-acri",,, eluled \lJl(JeT Ih~ MG2 p~ak or 
'nduded V(,llIme (V,). tl'eeze-dried samples of the Mlo2 c('nta in ing fr,lctions prepared 
ill a r~clllc.trig g~ I loading buller w~re al,,' ,ubJ e~led to I ()~--;, SDS-P ACi F (FigLLre 3 ."'1 
Ge l> woere sta incd for pL\,te lllS with CO'lillass ioe Bri ll iant l!llloe R250 (l'igurc 3.3.'\) and 

















~ i~ur~ ,'.J SDS_P A(a: .naly,i, ,,/' t l", M C2 m,h' I'ial. Fre<7e-d rJ . d ,,, ">pI., 130LJ~i of tb~ 
~l( ,: maleTial IT,,m ,i, <innn r, WeTC 1''-'1',,-,,1 in "due i'"!, ~.I Io, dln ~ butT ... and '.p"",ted on a '\1", 
SlJ~_r.,\(iF (id., weTe ,"ined w ith (',,,,,",,, i, [Jril,IO'" H:u< R-.' 50 iA) and PAS (Rj. L",", ,re 
'1Umh er~d nn 'k top "I' each gel ,nd ,1-.., n1(l1, eul aT w.i~h[ ,m ,-ker, .nd ic ared by IMw), The bl,,-k 
a",,,," _'r~ a l lk ,larl nrn"I[, i"g gel, 
In comm,110 th~ ~ 1 (J 1 containing Iraniom (F l gllr~ -' ~A) , lh~ C()Ol11"S"~ Bri lil ,ll1l 
Illu~ 11 -250 st"in~d gel (Joigure :UA) showcd morc 'lllal kr lllok("u lar we ighl 
~()l1l,1111il1al1l prol~lll~ :JSSlKi,Jltd wilh th~ MG? mudn imiKatmg Ihil t funhcr 
purification 01' lhe M(;~ cOnlaining li'a~lio [] , was r~qtll1ul \Vh ~l1 tile 'ml1~ gd was 
qa i[lCd WJ th PAS (Fi,,'lIlT J,3B) lh~ m1llcTiai lhal dtll~d tlilda lh~ /\'1(11 pt;llk or 
m~ l lllied volulT"" showed il rd;ui\tl v smililer ,1Zt mU~1I1 th,J! parti;dly ~ntel'~"{i the 
Tlmnlllg gd. 
:l.lA Ca~~iur1l chloride isopynlic d~n ~it} gradient centrifugal ion 
rhc Mlil matel' ial elu ti ng in tlw Vi ofthc gd fillml ion column wa, plIl'i fied by ~ two-
'kl' ~1l~SlU1l1 ~hl()nde lS"pycn i~ densily gril uiml ~entrirl1g;lli"n wilh" buoy,mt (knsi ly 
bel,, ~en I JSI and I..-lOg.mllo r~m",~ lh~ prOl~" 1 contmHHlanh, As shown HI F l gur~ 











fj-a~ t i(l11aled "I a lowl·'- ,j..,1l8ily .. nd IlmClrl~ (po:sit ivc for f'ASj Ihal fmctiomlCd at a 
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0, .. 1 -~--- " _~ -- 0.2 C." " , , , • " , , , , " , , , , , , • , , " ""h:;n -,m"Jbti, , ";lOt oo n '""= 
~ ig u ,"J.~ C ,iO"; rrru chl' " idt, i'op ) ('lI i(' den, il.,· ~radi <1I1 Jlu .-i lk-. li'HI "I' M ( ;2 1Il"1~'-;" I . 
f,,,,,e_driec1 \fG ; m"rer~'1 "'OS d",ohd ill ~ \1 Gull C'l "Dll(,illill~ IOm·,1 Loll IA ~",M l'-H I 8I1J 
(0)'.', <l IArs r l l 6" ""~ 0(11"Sle,110" u"",il~ of 1.39 to 1.~I)p,'ml wLih ".,Iit) "fie",,,m "l\lori& 
1)eI'lSi',. gralli e'" c~",rif"gati<)11 ...-,,' perf0 rll\"~ in 0 u",l,m,," H 5 ul" ,,-centri fuge f0f ~8h '" .' iO~ 
llilllg 0' 4"C MUCHl [,os i,!'" IT.C1H>n, 1. 1 0' a <le l"it)' ( .. I berw,," 1.37-1,42.'00 'ti ll ."""w',"ed with 
,-,,,ne pnltei l1 I . ) (A 1 ... ere p l~'kd ,,~I pr;'porod fnt" ,he "0(>1,,1 ("CllTr:fU?,C"(>11 step IR). FII"'.I), t'r."'imlS 
(fmotioll nLlI11 Ix:r~, 5 and oj wore ['Ookd, dial y«J again" ,h,-oe ,hallgc, of d""IIcJ ,,"atcr ovcm:ght at 
~"C and frcc7c_d ri cd, 
Subsequent to th~ two-step ca~,i\lm chloride isopycnic density gradknt purification 
the puri ty of th~ )"'lCi2 [radlOn W,lS ,1s~~"ed by SDS-PACiF (F igure 3_5) , Two v~r) 
clear bUI ddluse: PAS p()S iti\e bands (F igill" 3,5 lane -' arro\>,s) lor .\/(;2a and MG2b 
(MCi2 gly"ofiml1'» w~r~ ,e~n In lhe nmmng gel. Th~ MCi2b band wa~ more dilTusc 
(han the .\lG2a band_ Two protein b .. nds (l'igur,' J,) l an~ 2) \>,we ,een in t h~ s,1ll1e 
pos itiol1 '" the PAS poslli\-e )"'1Ci2,1 b,llld (F igure Li l an~ 3 atTow~) . There: wa~ nO 
cquivalcll( band to .\1G2b OIl the Coomassie gel. Unlih' the Cooma,8k ,wined gel of 
the ul1-r LLri lied M02 mmcri al (Flgure .'_3A'1, ol1 ly la im protem bands with molecular 
weiglll of :O;JOk Da wcrc ob8crvcd in the Coonws,ie sta il1~d gd of the purifted \ 102 
m"len ill (Figure 3_5 b l1e 21_ The~c 1,,,,, ll1()I~cul ar wC lghl rnmcrials uf <-,OkDa wcrc 
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Hgur~ .~.~ SIl,'i.- P'\( ; [ .n"I~·,;' "I" the pllritied \1(;2 ma!!' rbl. .. 't'cr c . c,ium ch:"ridc 
iso pycnic dcrsi'}, w adic1'.! puril,"atil'" h eczo _dried (.111,"g) QI" tho MG2 c~o tair.ir.r, materi "1 " "' 
prep"red in rcdl lC i1'.g gel lo,di"" b"fkr , " d ",p~rat<d on a I(j'/, SD S--PAGF, G. I, w! r! , j,i1'.od with 
('""mas, ie llri:li ~nt Rl "" R-250 ilal:"' I , od 2) ,od PAS C' ne J ) , r."1C I i.< 11-<: "",I,c ul,,- w"i~ ht 
marker , Tile a rrow, ill rod iuiieate tile \1(;2 InlJ(, 0 b , ".d, (\1(;2a ,,,d 'v\G2bl ' nd 'he bhck ",'QW .: , at 
,I,. .''"rt ~f nJnn ' ng geL 
3.2.5 \\' eltern blottiu ~ a ua lysis 01 the .\1(;1 mucin 
To ([etenll '''e Hi •• (kniily, 'vl(il Illl '~lll wa, ,craral~J hy S[)S-PACiE and lmllslCn-cd 
10 ~ nill'oc:d lll iose Illelllbrane, Aftcr probing Wilh mb bit ~m i Mu eS li polycj"n~1 
aJllihody, lbe MG I IlIUClll \Va, ("md 10 b.: Ml ;C5B IF.gure 3.6 lane, 2 and 3). 
R~spir~tory Ill tl ~in was \1s~d as a pos itiv~ control. ~nd was posi tiv~ t,., r rlc1UC5 1l 
(Figure 3 .6. !art<: 4) ("C Thomloll 0'1 01 1949). \I(i~ "lllC lll did not renet wi th lh~ 











.·i~ul-.J.6 \1",1"1"11 bl"ttin~ "",1),;, "I the lie 1 "lL"'in Il;in~ r ,hI,it "nt; __ \I ( I('~R 
p" l)d",,"1 .nlib"d)_ Lw,: I. M(;c rlll",][IIT":gaLLv~ con,,,,l)_ I'JIlo, 1 'JiKi .'. M(il nlLlCin, fmm two 
,kHKlTS a lxi 1'"'04, rc'''PLT,l\<''Y nll~'U' (r<>Slll V'- cont,,,:) were "-,p,,,,,,,,,j hy 10 ','; SD~ _ rA(iF ,,",I 
tWISterm ! to nll" " dlul,,"-O ""'ltlhranc_ ),ollowlng ,"'''might h lo", mg. :h" locll,hr"no """ ,nCll"" 'Cli ti" 
2h wllb ,"hh1t anll MU .' ll r oll',l"n,, 1 an"h<~ly (iliLLtc'd In 5~/. (m'v)](", f'"lllli , r'''''kr In TIlST ,,' I 
In 5(x) . TIl<.' ""-IlIIY,,",- ""' then "",hod ." 'imln w,th TBST ,md ,neLlh"" n j,,, Ih with HRPO Ij,-"cd 
go", "nt, , ,,11M SC'C(1)(iary ,mll h< xJ:, IllIulcd m _\% (m,',) _"" ii,t milk P')W(\cT III TBST "t, d-;ILJ""n 0;- I 
In <11111), .\1'", ,,,,,,Iocr T BST w",h (.1 x 5nllnl . ""n,i, wer,' JckctoliuSing ,m Fe l. ,io«cti,," ki, _ 
3.2.6 Wesl ern hlnll j ng anllly,j, of Ihe \1 G 2 m Ilcin 
The \1(i2 mlLcin wa, also 'lLbjecled lO 10'';;, SDS-P.\(iE and lhen lran,fcrrec\ to 
nilro~ellulose mell1 b r~l1e ~l1d probed w,lh goal al1ti-MUC7 polyclona l ~nlibody. Th~ 
two bands of the MG2 mllein that , lightly entered [he running ge l were fOllnd to 
>itrong ly 111t~racl ,," , th the ~111 ,- ML'c"7 polyclonal ~nlibody_ The"e could be the two 
glyeoforms of /l-1L·C7 (l-iglll"c 3.7. lanc 3). Again whilst the positi\·~ ,o!ltm!. ,md~ 
,~ I, va (Figuw _'_7. 1~11~ I) rea,ted wnll the allli-\IL'C7 anlibody. lhe negative COnlrol. 













i' igur< .1.7 \\ ",Inn hl"llin~ • nol) ,;, of tho MG! mud" u ,jng goal ""li'.\IUC7 1",I)'d,,,,"1 
ontihod}. LOll" I, "Hide >alj", lJ"",iLLvc ,,,nlrol). lane", g""i" 0" ' "'' (nep;i,-. control) "o(llolle J, 
MG 2 111", : n W.,. "'p,,,,,,,,,1 b~ ](1}, ~[)S- Y . .>, ( ,E "[l~ "'!L1s lio"cn to n-:'mo:".liul",. n-.,mhrclll<, following 
"",migh; bh;k ill ", tbe mcmbrcULc w,~, ,[~'LJt>t Ll cJ IN :h I'·i Lh gnat a,,:i-~ f UC7 ["" lycionoi ol1t ioouy 
dilu;.d in 5 ~', (m/Y) low f" [wlk po\\Jcr in nl~T at I in I(~I_ TIK mcmbrJn. wos ,11< " IYJsb.,1 3 )< 
SOlin with TBST "nd ;nc"""cJ for I h witil II RPO 1iL1'c~ ",hbi I awi _gna: "'''nodary ontil>i>(ly d i: ,,, .d ill 
5',';' (n,.,,) inw Iii: mil, 1'OI\d",- in T[;ST or a J:iu:ion GIl '" ~(J(J(J. Arkr a,,,,,:,c, TRS!. ""h (.1 " 
5mHL), hliL1ctS were dc'"c:cn '1< ing Oil EeL dOL.";U" lit. Whi:" c"mw' ill TeJ inJ'c',,'" lh" M(i2 mucin 
harl(l, l~f02J 01-.:1 \1020). the biOl'l lIrr"" ".,; Lhe "lITt ()frlLl:jlij]~ ~"L 
3.2,7 ,\millO add aDaJ~si" of MLC5R and ]\.fCC7 murin, 
Tu ddenl!m~ Ihe' ammo and composition of ML'(SU ~nd \ll1C7 lllucins_ bOlIl 
~111C5H and lI"flJC7 were subj ected to ammo acid anaiysi:;. /1.:; pre'SC'l\I~tl III Tahle .1_1. 
bOlh mucins wcrc found to contain m ore' se'Tjn~, glulamic' ~c"l. gl/~il1 e and a>panic 
ac',d lhan lh" mhe']' am1t'" a~id >. i'he \-111C 51.l c011l~ined high amounts ofdm;oninc 
bill the ~mOl1l1t of thrc('nin~ in the ML'C7 was In,,". ()C the,e ammo aCHls s~rine. 












Tabl.3.1 ·\millo acitl toml'o'itioll (mol 'Y. ) of .'lUC58 anti Mt.:C1 
Amino a~ids MIT51J MUC51J' (predicted: :\IUC7 MlT7b (pr~di~kd; 
~~parli~ a~id 
(mok %) mole%) (mole%) mole ~:o) 
'9 4.9 9.1 8,5 
! Thrt'OllJn~ 10J) 20.7 4.0 7.7 
Serine 7.4 11.1 5.S 9.1 
Glutamic acid 9,0 6,3 12.4 '.1 
Proline 1\,5 ,),9 18.6 14.0 
Gly~in~ 'H) 7,0 14.4 ]6 
Alanine 6.6 'A 3.9 4." 
Valine 6.4 5.3 4.2 4.1\ 
Methionine 1.6 1.2 L7 12 
looku~int' 4.0 2.2 2.9 2.4 
L~ucint' 7.6 'i .H 4.7 6.6 
Tyrosine 3.2 1 7 1.7 12 
Phenylalanine 3.8 2,3 1.9 ., .n 
Lysine 4.6 1.< 4.7 " Hi~tidine 4.4 2.2 3.9 10.3 
Arginine 4.0 3.4 5.6 6 1 
'Ha;;'u (M' [)~A ""IMnce dam from Iboms>on "' al (2002) and 'Li" et (Jt (2()(~n 
3.3 Discus~ion 
One of the ultimate objectives of this swdy was to test the hypothesis that it was the 
mu~us and purified mudn component of ~rude ~aliva \hal prevented the transmission 
of the human inmllHloddicieney virus through the exchange of saliva. The !irst ,tep 
towards the achi~v~mem Oflhis goal ",as to extract ~l1lde salh'a in a ,uitahk huffer 
that minimizeG the risk of endogenous proteolysis Wl(l to isolat~, purify and identify 
the mucin component of the crude se~rdion. 
According to AII~n (19Rl), mlKin ~ arc sll~ceptiblc 10 degradati(Ml by endog~nous 
proteinases during i solation and pttri Ikation, "hich ~ollid rcsllh in a collapse of their 
mechanical properties, This was confim>ed by Sellt'lO el al. (InR) who ,howed that 
she<:p submaxillar), and pig ,tthrnaxillary mtteins. which were isolated in the pre'Sen~~ 
of proteinase inhibitors, were dearly dilTerent in s\rudur~ from tho~e exlra~ted in the 
ah~~rK~ of th~ inhihiton;. As judged hy gel filtration on Sepharose CT-2R, in th~ 
absence of inhibilOn; Illucins w~re eluted in the indlKled volume rather than in the 
t'x~lttded volum~ a, the digestcd muelllS did. Therefore, throughout thi~ ,;tudy 
(slaning from sample ~olkction), GuHCl huller whidl contained a cocktail of 











~n/Ylnal l c dcgr.w .. t ioll which cOlLld o<xur dUri ng the coursc Oftlll;; e,'penrnt'ni. Wh ile 
PV1SF alld EDTA arc reponed to inhibit ,cri n~ and mctallo-p)'oteJ'cs IG'pcc!ivcly by 
ll1h ibllillg Ibiol protcils.cs. I\ EM i, hGl w""l tn block ;1)1 )' disullldc bond illl'lllal lOll 
i""lwe~n nlljClll ~ .. Ild othcr molecll le" F lLrth~T1llOrc. the addi tion of liullCL a 
de ll~(urall1 (,\Ilcn. 1%1 ) I> al,,) lh<lugl ll 10 enh,mce solubi li ty of LiIG,G mucill ' 
(Carlsledl ('/ al .. 1%3 j. 
Onc of thc dift'Cll ltic, io mlLCln pur ilic.Il,on,., t,",jr 'L%o,;iation with other molecule" 
Accord ing to l ic ei al (2004). SitU and Bobek, (~OOO) and Tabak. (1<)<)5). sa livary 
mucins ure known to bind with IlOn-mUCLnoU<' ,ali\'ary componenb ,u~h a , a1llyla,>~. 
Iy>ozymc, prolinc-ri ch pmlciol, '-latherin. h" lalilh. <;ccrdor, Ig .. \ (,lgA) and 
lactofernn to form u concclllrated proteclive barrier in the ora l ca" ty, Howe\'er, (hi~ 
complex formal ion ma; changc the ph ysicochcm ical prnpcnir:>< of the lal ivar; mUCIll;; 
ul1d 'ub'>~ qu~nt i y their fun~tion in the ora l cavily ( r abat. 1'195), rhe hydrophobic 
reglOn~ or lh6~ illlL<:; lh ar~ Ihe pan,> reporl"lJ to be rcs.pol1>ible for tlwse ~omplcx 
formmioll' alld lheir ,ticky charac(criq ic, (\Iehmlra c/ aI., 1999) DUri ng lhi, 
experimcnt cspccially du ri ng gel fil tration and dialy~il , ,pecLal CarC wal oeedcd (0 
llllllilllize or. if pos, iblc. to avoid ~ny Ill'» of mucin which could <'( ick (0 (hc 11IIr3(io11 
gel und dia l)'si' tubing, I hus CHAPS. u dctergcnt was included 111 our 
chmm~tography bu n"" 10 mll1 1m i ~ c the '>l lcky chJractenstic of mU~;lh and prevent 
lhe ir "h~ (fl 01 ,cher e/ a1.. I '1')9) , 
A~ m~nllOn~d ill tile pr~l'~d ing paragraph, although ,om~ ~al"ary l'ol1lr<menl<, ri my 
adher~ 11\ and clute " il.h mUClns, l'l[gc-porc sizc gel fi ltra l.i oll ~olumns arc reportcd to 
~ eparale muciLl<; in Lhc CXC llillcd vo llLme Irom the lo\\er 'T\o lecuiar ,,·eigh l~ pro(c ln<, Ln 
the inc luded \'o l ume~ (A llen. I 'IS1). As'l result in Ihe prc>cn l '>tudy, SephJwse C I 
4B gel fi ltralwn. which ,cparal~d hwnan (Tude ~al"a 11110 M(1 I and M(j2 mucin-rich 
pllpu l atil~ls in the \'0 and Vi respectively, was u>ed. Tilis find ing agrced Wilh Ihm of 
~ l ehro!rae/al. (199g) , Tabak ( 19<)5 ) al1d Tholl1ton elal. (1999) l.hat geili llralH ll1 Oil a 
Sepharosc CL·4R sepumtcd human cnllk suliva into lhc larger (Mul) and smaller 
(Mu2) Inll~in populat ions. Sub-.cqucnlly cae';lIm ch loridc Isopycnic d~n~lly·g radi cnt 
~~ Illrirllgali nn \Va, al ~o employed lo rCmOvC H, e IH 1I1·mUCIllOU<' sa livary componCTlh 
Or prolein~ which WCre detectcd in the Cooma'.>ie Bn ll mlll Blue R·liO ~(aincd gel of 











llldhod " known III s ~parat e mlLc in~ Ii-olll low~r dell s iT " lipid and prokitl and h'gll<'t' 
,ic'n'ltv IHL~k1(' aCid , smTes~ f\llly _ A, ,t i~ ~ondlld cd ill the pr.'~ ence 01- high 
conce-l1tratron\ l\f GIlIIC!, this m~thod lIot only T~moved protein cOlllam;nalll;;, hlLt 
al so 'Llppr~ ,s ed th e ad;v;t" of the dcgradat"": ('n/yrn~s (Clrlst~dt e/ aI. , I <)~31. 
In thi, e'pnirne11l the silliva sampks fi-om dil-tCrelll donors bo;IM\'~d simi larly upon 
gel 1,llralron_ snS-i'AGE ,md Westcl'll hlottin,[!. H()we"e,., a d rff~r~nl elution pwfik 
o l-the S~phaJ-(),e 4R gel IJltnl1ion especially Wilh the ~'l(jl peak wa, ,ecn wilh few 
la l1\'aJ-y ,amples which wer~ fl'l>l11 dl\nors wlm \Verc sutTe-rin~ limil dlnHlic ,inu,II.' S, 
/\lth'1L1gh lh~ Te,Nm "nl\1. clear why thes.' elution plOfik~ ~hould ,lIlfe-r. there c()u ld 
be a Il1lXing 01" ,~ ~re l.l l\n s ti-l\lll the na, al ('ilvity and the ~ahva which c()llid he tlw 
rc'al()n Ii" Ih(' difTerent P<'ak paltems of the elLltLl\n profi!.'s . rhus thesc sample~ \Vel'C 
excluded fmlllthe study, 
Ac:cl\rdmg Il\ the r~pl\r! of Creeth (l ')7 8). whi!.' th~ separation of lipids can be 
ac l" eV('d wilh lo ttie d il-li~ulty, the separation or the nl\n-covalemly bOllnded pwtcins_ 
and nlLdd~ acid" Ii-om IlllLdns by non - ,le~radali\' e melhl\(b wa, found Il\ be \'~r>' , , , 
diificult. l l owcv~r. Liu eI a/. (I'N'll I'ep()ne,l that lairvaTY lll llcin,. whrch were 
purified by reduct;\e methylation and alkylat ion pnKcdurcs and whi ch re~ ulted in 
C()Va lelllly mmhlic,lmLLcm" cat,,~d mucin, lO lo>e Iheir ilbility to promote baderial 
adhcrcnce and aggregation_ Sinc(' the Ob,l(,C l1 VC ol-lh" pilrt ol-lhe e\rxTill1~nl WJ\ 10 
ISl\ lilte ,md puri!)' sulivary mucins and dctcnn ine tildr anti-H1V-I aCl ivit ics lL,in ~ in 
dim inh ibitioll assays, th~ usc of thi~ pUrificatIOn method was avoid ~d. In,lead 
cumplcx fl\nnatlon octwecn the sal iva ry mucins and milcr ~a ll "'lr) pl'Otcin, (Cr('elh, 
Ins)_ 
SLlb~ eqLlelll l() S'1'han"e CL-4B gd lillral]on and cae,rLLm ch l()rrde r,opycn lL" den>lly-
grad ient purificalion, the purlly of til~ ~ amplc, wm, as~ e~ sed by SDS-PA(jE qaincd 
li)r prolem wrlh Coomu" ie Rri lli ,lll! R1u~ R-250, The reml\vu l 01' cl\lllamin;mt pwtem 
alkr cae~ ilLrn chlo ride i,,)pycni~ ,k'Nly-gradl('nt pLlrificati()n ,,'a, evidenL H,m'e\'er. 
th~ higher cost of the (;ullel, long tim~ llf ul!ra-cell1rifugatlllll and IractionatlO n made 











Onc~, thc runt} of the 1\)(,1 and :>'1(;2 ,;ahvary mll~ms was confirlll~d, their id,"Hllly 
"';IS dct<,[lllin~xI hy Western blnnillg , A, a rCS ll it The )'IG I ,mti M(j2 mlKills \,,;rc 
fonnti lu b~ \HJC51l and M[~T7 mu<:ms r",p('d1\'dy, 'I IllS w,,~ III 'l)!re~Lll<.'lll wlih Ihil l 
of ThoflllOn <'I at 11')':)9). whn IIHlicilkd Ih,1I \IG I Jnd MG2 nl1lcins aj'~ ~TK,,,:kd hy 
th~ \llJC511 and MI}C7 g~n~' rcsr~<:Ii\cl;" 
Thornt"n eI at. (199')) r~l'nrl~d lhe prc><.'n~e ()f t",o iSOj{')l11S of J\'lU('5U InUC'ln III 
human saliva "hich dllkr in lheir chilrg,' d<.'n"ly , Allholl:.!h The SOS-I'.AGL ~llJ lysis 
dcmon~mllCd (I", prc'~TH;(' 01mo lll(lci ,) b",-...b c"lo><.:[ y ,iTt illg 011 the lop of Th e gel. it 
i, I '~) cal ly to eOlll,lude Ih"1 Ih<'O' ar~ (11<' l\\'o i~010nn, 01" \-1l!l58, Acc0rdmg 10 
(i1Jlsnn <:/ ,iI. (2()OI), Ille ldcnlil ieal10n ,mu cl."raCIcr l/alinn of" Ilw,c )l'IY<:0fimn, 
rcq\lir~s inlLlllOilo anah'Sls eln the tllucin Ii'aeu"ns 11, a \,id~ range nl' lll11cin-'JlcC'lfie . . 
"ntibouics. in addit io ll to the ext~nsi\'C Ca~~i\lLll ch l urid~ iSelryC'ni(" dCllsi(y gj'adi~nt 
rU ri f",ati()n" Ilo\\'~\ n. T b i, i~ \ ery n pensi\ r ~ nd rtquir~s larg" a",ount:; (,f , ampl c 
l'u ti.hl'rll1or('. as rq}(l ti~u by Thornton 1'1 "I, ( I ~~51. The dJtlicll l ty of HlcnT i fy ll1)1' I h~,;(, 
glye0f0nTlS by "''''H.>clu'hJi iIl1l1h(~Il<" " thill. ,;In<;~ th, m()n()c l,,!),,1 ,mlib()die, "r~ 
dil1.:C'll't! at '~'-iuc"nccs pr~sLlll in llic lugh ly O-glyc-osylatc-d domains of thl"S'-" 
molccules. ~cpamtion and (kgl)To,;ylati()n ofthcse glycofonm is rcqulrcd, 
Mlle7 mucin gavc tlVel bands oolh in th~ SDS-P,\(j E and W~s(ern blo(ting 
mcmbmnc, As both are deTected by the same antibody, it is possihk that these two 
Bolsdocr (;1 al. (1')9')), Mdlmlra (;1 "/ (19'lS) and Reddy eI ,,/. (1')92). which 
dcmon,;lr~kd th~ pr~,cnc~ of 1\\'0 i~ol{mll~ of MUC7. design,lkd ",rl}e7a and 
'vIUe7b in human sal iva, Ac-celrding to these authors. these rwo isofomls ,'ontai n the 
S;lIne ilmmo ac"ids hUl (h lkrelll (~nrunal sugars such a" ~ialie a("ids and fucose. 
Therefore separation ol"thcse b~nus alld uetcrmination ofrhL'ir ,1m1llO ildd :lllU ';lIg~[ 
~()mJlO~ l l ion lS r~'llLl r~d. 
The amino .lCid anaIO',i , re~ult, agrecd with tl.., finuin)l'> of" Tilbak ('I ai, (19R2) who 
indK~kd 11-...: pre~enc~ of lar)l'e amount, of" ~crine. th r~onm~, j1rolm~, )!Iutalllk: ae l(i. 
glycine and alanine in the r~ptide punions elf the sali\'ary Lllllcins. 1I0weYer. thc 











valu~, According to 'vlehrOlra e/ ai, (1998) this could oc cau,ed by the level 01 
oligo"lcch'lrid~ ,ub,rirlllioll of (hi, rc,iduc. 
All the 'lb<)Vc biochcmical me!hex.\<; <:onlirTllcd lh~( the s~livary mucin wbicb wa, 
dured in th~ void \'OiUlllC o[(he Scrharn,c 4B gclliltralion column was rvlUC5B .mu 
(h~ mUCll1 whIch was dutcd in the includ~d volumc \Va, 'vIlle,. /\, illilUan sahv~ry 
m uein, are known 10 inb i bi! a numocr of micro-organism, including bacren a, >lm,c" 
yea,ls ~l1d (ox in, ;n the oral <:avity (Bobek aud Situ. 2003: Bosch <'I ai"~ 2(00). (hc 












nn: I'URIFI(',\T[ON A _'O[) CIL\R\CTF:RIZATlOI', or- IUMAN IJRl:AS'1 
1\111.1..: I\Il !ClN 
-1.1 Introdllr1ion 
The ohjl't: ll \,C or the SLLLdy rq1orlt:d 111 lhis Ch~pler was 1(\ pl Ln i'y and ~h ~nLlcn~~ lhe 
InLlnan hwa" l mdk lI1Ul'm and lo laler dc:lel1l11ne ii, am i-H [V-I al'li, nO' (sec Chapkr 
1'»_ Mil k r~l globu k ll lCmbr'lll e (\I]-(il'>l ) ,,',I S prcp'll'cd from!lw hUIllJn bre,,,t milk 
~nd cilrolll"wgrapiled 011 :l Ser il" l\l,\e CL-4 U ge [ 11 [t '<It 1011 w [ lln1l1 . l ppn pll n 11 (,:111 on 
by ('"e sium ~h l() nd ~ l sor y~lll ~ de""ly gradl,," l eellln rngall!)]l. lhe' jlunly ami idcnil ly 
of Iii<: mLL~in ,,~, a>scs>ed hv SDS-P/\(i E and WCslern blotl i n.~ respcCliw[, 
hJr(hermol'~ lhe Jtllino ,", it! compoSItion of the tllllClll W ; l~ detcrminn l hy HPLC 
-1,2 [{('sulls 
4.2. 1 I'r rpan tiullufmilk falglubllk membralll' 
To prcparc lhc milk ELt globule mcmb ranc (MF(i\1). human bre'blmilk ""IS def:l1led 
by ('C l1l nfugalio ll m.l ()()(jg for [h ~14'C The Cream ii-al'lion llldicalcd hy the amm in 
Figllrc 4_1 'I'as colleclcd and processed as descri bed in the /I.'lateri:l'" 'Illd Method, 










wnfigu," 4.1 Pr<p~ ration or 'nilk <"'~m . H u,n"" bIT"'t ",ilk w"' defatted by centrifugation oJ ,'OOOK 1(" I h af 4"C. Th e cream ITac lion (red armw) w", collected and proce"ed [or the p"'pararion of 
MF(i"'1 (for <leI.il, sec the MaiGri.b and Methods ,eclio" in chapler 2). 
4.2.2 SCf,haro,e CL-4B gel mlra1ion of the milk j~11 globule membrane 
The mi lk fat globule membrane ('VI I' GM) w~s subjected to Scpharo,e CL-4B gel 
iiltration ~hrO\nalOgJHp/l}' to iso lilt e thc milk mu~in. The elulion pro li le (F i g llr~ 4.2) 
indKa1cd thaI \1FGM ~onlain, two popuiatiolls. a l\1u~in rich popul~tion (\-II-GM-A) 
eluting as sharp PAS positive peak in the Vo(void vo lume) of the co lumn and anolh,'T 
(MFG\\-8) tbm elu1cd In tJ, e V, (included vohl1n~) of lh~ ~ol u1l\n . separated on the 
ba, i, of size. Th~ p" 'lein pm lile ;)1 an ahs(1fh,uK'~ 0 r /\2.0 sho"ed ~ large jX\lk c I u1i tlg 
in the Vo of I h ~ cohl1nn 'L%oci;)tcd wilh lhe MF(iM-A I;-octions. coinciding with but 
hruaJcr lhan lh" PA~ pOSilhc peak, whilst ~ small prote in positi ve pcak. i,,,jiC<llin)! a 
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Fi~ un4.2 ~,pIHlrO'" CL-~lJ ~d Ill!l-~lio" of lil t milk ra' gloi>ul . rneml..-a n • . ~()l llhk 
(2(lm l) _\1TCM ",os cbrulllawg' flpiLcJ on. S'Th"" ",(' CL -41l W ILLrl lIl j Ji~) x i.ocm. \·" luI11 " 2i~)ml) 
j h~ co ,um:\ w'S dlll~J wilh {I .2 M NaC L O.IJ:" ·', ~"N, "<'Lllfl" ll llg l lhn\l h [)T,\ and -' 111M ~f- \1. a' ~ 
~ow "" o f ~8ml b ", ' '''IlL Iml!,,-'r,1'"," 1"flclllJLl' 12 .ln1O l) "'Ofe '""'y,~d Ii" "a,b nhydraLc "i lh r .. \~ .1 
555nm I. ) "nJ pro l~: " A,x: (_ ). I iK' \ "_ \ IIO(,~h\ .nd \ .' MH iM B wLllaioill g li.CLi " ,-", wcr~ r(~llcJ 
sc!,,,,, ,ei)' "nd d'<l !),;cd "r"i",' ,il rt' t' d>Jnge, of di,,; llc.i w" '~r O\' LTOl i ~hl a' n~ and li -Lac_dri~d_ 
4.2.3 SD~-PA(~E analy<;i<; of the mi lk fal glohule rnc m hrmlc, 
T" ,klCl1l1inc thc p r~ '~ncc of mucin/, in the mi lk iilt gl()bule membranes, I-reeu-dried 
V" (MHiM-A) and V; (MFUM-B) mal erial ~ "ere di',o l\'cd In 'ample loading butY",r. 
Sa L Hrle~ were ll"", ~ ubj ec l~d 10 Im{' SOS-PAGE and sta ined lo r protein with 
Cooma,>,ie Bn lliant Bluc 1{-25 11 and lo r cadJohydraie with PAS (Figure 4 ,3)_ PJ'Lllem 
slaining , h Llw~d a larg~ n llmber " I' band, ranging In size from >120kllJ 10 txe low 
J..\ kll'l fur thc V~ materia l (Figure 4,3 lane 2) whi lst lL's, pJ'Llldn elu led in the Vi Wilil 
d~ar band~ al anlllnd (iOkDa. 25kDa and 20k l) ,1 (Figure 4 .. , lanc 31. l.'pun ,taining 
wah PAS the \-'0 mmcrial , how~d high molecular weight mucin bands , iltlng on lhe 
~1 ,lc k ing and at lbc l ' .~) o r the runni ng ge l (>220kDa) with an addit ional Threc ' ll1 ,illcr 
bands that mtcred tbe numing gel ra nging in , ize 511-30kDa (F igure 4_ J lane ..\). 1',:" 
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hgU'T~.3 ~D~-PM;.: ",,"I)";' "r 1h,' n, il~ fal ~MlIll. rut'milc.n." hee,e_dTl, d ,,"'pk' 
\jO,-~) or \H' (;\l -A (1:""" 2 a'1(1 4i and M FGM B (_ane, _, an d 51 worc propared III redLl oin,' f'ol 
loaJlllg hul']:.:r .wl 'epar"le-d """ I (~'" sns PAG I' Ge!, were <rained wit h C ..... n .. '<' <: Rrilh ,nt RI,lC 
R :'51) (iun", I. 2 a Lld -'J an d P.-'-~ (la,,,--, ~ "n..l 5)_ The on·o,,· , "' re d ir.d,cat" 'he mue ins " n the 
,tacling_ "" lOp or ,ho rulLlLllLg alLd ,ilgh'.Iy O[llOrlng lilo rLmllTLg gel "nd the arrow lL1 hl"c' " a t II ", 
, I", ,,1 llilUliLlg gel Lan" I " a , rKlic-ClLlaT v. oighllll,, ~ cr_ 
4.2.4 Ca,'siu III "h 10 rid,' hop) cnk d,'n ,j(y !:rad i,'llt (cclltrifngatioll 
jhc \'0 m~tc[i~l (\lFG/l.I -A) of dw Serharos~ CL-4B gel filtmlion column was 
,uhje~kd t() Cae,ilLl11 "hlori'k is ()py~ll lC d~l"il.y grad 'ell i. ~elltrif!lgatiol1 to purify th~ 
mlLcin by [,'moving tilc a"slX'im~d cOlll~min~ll1]g prote iu_ Th~ plLl'itication protiic 
(Figure 4.4) d~lll(Jllstrated thai Ihe f'AS p()sill\T l11LlClll was d early separated ii-om Ihe 
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Fr.c! ;" n nl>'"C>er 
F i~ "r< 4A C •• ,ium ,'hl"rirl,' ;,"p)'Cllk Mn,it}, ~r~dkn ' p u rine.lion "f \l FG M _A 
~"lIt~ini ll ~ I..-,,<'!ion>. fr~" ,~- Jneti ~I H;M-A " (~ L"'L [] iLlg reo"lLon, were J i,,,,,[, eJ L[] ~ ~ j (iuHCl 
contai"c " g [(lm~1 UHA. 5m'] " J , ~1 m><.l (I .IIS'Y. ('flAPS pH 1>.5 au,j "uju',[d lu a de",ily of 1.3') Lu 
1 . ~Og"'ml wilh "" li,1 .'a,·>LUlll chlurid: [)m'll)' gra,I;';:[ll CC lllTi fugaLiun wo, pdfuI'md in" Uc-ckmo" 
L~5 UiLrO-CC'lllTifuge ('" ~~h allL [115 I~~)g a1 4'C Frxll",]> (C"~' ''un Huml,,:] 4. 5 000 6; pu,j, j,~ fo< 
PAS (. ). lL[~1 ",iLh hanHy an)' PW[CHI I Luy. ry) (_ ', and uf ,jetlSil), I A ) beT', cen I, n-I 42 were p",,]ed. 
J llLly;ed ag' i ,,,, ,hrN" chntlges uf di still~J ""t~r o\~rr. i g ht .or 4"C ",~I fr~e,e_dr'"d 
FoIIO\\'lllg ocsiulll ch lon de isoPycllIC den, il}, gr~d l ~nt purifko li l>n , th ~ pmi lY of the 
.\ I I-GM -A matnia] was dC lcnnJtl cd by SDS-I'AGE (Figurc 4 . .'1) . Stammg for protcin 
220kDa lO 31lkDa (F igll '<" ·L \ IallC 2) h,,,](1) allhc stackillg ge l (>22l)kDa). JOkDa alld 
21.5kD<l wcr~ c l ~arly sc~n in tbe gd ( ]-igurc 4.51011e 2). The PAS st ~il1ed gd l>flbe 
puri lin] V" malLT",1 ,h"" "d " '11 i ] ar hand pat tems to thai of the un-pun fied \ '1 F (1 7\·1 -A 
tooterial (Figur~ 4 .) lone 4) with higb nwiccuial' weight muc in honds si11lllg at the 
' Ia<:king and at tlX' top o f the runn ing gel (>22l)k Da) wltll an add itiO l1a l lllree sma llcr 
ban,}' that entcrcd Ihe runllil1g gel r~ ngin g in size fmln 5IJklla to JOkLh (Figure 4 . .'1 
Inne 3). A el egraded or faim ill ucin anel pro l~i n hallds rang ing in siz~ lrom 30kDa 10 
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Fig u re 4 .~ ~ I) ~_ P .;\( ; .: ana lp i' " I t he p"rilled Mr(; ~l _A ma t..-ial. AlteT """,iUlll ,'h l()ri~,' 
i<'<'PHnic ilion,il) ~mdL~nL PLLLlicalion j;','e"~-JTieJ .~lI,( ;~I-A ][[alerial dO~g) "d, prepared Ln 
rcUu-.' Llll' gel luad][l~ Duffer and '"permed un" 11)"/, ~ LJ S-P,V,L (;eb "ere sTained I',lb Cuumdssie 
lJn!!La!]l UI "" 11.-::'50 1I""e' I <1",1 2) and PAS (1<1"e J ). Th" firrul" in Jed ltl<hCflle fhe mLLl'in, un II,. 
" "eking. unlU!, of Th" JlLn:\m~ and ,ligbL!y emering .he JU""ltl~ gel drld ,he blac k mroV. j, attn.. ,t"rt 
ul,unning geL L",,. I " " ,r,,, lecLLlar ,,~:gbL Illarker. 
4.2.5 Gradi~nt :::~ I 
l:or rurpos~s of better reso lution th e put'i ii~d V" material (r iglLre 4. ~) was subjected to 
J .1-5% grJuiellt gel (Figure 4.6), As indicated by 1he red Jrrows prominent ll1 \1 em 
baIld ou lop "r ille [lInum!!. gel (;:,nOkDa) wIlh an addilional bmad and dillu,~ hand 
sloghlly ~nter~d lh~ runnmg gel (ranging in , i7c fmtn 95kDJ to (iOkDa) we'" clearly 
seen (l ' igufC 4.6 lane 2). Un li ke in lhe 1O'~,;\ SDS-PA(jE (F,gurc 4.5 lane 3) lhe 
,malkr bands lh,il ~nlered the rLl11ning gel JPP<'arcd 111 a COl11p<lcled manner at awund 
21.5kDa (hgUfC 4.6 lane 2) . Once more, unlike In the l()",{, SDS-PA(jE (Flgurc 4,5 
lan~ .1) no degra(kd or f<l int lnuc in bands f'l1lging in size fwm JOkDa to 14kDa were 
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Fign TO 4.(, (;,adient ::eI . ".Ip i, IIf the purifi ed \1 ni \1 · ,\ malerial. Aller cae,; 11m chloride 
;'»Pycl:ic dens ity gra(\'cIl L pmi',o"ti"" I,cue_dried MHiM_A m.Lerial ('()~gl ",a, prepare,i ir. 
redu<i ng gel 1,,,~ling hull,-, and scpara ted on " .1 __ '% ",.diel1t geL (ie!> ",ere ,wined with ('""rna,,, ,, 
Rri:lial1t R:uc R_250 Ila"e 11 a,,,l P,\S (Ialle 2). The arrow, in red indie,,'c tl>< 11111,,'n, 011 LOp "fthe 
,"lllC ing gel. , lightly entering ' Oe ge l and [lear th e b" LLOl1l "rille gel a mi tlo: b lack aTrO" i, 01 Lh~ ,Ian of 
fUnning ~d bile I j," molecular weigh_ mar'eT. 
,,\.2.6 We~tern bloning anal.n.is oflhe milk fat globule membrane A 
To uelenninc the id~nli ly "rthe hlL t11an hrea,! milk mUCln. the MFG\l-A tllatenai was 
separated in a ['Yo agaros~ gel and tmnsfLrr~d on lO a nitrocd[ulos~ membrane. Thc 
blot was inl'lLbated wllh th~ mOlL;;~ ami-\ILCI monodonal arllihody ,howing lh~ 
hUll1an hr~ a't mi lk 111ucin (\HG\I-A) to be MUCI (l"igurc 4 .7 lanc I). Whilst the 
p<',i tiv~ ~ol\lrok ('~r\"i cal aLld gm.tric muc us (Figur~ 4.7. lane, J and 4) read~d with 
the anll-\ll1CI nnt]l){)dy as expe~t~d. the ncgativc control. purified sa livary Ivll'C513 











FIg"n' 4.~ \\ .,,<m hl"I'lng "n"I~,h "r th. ",Ilk "","In u>in~ mo"," "oui-.'ll,CI 
m"""d"nal antih"dy. L"ne I. pUTilicd ",ilk muc in (!>.ll'G '\l-A m"l<r i"ll. I"ne~, puri tl erl hH T .lfl 
(r"'~dli \'e conlrol)_ and lane> 3 an,1 4, (ervic,,1 and ~as."ic 1llLL"," ' lrosi.i,'e O<)!1rr~l, ) were "'1""'''0<.1 loy " 
I','j, agam.'. ~< I and trdl"f' lTeu 10 nilrocelluk"e " le mbr" 'le f ollo"'ing '''em lgh. hl~okillg_ ,I>< 
"'eml'" '''' "'''' inoubdlod I'lr 2h wl ,h ","LI> e "nli-.\lU( I munoc:una: " n11l>o<ly dill",,1 ill 5 ~', ("'/\'I I~w 
b. mi :, p',wde r 111 Tfl~T " I III 1(~1. Tbe membrane ,," , Lben "a,l;cd 3 " 5min wL.1; TR5T ",,,I 
il~'uh,"<d I,,, 111 wtth HRP'll lin ked guaL anL i m(~"c ,,",cond a,y anlibody Jilu,,,1 in 5% 1m y:. low fot 
mil~ IX",,,I ., in THST :Il" <li:",io" ,,( I in 1.lrK!. .\~c, an(Jlh" , nj~ I wash (3 " 3111ln), "OrKi> WeLe 
lie,.ctrd llS ing ;cn FCT .1 . " ,,, i,, ,, ki L 
T 0 (kl~rlll i n~ whelh~r the prominmt muc in b,IlHb Ih"t enlncd Ihe mnning f!d "j'the 
iO'y;, SDS-l'AGF (FlgLlrc 4.3 lane 4) are rCUb "r' lh~ MUCl Il1llcin Of non-mucin 
glymrwtcins (l111rl1ri ll~s), the \ lHi\l-A (Vo) material was subjected to ,I [0% sns-
PAGE ,md then Ir , ](l ~f~ rred tl) nilm~dILlI",~ membrane anu r['()b~ct wLlh mouse allli-
'vIUC! nkmndonal an libody. The result s how~d that the band, th ,ll ent~red II", 
IlInlling gd were lO"mu In bc p",ill"" In Ih ~ mouse anli-/;·IL'CI antibody along with 
[i,e harKls on Ih~ stacking ,lild Il1' of the rnnnmg gel (hgme 4 . .': lan ~ 3). As inuintl~u 
by ll", red am"" Ihe anti-\IUCI aut ihocty also oclected a t:1 inl balld of roughly 
~OkDa . Once again, whll sl th~ positIve control (ce rvical mLlcLl,) (F(gLtre 4.R, lane I) 
r~,lCled " 'ith the ,1ll 11-ML'C I ,llllil1ouy, lh ~ n~f!all\,~ "outrol (pul'ified " di va!)' 











Hgllrt 4.N We,lerll b""li"g ""al),;, "I Ih. ",ilk mlldn \I';n~ mOil'" onti _'JlT('l 
monocloll"1 "n{ibod ,'_ Lo". I. ("-n UL [[llle'_", (p",i:J.-c ( ,)l:1l,, 1). 1,,",-' :'. rllTi lLt'd \11 ;(" 1> (nega" ,",' 
co ntrol) o[)d lal" 3 p '_ Lrii'ieJ milk ""_LOl[) (/'-ll '( , M-A malt' Ti"l ) weTC _,cp'-,,,, Ied ~Y" 10"·. ~ I)S_r.'\( iE and 
{r;lI"fcrroJ (o " i{,<)Cdl "lose meJlll>r,,[)c_ ]'00"", i[)g '" emighl ~ ,<>" ki ng_ II", mcmhTlLl:c w'" i n ('H~a"~1 t<lT 
210 with n1O",,' aloti- _\1 L,C j m"I""j"",] anlib()J), di IHleJ :n 5'\, \ m \) I"" f,, ' mil, p()wdc'T' 111 TRST at ] 
in I 00 'I he meml"" ,,, "'os <I,." was ll<J 3 x ~," ill "ith nl~ I' "Iod i,,",_L~alcJ f,,, I h " ilh HR PO li dc~1 
gom on, i-m(l U'" , ,,,,,,dar; a [)tiM~ dil'_L<eJ :" ~% 1m"; low liLl nd~ J~)wJeT '" ] llS'1 ala JO'LLL'O!> ()j' 
I 'n 1.100 .-\ Ii", " n(),h< r TRS] "'ash (.' , ) milo '. l>., ,,J, weTe JclecLeJ "' ing an LCL delccti"n kit 
4.2.7 Amino add ana l~'sis of fhr milk fat glohulr memhrane A 
On~e the 'vIFG~! -A muc m g:1 )- ~oprl)tc ill wa, isolatcd <llld puriikd. its amino acid 
composition wa~ dclcnn 'tl cd by amino a~id an ~j y.\ i , . As shown tn Table 4. 1. th~ nllik 
mllcin waS found 10 conlain higher amOULllS 01' lhr~on ine. serin ~, glUlamic' :>;:; ,d , 
aspart, .. acid, 111.I lid,,-,., and IClid ac. llo\,c\'e r. thc amount ofpl'Olinc was relativdy 
smaller. A, , hOWIl in T~blc 4. I. Ilk:: .\ Lgll allln; all1mo a~ id s i()]- JIlUCln ",IHch are senne. 










rablo 4.1 A m,no add Oom[lO"tion (mol "!o) oftho hF~'" milk mucin (M H; M_A) 













































H'stidin<: R.2 25 
Arginin<: 3_6 4.9 
I owl "1rGM !'fot.in b" s<~ on ~"la IT"", ~himi'u and YamaLl<hi ( I ~S'1 
4.J j)i,cussi"" 
Among th!! Liltimate objectiv~, 01- this study ""as to determine the role of br!!ast mi lk 
and milk mucin in Ih~ inhibition of HIV-l aClivity_ jh~ first step towards the 
achkv~ment or this obj~dive waS lO isolatc, purify allll characterize br~ast milk 
mucin using suitable bio~h~mi~al methods. 
After defatting. th!! milk lJ.l globule membrane ('vI]-"(,M) "as prepared from the 
cream fraction of the bremt milk_ Th~ r-IFG\J was then s~paralcd into a mucin rich 
Iraclion. the milk fal globule membrane-A (MFG"-l-A) in th~ Vo amI non-nmdn 
fraction. the milk b.t globul ~ nl<'mbrane-H {IItH.iM-H} in the V, of a s.:pharos~ CI.-
4H gel filtration column. The MFG\I-A material had lo lJ<, purilicd by caesium 
ch lond!! isopy<:ni C Jensity gradi~nl ~~nlrifugalion prior to Western blott il1 g and amino 
add analnis. 
As (,uHCL which is a denaturing agent (Francis ",l1d Bradford, 1976). is too ap;:llsive 
to lJ<, used rOLllindy as an elmion bulfer in ~olumn chromatography. O.2M '<ael, 
O_02%Nal'.l butfer containing cocktail of proteas~ inhibitors su~h as IOmM Ell] A. 










such as PMSF 'Ind EDL\ were used as serine and m~tallo-proteasc inhibitor;; 
respectivd y anJ "IF\1 w,,-> used ,).> thiol protease inhi bi lor (Carl sl~JI «I a/. , 1 'l82). 
As in toc cas~ of >., Iiva (Chapla 3) and pregmlllCY plug mucins (Ch~pter 5). th~ milk 
muein (\1H ;I>1-A) was also purili~d by ('aesium ~hlo[ld~ isopycnic <knsit} gradicnt 
~entrilugmion. a method which separa'-"s mucins Irorn lh~ low<-o densily p rotein ~ and 
higher d"nsi!} nucleic adds (Allen. 19S1 ). However, huge r~ducti(,~ of Ih~ 
cont,mlinanl pmtein was shown 'I1'icr one sl~p caesium chloride isopycnic d~ nsily 
gmdient cenlrirugalion, lhels ;;aving lime and co,1 compareJ 10 the saliva and 
pr~gnancy plug mucin purifications. As 00 protdn was ddec!~d by the Lowry assay. 
tl~ low molecular wei ght bands. "'hieh \\WC revealed b} the Coomassie Drilli'll1t 
Blnc R-250 stained g~L could be mncin fragments, 
A~cording to Mall (19SR) interference hy protein Can exaggerate a PAS po si tiv~ I"'ak. 
It is illso unusl1<l1 ror a prolein peal to be as large in the Vo as the on~ descrikd here, 
coincIding with the PAS peak (\fall d at .. 1997; \fall et "f.. 1999). However. most 
previously r~portcd gel filtration dati have been lor gaslrointestinal (Allen. 1981) and 
res pi ratory (Thomto[1 e/ at" 1999) mucus and mncins. Thns the PAS posilive V, peak 
lS mo'l1i~ely a, a result ofi~tert(-rcne{' from prote in. 
A~ sho"n in t)", r~sul l ,cclioll high molcculm weight mucin bimds o~ the , lack i~g alld 
top of the mnning gel together wilh lhr~~ sma.ll ~r molecular weight mucin hilnds Ih~l 
sligh!ly cntered the running gd \\(ere seen U[1 the PAS slain~ d Sl)S-PA(;L While the 
muci~ on lh~ s!ackin!, gel is most likely to be 1>1l'CX (1'''110[1 I 99'l), lh~ banJ On top 
of tm, running gel together "ilh the bands whkh sI1ghlly enlCT~d !he running gel is 
r\1(),l likely lo hc M\JCl. This l'in di~g 31"<) agreed "" itll the find;ng~ of(P,lIlon e/ al.. 
1995; Patton. 19 ~9; f'etm;on ~t ()/" 1998) lh"l on<: or t''''' hands of 'vIUC 1 from the 
same sample may be detected by SDS-PA{iF. 11Jcse hil1lds could be thc result of the 
lwo allel~s inheriled from each parent. As reported by Patton er at. (1995), si~ ce hOlh 
M1JCX ,md MlTl 8h,l[e th~ same carbohydralc structure and ei1ne in void volume8 
of J iffereli! porc size gel liilralion columns. MUCX ~ould simply be a highly 











\l,'hen the MFGI\.1- .\ matcrial "as sllbj~clcd III 3-5% gradient gel tlw proTllin~nl rnu~in 
halllls lln lop ofth.: gel nppeared in sinlliar f~shion 10 thaI ofth.: 10% SUS-P.\(JL 
However. Ihe sm<llJer bands that cntered the gel "er~ lound 10 b<: very compa<kd and 
show.:d (l higher electrophoretic mohil ily cOTllpared to I ho~e in the I fr}'o sns-p A GL 
t\~ gradient gels nre preparcd by mixing lwo Solulions of di/Te rent A~ryblllide 
~on~e ntrBt;on to 101m a gradient with decreasing a<',rybmide eoncentratiorb ( I'ierce 
Pmleomks) (www .ri.:n;ene1.~o1TL·Trot~J!lil;s).this could affect the band pattern <lnd 
mobility of \I.e same h(lnd~ in gr~dieDt gels compAred to lh.: di"'On(inlJ()US L(lemmii 
gels_ The hi gh~r cOnC~DIT1llion llf rterylamide is ot the hottOIll of the gel gmdi.:nL 
explaining why \I.e ~rnalkr bands althe holtom orlh~ gel (lre comknsed ~onlpared to 
the sam.: b;md~ in th~ Lflelllmli gel. 
The id~ntil )' of H,e human brca,t milk m"cin WaS confimled by Western blotting. As 
shown in the results section the' milk mucin "as found to he MUCl. To conlirm 
whdher the bands 11",t entc'rcd the running gel are DOD-Illucin glYCl1pmleins 
(im pllrities) or toge,ther with the b<lnds on the strtekiDg Clnd on lOp of lhe nmnillg gd 
arc alleles inhcrikd from CJch pMents (Patton "t II/.. 199 S, Palton> 1 1)<)9; Pcler;;on l'1 
til.. 1(98), the milk mucin was separated h) SOS-I'.\GI-, instead of ag~rose which 
gavc di;;linCl hands and pl'Ohcd with the mouse anti-ML'CI <lntibody As the hands 
rea~t(!(j with the antibody ~trongly. they are more likely to he polymorphic forms of 
ML'C1 or 'vIliCl fmgments than implll"i lics_ 'i11is confirms the report> of these aulhor~ 
that as a result of the inhcritance of two alleles, :\1UC1 may ~onl<l1n more lhan one 
band on SDS-P AGE 
Amino add analy~is showed lhe rres~nce of rehltively higlliCr amounts of serine. 
tllreonine. glutamic (lcid <lud ~sJ1<lrti~ acid in the pmilied milk mucm. This reslilt 
agreed with the findings of Shimizu and Yamauchi (1982) whidl demon~tro;led lhe 
presence of higher <lllloun(S of serine, Ihreonine, glutamic acid and aspartic acid in 
human and ho,-ine milk fat globule membnUle~ (milk mucin)_ Surpnsingly proline, 
the amino acid which is responsible for the lormation of aD extended rode like or 
filamentous structure rising <lhove the cell ~urfrtee (Peter~on ('I til., 1998). presenled in 
rehltively smaller amounts_ Thollgh the reawn i, not clear. its exposed ~tructure may 
facilitatc its destruction during purifi~atioD Of hydroly~j~. \10 Iryptophan was li)lmd 










In >lImmary. bas~d on il;; sizc. ilppeilrill1C~ of [he bands ~nd ll;; ekClrophoretic 
mobility on S[)S-P,\(JE. Wcslern bi oI. re>lI ll s and amino acid composilio11, [he 1",m<l11 
hI'casl mil~ illlLcin LS MlJCL 
Human breaslmlik is reporled 10 be I:he fi rst 1ll1~ of ddcnc~ again>t micml,.,;s. "iruses 
and lOx ills lor Ihc flew-borns. l11m11nl/lng Ihe incidence of diilrrho~a. r~splmtor;" 
d l s~ases. and OI,I-,S m~d1a in breast fcd infant:; (Wkderschain and l\~wbu['g. 2(01). 
Tog~lhcr with Ihc other l1111k compon~nr:; >uch ,I> secretory 19.A (slgA). ly'ozym~. 
lanotclrin , hlStalms. nwcrophagc> and lymphoc.,1es. milk mUCIn plilYs a ,:ig11 1fi<:<I111 
[Ole in ml;1l11 rrot ~ <:1101l (SdlrOlen ,-'I 0/ .. 1992). Among'l Ihe nLLillCL'OLLS henctils of 
mJik mll(i11 is 11;; abillly 10 mhibil rola vi ru;; in feclion which CaUSeS gas[['()Colcrilis III 
mfanl.s 01' bolh deve loped ~Lld dc\'cic)p ing counlries (Yolkcn CI 0/" 19(2). The <Inti-
IIIV-! ~c l i\'ily urlhc pllrified milk llIl1ClJl ('vIUel) will he detcrlllin~d a11d presell1~d 












PLI{I FI CA TlO~ AI\[) ClI,\R."CIl:I{I~ATlO~ OF HlT'IlAl\ PRECr-'AI\T'Y 
I'LLG 1\1lIC1I\S 
5, I Introduction 
I hc lmjcctiv~ of thc mldy rcportcd ][1 th," Chapler wa, to pun f)' and charactnizc 
IHLtnal1 pr~g;nan~y plug I11UC1n> end u ltill1 ~te l y their anlJ-HIV-1 a~li,.ily ("'e Chartn 
0). HUJllan prcgnan~y plug mucus was subjcctcd to a two-,kp i SD]1y~ni~ dc",ily 
gr~dicnt ccntriJllgalion 1ll l'aCS1tLll1 c'hlonde, Tht purity and identity of the ll1\KIn, 
exprc>sed by the female ITI'l'OdtLni;c tract w~>re delell1ll11ed by SDS-I'AGI-.. WeSTern 
blotlillg and ' mmUl10-h l'tlll'hcmi,'a l ana lysis, 
S.2.1 SDS-I'AG I': ullulysi, of th~ prq:nancy plug mUCH!. 
Prio r to Tht puri fic~tion ~nd chai'ac[eriz~l ion ll1cllw-{h. lhc I'rc"cn~c or mtL~in , in tht 
prcgnancy 1,lug 'mL~tL, wm, dctermincd by SDS-f'AGE. Fr~t/c-dried crude prcgnancy 
plug mucus wh Ich had bcen CXT raCTed in Ii.'vl GullCi ~nd prOlca>c inh ibiwf:i wa, 
di%olvcd in s~mpk loading btLllcr and ,,"bjcl'wd lo IO ~" ;. SDS-P,ViE (rei, wcrc 
sUlI"ed for carbohydrate with PAS and with Coomassic Urijji~nt llilic R-2S0 for 
protcin (FigllfC 5. 11. Thc PAS ,taincd gel (FlglLr~ 5. 1 lanc J) r~,,,akd the prc"' n~e 01' 
~ high molecular we ight mucin b~nd (2:220kDa) at thc lOp or lhc nlllLlIng gcl Wilh 
arwtiler ""mller mLLc in hand (--- 97.4kDa) cmcnng till' J'Lmnlllg ge l. When thc ,amc gel 
wa, ,lamed "lIh the Cooma»k Ilrilli~nt llilic R-2S0 (/'igme 5, 1 l ~llC 2) a prOTc in 
band larger 1l1an 220kDa at lh~ lOp 01' the run llllljl jle I WIth addl l lOlla l 1o" ~r lllO I ~~Lllar 
,,~i ghl prote in hands (~Iwecn nOkDa and 14kDa) in the mnning gel wcre ob>et'wd, 















Fi~ul-.5.1 SIlS-PA(;r. "n"l~',h III' pr"~I1"""~ pl.g 11111"'''. F",eu-drie,1 cfude preguLI,,!' 
plug l1ll~' ''' (.l0ug) wa, pTop",cd 'n m locir,g g<II ",din" buft;,r ""I ,.p,,"ed 0 '1 , 10'\ ', SIlS-I' .\GE 
( ;C], weTC "aio"l wilh ('oom",,", flnllia'll fl lllC R_2 <lI Ii"",., I ,,,,,I:' j ,,',,1 1' .. \S (10:'" ,11 1."" I '" 
moioc" laT ""C'i~hr mar kc,- a,,<1 rhi: hl,,,k am'"" " at the <tart ofrunnin" grl 
CarsiullI chloride isopycnic drn~it, II.r3dirnt crntrifugation 
To rCLllmc the prolein ~OnlaLlllllanl> "hid\ were C\'iJclll ()L] the C()()llla>SlC Brilliant 
Biue (J -250 sr~ined gel (bgurc 5,1 l ~nc 2). rhe pregnancy plug lllUCUS was purilicd by 
a lWO SlCP l'ac;i lLill chloriJe Isopycni l' den>Lry graJicnl l' clllril'LLgat ion ( Fi f'LLI"C 5,2A 
and 5_~1l) al ~ h llQy ~ lll den,;ly of 1.3<1- IAOg/ml. The puriikation proiilcs ;ho,\C'd 
dcar separal ion ~twcGnlhe protcins (pOS tli\c j'lr Lowry) lhat iraclionalcJ at a lower 























~i~u,,' 5,2 C~",ium ",lurid,' h"p),cllic MIl,it)- gr.diCllt purifKotion of [lrc~n"n<)- plu~ 
mn<n., j'reeLe-d[Led p,."~tlatlCy plug tl ll"." ll> wa, di""I;- ed _[1-1\1 (iuH('1 c,,,"auiClg l(hllM FDT .-\ , 
~m\-j " H ! ""d 0.05% CllAl'S I' ll td ."d lLlI_"l'lcd Lo lL d-c[l.,iL)· c,1" 1 . .19 Lo I Allg'ml wilh ,,,lid caeSium 
d l luride. D"" iL), ~r.d ietl1 ,"~"TriLlI~lLl iutl '''" I",rh,rtr",d .CL" fled),""L L45 ulLm · ceLlri i'LI~O Ii" 4~ll III " 
105 OOOg 01 ~0c. ~!L~',,' po" ,i"C' [',ae'Lio[1,' ( . 1"'" dC~L>")' ( & '1 bel "eeL 1 __ 1' 1.4::' aLd 'Iill ",,,,,,i'!led 
"i Lil ",me prole ilL (_ ', ( .\), were !,,'C led mid pre'p ar<d Ii" Lb e ,e,"(oLU ce"LTifLLgall"" <l<I' mJ. FI""ll )' 
1i-",:l ioL' (fracli "" LI 'nLbeT 3, 4 "LU 5 ) "oro !",'I<u_ di "ly'~u "g"i"" Lh,« cl~'"g", ~I' di"jli <u w" o, 
u,ernig ilt "' 4''(' and fr~eLC'-drKod_ 
SlLb,cquclll h) th~ ca~, i lLrn ~ hlnridc j,;"pycni" den ,i ly gradl ~Tl l plLnli~all()il_ lhe 
cffkien" o l'tilc tncth()(1 and remoq[ of the rlOtein cont;ll11inaIllS was assessed by 
SDS-PAGE. G~b we re ~lall1ed for c;n-bohydrate with PAS ,111d tu r protein w ith 
('l)<l Lila" ie BL'illialll Blue R-~50 (FIgure 5--')_ The (\Xlnl"",e Flnllra" l BllL~ R-~50 
smincd gel (F igurc 53 lane 2) i lhNr~\~d the relll o \~l 01- 1\10;;\ oj' the,e prc)(ein 
C "" I;UTlll1anl~ WhlCh "ere ,j,ihle mlhe C"O l11 a~"e B11l lj a111 Blue R -~5n ,ta in ed gel 
(Figure 5, 1 lane 2) Mthc l'flLcic prcgnancy plug IllUClL', Fa lIli pwkin pl), iti, ~ hand, 
w~rc ,1 111 \ ' I S l hl ~ "1'11r')Xlm"I~I , li-olTl helow ~20kTh 10 40kTh The ;·,·220k[h harrd 
was also , isible (l 'iglllT 5.3 bl1~ 2), Two largc diffllse hands, on~ ,it the tllP of the 
running gd ami another with gr~aler d~l'Iwrlll)relil' 1\1obilrly w~rc ,,,en '" I!J~ PAS 














Fi~",'" 53 SllS-I'AC!': "nal)" ;' of ,ho l'urillL'd pn'~na",) plug HlUC;"' . .->.flo, c"",iulL\ 
chl oride is''P}"Uli,' den,il) gJ',dien< puri i;""ion, fre.,.-O,i.o r'~gn""cy plug mucin, i3{)fLgl wert' 
p,epar,:.! in , educi ng gd IG.){liLg huffe" "no ,.pormcd 011 , I()~" . ~rJS_P'\(iE. ( i~ls we,e """x'd ,,·ilI1 
("~)llla"i~ Hn!li,mL fll"" R-l~{) (Innos I ono 2) " ld P .. \S (I,n~ oj . Th-o a!r""" Ln ,0,1 LlxlLc"'" dlC 
mL,,:in, On lOp Oflh. rU<lning .eel ond sli ghd)' Ol"tc,illg lh-o runLllL1g gcl "'hl :he b l",'k .nOW is olTh. sWT 
oi"nLn:li:Lg ."<'1. Lo,,. I is 0 "~l !e c"b,- ",. ight 11l",ke, 
.".2 . .1 W{'stern blOltlng analy ~is ufpn:g;"a"Q' plug ",ucin, 
Westcrn blot anJly,i, WJ, pcri<.mlld l(1 ddLn lline lh~ idenlity ofthc mucins pres~ "1 
in I h~ pregnancy plu,~ tl'UCUS. Samples wer,' IO(l(lcd on a 1% (lgarOSe gd and subje:ded 
10 cle,tropllore~is. MlI<.'ms "Tre lhen lnlll sk rrcd ITorn the gel 10 a nitrocd lnlose: 
m~mbmnc :lIld prol-.:d with mouw J nli- ~lCC I mon()(:lonal (Figllrc 5.--1 lanes I. 2 [md 
\) ~nd rabbil an li-'vlUC2 (F igu rc 5.4 lancs 4. 5 lind 6) , rabbil anlHvtlJC:iAC (F 1 glLr~ 
5.--1 lan~~ 7. I! ,mel ~) lind rabhil an l.l-lvtCC:i B (F igu(\; 5.4 lanes 10. II :md )2) 
polyci ()nal aLltibodic~. Wcstern bloning confLl1ned the pr~",ncc o i" ~1UCI. \HT2, 
\ 'lUC5AC and MUC5B mu,ins in the prcgnan,"y ping lllnCllS (Figllre 5.4 l an~s 3. 6, <) 
and 12 r~'p" cti vdy). \Vhik ~tUC5AC was strongly exprcssed (I'igurc 5.4 l lln~ 9) 
Ml}('2 appcar~d in relatively smaller (lmOUIll~ and as a doublel (,e:~ the: red a ml\V~ HI 
f'igurc 5.4 bne 6). As shown III Figure 5.4, whilL the posit i; c conlrols purifkd Ml 'CI 
(lane" I). e:olonLC mucus (lanc 4) and pscudomyxomll perilOnei ( lane, 7 and 10) 











ant;- .... lUC'i B 'Ill lioo(ties res p~d;,. el y, Ihe ll "gall\'e cont l'Ols n",udy Ihe ]1 l1rifitd 
",divilry M LC513 (lane 2). I l~Lh e,tI "1'" 11I111 ([,me 5), plillfied sal;v~,)' ~1l J( 7 (bne 8) 
'lnd g:lsLric mucus ( lane I I ) d id llot r~ a( ' WJlh the anil -MUCI. allti-MUC2, alll i-
MUC5AC and alll i-'\ IUC51l ant ibod ies rc 'pecll\'dy 
Fi~ur('5.4 We""r" h l "tti !l~ " nall, j, " I '~e !,,, r ill od !'fog"O""), pl\l~ mllci,,'. Len< I. 
puri tio,1 M! 1(' I (I'",;'i\ 0 con lro l). I""e 2, pmi ,ie,1 ><.Ii, or, ~ l lC5U (r><£o1\l\" ",)ntml), Ion< 4, ",)I,)ni,' 
11"CU' (P'";';''' cOll lw l). lane ,. ITach e"1 'pulum (negoli,e COI"",I), J"r>< 7. p""d'll1yx,)n", pcri'OllCi 
(1'",;1;", cOll lrol), I"ne ~, purilieJ ,oln-",,)' .\l UC7 Ine£ol"" ",,,nmJ). 1.1n. I O. r """,k)tny)'on", pc,itonoi 
(Ix,,;t;;-e cOlllrol), Jane I I. go",i" munL> (neg"' l\" control) and J'n., 3, (,. 9 and I! purified pregnancy 
p ILlg mucin, were ,e!,,-relcJ by" 1% aganhe ge l ",,,I ".1 n;f.rr<d t,) nitHe",.11 "los< 'nctOO' .'1". FollLm ing 
",-emigh' blod.illg, n>.;mhrm.;, were il",u,,",.J for 2h Wilh 11)(>"" ant ,-\ILlCI mOIIOCI,,,,,,1 (lan<' L 2 
.,vi -') an d rant-i, .n li -MUC2 (b"" 4 .. 5 000 6) .. rabbi, anli-M LlC5AC 110<><, 7. 8 ood 9) ond rabbit a tlti_ 
\1UC5lJ (I" n., 10. II end 12i I",, :yolon.' .'I1<d)od'« (ILluted m " _;' (n,·, 110" j il, [[] ilk )"-'''OC' in T lJ~ T 
" I ill 100 (,,,,me ."'i_M!.I('I). I in ,(}()() lre~~ i t <lI.i-~l!_C::' onJ OIlli-'\ILlC5AC') ,nd I ill 2f)()() 
(rahh;1 anll-M!.IC51l 1. I he n)C[ [] h,w", ,"" ItlCn "o;]\Cd 3' 5min wi,h TRST alvl illCuh~l<d Ii" Ih 
'" llh H RPU liIl l e,1 guol wti-Im"", .'Il,1 gum anti-rahbi t "",,,,,",,,-- "n" b<xll<' d,lulCd ill "_;. (m \) lu" 
I:" lLLil~ powMr It, TRST ." di :ution, or I in 1,00 .1nd I in 2f)()() "·<rec~i,el)'. Afier ",,(,,],e, l lJ S I 
wo,h 13 x 5mi Il l. ball<1< wore d otocted Ll''"g an F( L delection ~il. I be reJ ""uwi> ll' Jar", ~ in,1i ,,"10 th. 
,1,-:.ub let of Ml 1C2 
5.2.-1 I mmullo-hislOCht mi ral analysh of the tIludn ~ up rc ~~i"n b} the fe rnal., 
Due \l) the lil ck of cOllllllerc i:ll ly ,md pri vale ly ilvall uble umih ()(l ie> f()r \\'c,wrn 
blOtling, rnUClTl expre,s]OTl waS ~I;;() >llLdicd ill ~en' l c a l and endometrial tissue by 











~nd 'HC'uhakd with rabb, t antj ·.\lUC4 poiycionai ~11(11l10"'" illlli-!vJUC6 Illnllociolla i 
alilihodi~, (hgur~ -'" S), The r~~lIil dClllon,ll'ated ,l,on:;, ~xpr~'~ 'OIl l\f II,llTC4 (i'igmc 
5 5,\ ~Ild ';.58) and il\w '1ll1011llTS of MUC6 (Fi:;,ur~ 5.<;1' aild .'" ."'1'1 by lh~ 
CnOOIlll'lriulll epilhdllLllL Hl\w~vcr. no cxpress ion of .I.1LlA (FiSlm: S.5C ~lld 5.51)) 
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rigurc 5.5 ImUlllno-i,istorhou,j,.1 "'pre";u,,, OJ!" \IlIC4 and \1l;C~ in 'he f<l1lHi< 
I"('pnoductin '.-oc', Hum"" ""dOlllerr iulll (A, U. E ,,><j I' ) lL[J<1 co",,"i {C D. (i and H) Li",uc w,,, 
1".0 ill forill" lin "nd <n«dd<d Lf] p"offJn. Slide" Were iUCLlb"'c,j ,,-il tl ,""ULl "nI; \ 1 U '4 (A fl. C "''I<I 
[J) ond "nti-~ llT6 iE, f, (i and m "";\>",1[,,,_ 1i." ,,,' ''I'' ""'m!CT ,,.illcd '" .it-,",,""d lLl1d", M ale,;"I, 
nnd ~1 erhod, Slides A, C. E "ud G ore n .... ~ni fLc'j , 10 "",j didc·, I( D. F ,,,,d H " 4() 
Til l' Charl~r de,cribed the is()l at lOn, pun l!cation ,,"d characterizatio 0 of Int!\: ins from 
Illil uan prci!nancy plug mucus usin)!: appmpriale hi()chem ical and iml1luno-
his[()chemical tC d 1111'llLCS, with ,he Ullil1l,ll~ ililn 0 1' comp"nl1g lil e l[ .1111; nTV- l 
actiVitY to (hal of cl1ld ~ mUCllu,_ 
Cervi Cil l ' craping' yl elJ ~d very litTle materi,1I for bi<xhemicil l arhllysi s, Tt WilS dedded 
I() fill,1 an a l l~matl\' ~ source ol'rl1l.l~I" and mUcin from the I"mal ~ reprodu~live tr"d 
111,11 wuld yie ld sllf'ficl enl mat ~ri,1I for analysis, We foutl{ithe human preg natl{:y plug 
IlIl.>ClI', lilat si ts on the nlllmh of th,' meru, thro ughout tile p~nod ofprcf!mlllcy alld 
whICh" very Ih,d il nd large ill "~,e (Friben "I at" 1<)981, t(l be suil.<Jbl e lor the 
pllrpose of this , t udy, We "anted l() ,ktemlil1o ,\!": Iher c'eni~alll1U~US and m ucin 
bdl<lwd >lTllll<lrly Iv s"lil-,Il)' l111j~US ,Ind mucin in the inhibit ivn v l'the to vims ill an 
mhihillOn ""a) The an'mer lo lili , qUeslion would lak~ us d()' er t() an illv~,(jf!aliml 
(If why the cer\'i ~,11 route of tr:m S111 is> i (In (If the virus dmi ng se~ua I 'ntCl'wU[se i, ,(I 
L01lllllOn, ~onSldenng lilal 1llUcilh ill tho s" hva hav e broad slrudllral ,mlliarilio, l() 
those in tbe c~rvix . 11 \1,-ou ld abo lilmw morc light OIl Ihc impli(,atioll lhm c~rvical 
tnUCIl> ,ll1d l1111C Ill, ,Ire unable ll\ l'revell1 the tr3nsm i,sion vf the hUI11,lll 










Fndogen,m, pruk<Jly,i, W'~~ minllnizcd by l'xU'ftClLng mnc", in I>M CiliHCl al\{I " 
c"dmil orpro[eolyli~ i(lh,b,1011i ,ueh a' 10mM LUI/\, SmJ\1 NE\I and 111,\j P~l~ F 
(Carl'lcdl <'I 1.11., 19R,l). \Vhile P\l') l ilild F [)l ,\ 'wr,' added [0 in l'1]'i[ ,erl11~ ftnd 
l1\Cl~lln-pwleft'" ftclivily rc~r"':I.! \'dy, NEM W"S inclilded to inhibil th io l pWlea'L' 
aCll\' il) lIL'" prC\-eTltmg ,my pO"~lble tllIol-disu lfi,i(, ~xcllangc lx/ween mncin, 
(Carl,ledl ('/ "I., 19H1) ftnd other pro le ill' <Jf th~ nllde nlllcll'; or ewn 1l01l-(OVft lem 
1Lller~Cl101l ' v..ilh lipid" lH.l ckic a~id" laLl()rl~Tm. IYS<Jzymc. lmln\llwglobull:l s 3L,d 
inn, (\Viggin, <'I af . 20() II . .Ill Ihe same lime (iLl IT CI, wh ich i, known TO b~ a 
denalurinr; ar;en l (FJ1lnci, and flradloTd, 197(,), '""a, Ll,~d I<J 1Ilcr'''N' TI", so lubilny of 
l11l"IllS (C" rl St.CdT el al .. 191G), 
ThLTC aTe' Slrong non-covalenl mlcraeI1<J1" b~lWC~n mUClllS and Illc oTiwr known 
pro[c 1I1 ,md (lon pwtci(l comp<)Ilenls of crud" I1mc", ,;cn~ll()n s (Tabnk. I<)<)S). In 
ftddninn. ml1Cl" plug nm1eria l durmg lfthour ha, c<JJlSldewhk am'l"nb of blood. 
nwl"ing lhe punlicminn or mucin hy cft~'nl)Jl ch loridL' iYc'PyClllC del"'1.y gn«ilel11 
ccnrrifugatiol1 css~nl i H I I he rcmoni of Ih~s.; non-mucinolls (omponem, " reporled 
10 lx' by u",<)(""ll'C' cOlllliti,)]" (C"rl,leul el ,,/., 1'!~2t which ilre ~apab l e of 
dcsTroY;llg the t~rtiary stnlcmre of illucin, (Ll'ik,en el af. 1991lL 
\Veskm blOlling ~<Jnfiml~d the pr~senc~ of Ic IUCl, _\IUC2, _\IUCSJ\C'. ml(l M UC513 
m\lcm~ in the pregn,m~y plllg m\l~Il'. V/hilc MUC5AC ilpp~arcd 10 be thc dOlllinanl 
muci n a, in lhe ca,e of p,el.domy~onm pcri lonei (Chim'a ,.,1 aI., 20(7). 11 Le amo,,11 l oj' 
\lUC2 wa, ver;,: low and "PPcilrcd ,IS" d<Jllblel (Go\'end~r. 2IX1S). As the dOl1b lel was 
I'ccognizcd by th~ samc antib.xiy this could suggest ft similm'ity in thcir amillo acid 
c<Jntenl (Rol,ch ~r er af.. 19'1<); Thomlon d d . 1997}, but il JS nol clem whdher li,,, 
doubleT i, a glycoform of MUC2 Of is iT tk resliit of thc di>u lfid~ bl~ld cklV"gC, 
Th~rd("re rLlnh"r analy," mcludmg th~ amm" ftcid >, charge d~n'itj and cMhohjdrat~ 
COlllpc>sitiCllIS of th is doublet is rcquil'~d. It is important to rcmcmocr thM caesium 
chloride lWPYCllic densilY gwdicnt ccnlrifugali<J1l for the plirific,lI;on and "olalion of 
mucin, enabled ", 10 plln I}' MIJC I, MLC1. MIJC5i\C and \HJC5B togelher ft~ These 
mUCIns aplXm'cd ftS ft sillgk grmlp of purifLcd maT~rial at a density of 1.40g/ml 
(Figure 5.2). We did not ftll~ll1pl 1<J '''paJ1l1.e the'~ mllcm, allY Ii.Lrlher inl0 lh~ir 
individual componems. in llli, cft,e. In lhe case of cervical mucin (pregnancy plug 










used collectively in the HN inhibition assay. Separation of individual mucin and its 
use in the HN inhibition assay was more successful with saliva (MUC5B and MUC7) 
and breast milk (MUC1). 
Due to the shortage of Western blotting antibodies against all the cloned human 
mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC5B, MUC6 and MUC7), 
(Gipson et al., 2001) the search for the other mucins expressed by the female 
reproductive tract had to be done by immuno-histochemical analysis. The 
endometrium expressed both MUC4 and MUC6 although the expression of MUC6 
was very low. Cervical tissue on the other hand did not express MUC4 and MUC6. 
The endometrium appeared to express more mucins than the cervix, a finding which 
agreed with that of Gipson et al. (1997) in that the endocervix is a major mucin-
producing gland of the female reproductive tract expressing multiple mucins. 
In summary the presence ofMUCI, MUC2, MUC5AC and MUC5B in the pregnancy 
plug mucus was confirmed by Western blotting with MUC2 expressed as a doublet 
and in a smaller amount compared to the other mucins. Immuno-histochemistry 
confirmed the expression of MUC4 and MUC6 by the endometrial tissue, but their 
presence in the mucus plug could not be confirmed due to the lack of antibodies to 
these mucins for Western blotting. This result agreed with that of Gipson et al. 
(1997), Gipson et al. (2001), Wickstrom et al. (1998) and Wiggins et al. (2001) 
studies which reported the expression ofMUCI, MUC2, MUC4, MUC5AC, MUC5B 
and MUC6 by the female reproductive tract. However, because of the close similarity 
in size it has been very difficult to isolate each mucin using the traditional 
biochemical techniques such as gel filtration, SDS-PAGE and caesium chloride 
isopycnic density gradient centrifugation. 
The quality (glycosylation pattern) and quantity of cervical mucins during the 
different phases of the menstrual cycle are reported to vary either through the 
influence of oestrogen (proliferative phase) or of progesterone (luteal phase). For 
example the production of MUC5B was reported to increase at the mid-cycle and 
decrease during the secretory phase of the menstrual cycle whilst MtJC4 increases 
during the luteal phase of the menstrual cycle (Argiieso et al., 2002; Gipson et al., 











known to be influenced by the menstrual cycle which is hormonally regulated (see 
discussion part in Chapter 6). These cyclical variations, together with the fact that 
cervical scrapings, which yielded very small amounts of crude material, made it 
difficult to investigate the anti-HIV-l activity of these mucins per se. Therefore 
pregnancy plug mucus which occludes the cervical canal throughout the pregnancy 
period (Carlstedt et al., 1983; Eriksen et al., 1998) was used. This large mucus plug 
which is more like the mucus of the luteal phase than the mucus of the mid-cycle 
(Carlstedt et al., 1983) was obtained during labour and just prior to delivery. 
As cervical mucins regulate the movement of sperm and micro-organisms to the upper 
reproductive tract (Argtleso et al., 2002), the anti-HIV -1 activity of these mucins will 












THE ANTI-IDV-l ACTIVITIES OF CRUDE HUMAN SALIVA, BREAST 
MILK AND PREGNANCY PLUG MUCUS AND PURIFIED SALIV ARY 
MUCSB AND MUC7, BREAST MILK MUCI AND PREGNANCY PLUG 
MUCINS IN AN IN VITRO INIDBITION ASSAY 
6.1 Introduction 
The objective of this part of the study was to determine the anti-HIV -1 activities of 
crude saliva, breast milk and pregnancy plug mucus, together with purified mucins 
from these secretions namely, MUC5B and MUC7 from saliva, MUCI from breast 
milk and the entire spectrum of pregnancy plug mucins, in an in vitro inhibition assay. 
The crude and purified material from each of these secretions was then incubated with 
HIV -1 and the mixture subsequently added to phytohemagglutinin (PHA) stimulated 
human T lymphoblastoid cell line (CEM SS cells). The cells were then cultured and 
viral replication was measured by a qualitative p24 antigen assay as described in the 
Materials and Methods section (Chapter 2). 
6.2 Results 
6.2.1 Toxicity assay 
Prior to the HIV inhibition assay, the toxicity of the crude and purified material to the 
PHA stimulated CEM SS cells was determined using the toxicity assay. As shown in 
Table 6.1, none of the material was toxic except for MUC5B and crude breast milk, 











Table 6.1 Toxicity of crude saliva, MUC5B, MUC7, breast mDk, MUCl, crude pregnancy plug 
mucus and purified pregnancy plul mucms to CEM SS cells. 
Sample Con CEM SS cells % of dead cells % of live cells 
Crude saliva O.9mg 2.5 x IOb/ml 0 100 
MUC5B 0.9mg 2.5 x 106/ml 5 95 
MUC7 0.9mg 2.5 x 106/ml 0 100 
Breast milk 0.9mg 2.5 x 106/ml 4 96 
MUCI 0.9mg 2.5 x 106/ml 0 100 
Pregnancy plug mucus O.9mg 2.5 x 106/ml 0 100 
Pregnancy plug mucins O.9mg 2.5 x 106/ml 0 100 
The percentage of live cells was calculated as the number of live cells over total cells (live plus dead) x 
100. 
6.2.2 The anti-HIV -1 activities of human crude saHva and purified saHvary 
MUCSB and MUC7 mucins 
To determine the anti-HIV -1 activities of human crude saliva and purified salivary 
MUC5B and MUC7 mucins, HIV -1 was incubated with these secreted substances for 
60min prior to addition to the CEM SS cells. It was shown that when HIV -I was 
separately mixed with each component namely, crude saliva, MUC5B or MUC7 and 
then each mixture incubated with CEM SS cells for 30min, crude saliva and purified 
salivary MUC5B and MUC7 mucins inhibited HIV -1 activity by approximately 
97.6%. Only 2.4% of the cells were infected as measured by the p24 antigen assay 
(Figure 6.1). To determine the effect of time or the length of the incubation period on 
the inhibition of the HIV -1 activity. the CEM SS cells were incubated with HIV-l 
plus crude saliva, or MUC5B or MUC7 for longer time periods (lh and 3h). There 
was no difference on the rate of inhibition of HIV -lor infection of CEM SS cens for 
different lengths of time (Figure 6.1). 
In the controls, when HIV -1 was treated with the media instead of mucins prior to 
addition to the CEM SS cens, 100% HIV -1 replication or infection of the CEM SS 
cells was detected (Figure 6.1). The heat inactivated HIV -1 was also shown to cause 
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Figure 6.1 Inhibition of mV-l activity by human crude saliva and purified salivary 
MUC5B and MUC7 mucms in an in vitro assay. Crude saliva and purified salivary MUC5B and 
MUC7 mucins (500J!1 or O.9mg each) were incubated with subtype D HIV-I for 60min and filtered 
through OASJ1m pore size cellulose acetate filter. As controls HIV-l treated with media and heat 
inactivated HIV-l were used. The unfiltered samples were then incubated with CEM SS cells at a 
concentration of 0.5 x 106cellslml for 30min, Ih and 3h. After PBS wash, cells were cultured and viral 
replication was measured by a qualitative p24 antigen assay. Letters A, B. C and D indicate the anti-
HIV-l activity of each sample in a serial tenfold dilution of 10,1. 10.2, 10'3 and 10-4 respectively. 
To determine the lowest concentration at which mucins inhibited viral activity, serial 
tenfold dilutions (l0-1 to 10-4) of the crude saliva and salivary MUC5B and MUC7 
mucins were done in triplicate. No difference in the anti-HN-l activity of the samples 
was detected down to a dilution of the mucin to 10-4 (Figure 6.1A, B, C and D). 
To determine the mechanism of the anti-HN -1 activity of these mucins, mixtures of 
HN-l with either crude saliva, MUC5B or MUC7, or with media only (control), 
incubated for an hour, were filtered through a 0.45J1m pore size cellulose acetate filter 











for 3Omin. While the filtrate from the control caused 100% infection of the CEM SS 
cells (Figure 6.2), that of the other groups in which mucus or mucins were present 
gave only 2.4% infection of the CEM SS cells (Figure 6.2). Incubation of these 
filtrates with the CEM SS cells for longer time periods of Ih and 3h gave no 
difference in inhibition (Figure 6.2). The results suggest that HIV -1 inhibition is by a 
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Figure 6.2 Inhibition of mv -1 activity by hnman crude saliva and purified saUvary 
MUCSB and MUC7 mucins In an in vitro assay. Crude saliva and purified salivary MUC5B and 
MUC7 mucins (5001l1 or O.9mg each) were incubated with subtype D IDV-l for 60min and filtered 
through 0.451lm pore size cellulose acetate filter. As controls IDV-l treated with media and heat 
inactivated HIV-l were used. The filtrates of the mixtures were then incubated with CEM SS cells at a 
concentration of 0.5 x 106cellslml for 30min, lh and 3h. After PBS wash cells were cultured and viral 
replication was measured by a qualitative p24 antigen assay. Letters A, B, C and D indicate the anti-











6.2.3 The anti-DIY -I activities of human crude breast milk and purified milk 
mucin (MUCI) 
An experiment similar to the one above for saliva and its components (Section 6.2.2), 
was performed with human breast milk and the MUCI purified from milk. The HIV-l 
virus was incubated with human breast milk and purified milk mucin (MUC 1) prior to 
addition to the CEM SS cells for 3Omin. As controls HIV-l plus media and heat 
inactivated HIV -1 were used. While the purified milk mucin (MUC I) inhibited HIV-l 
activity by an approximately 97.2%, the crude breast milk unlike the crude saliva 
(Figure 6.1) did not inhibit HIV -1 infection; instead 100% HIV -1 replication was 
detected (Figure 6.3). In the controls, when media was used instead of MUCI there 
was 100% infection of the CEM SS cells (Figure 6.3). When the CEM SS cells were 
infected with the heat inactivated HIV -1, an approximately 30% infection of the CEM 
SS cells was also detected (Figure 6.3). 
To determine the effect of time on the infection of the CEM SS cells or viral 
inhibition, mixtures of HIV -1 with either crude breast milk or purified MUC 1, were 
incubated with the CEM SS cells for Ih and 3h. No difference in the rate of infection 
of the CEM SS cells or inhibition of viral activity was detected (Figure 6.3). 
Serial tenfold fold dilutions (i.e. 10-1, 10-2, 10-3 and 10-'\ giving different 
concentration of mucin also showed no difference in the anti-HIV -1 activity of 
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Figure 6.3 Inhlbltion of HIV -1 activity by human breast milk and purified milk mucin 
(MUC1) in an in vitro auay. Crude breast milk and purified MUCI (500111 or O.9mg each) were 
incubated with subtype D HIV-} for 60min and filtered through 0.4511m pore size cellulose acetate 
filter. As controls HIV-l treated with media and heat inactivated HIV-l were used. The unfiltered 
samples were then incubated with CEM SS cells at a concentration of 0.5 x 106cellslml for 30min, Ih 
and 3h. After PBS wash cells were cultured and viral replication was measured by a qualitative p24 
antigen assay. Letters A, B, C and D indicate the anti-HIV -1 activity of each sample in a serial tenfold 
dilution of 10-1, 10.2, 10.3 and 10"" respectively. 
To determine the mechanism of the anti-HIV-l activity of milk and milk MUCl, 
mixtures of HIV-l with either crude breast milk or MUCl, or with media only 
(control), incubated for an hour, were filtered through a 0.45J.1m pore size cellulose 
acetate filter (25mm diameter). The filtrates were subsequently incubated with the 
CEM SS cells for 3Omin. While the filtrate from the HIV-l plus MUCI mixture 
caused very low or an approximately 2.8% viral replication or infection of the CEM 
SS cells (Figure 6.4), 100% HIV-I replication or infection of the CEM SS cells was 











HN-l plus media were used (Figure 6.4). It is very likely that once again the MUCI 
inhibited the virus by physical aggregation. 
Again, no difference in the rate of inhibition or viral infection due to the length of the 
incubation period or as a result of serial dilutions (lO-lto 10-4) of mucin was observed 
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Figure 6.4 luhlbition of HIV -1 activity by human breast milk and purified milk mucin 
(MUC1) Iu an in vitro assay. Crude breast milk and purified MUCI (SOOJ,l.I or O.9mg each) were 
incubated with subtype D HIV-l for 60min and filtered through O.4SJ,l.m pore size cellulose acetate 
filter. As controls HN -1 treated with media and heat inactivated HIV -1 were used. The filtrates of the 
mixtures were then incubated with CEM SS cells at a concentration ofO.S x 106cellslml for 30min, Ih 
and 3h. After PBS wash cells were cultured and viral replication was measured by a qualitative p24 
antigen assay. Letters A, B, C and D indicate the anti-HIV -1 activity of each sample in a serial tenfold 











6.2.4 The anti-HIV -I activities of human crude pregnancy plug mucus and 
purified pregnancy plug mucins (containing MUCI, MUC2, MUC4, 
MUC5AC, MUC5B and MUC6) 
Like the above two assays (Sections 6.2.2 and 6.2.3) the anti-HN-l activities of crude 
pregnancy plug mucus and purified pregnancy plug mucins (containing MUC 1, 
MUC2, MUC4, MUCSAC, MUCSB and MUC6) was determined by incubating 
HN -1 with these substances for 60min prior to addition to the CEM SS cells for 
3Omin. As controls HN -1 plus media and heat inactivated HN -1 were used. It was 
shown that while the purified pregnancy plug mucins inhibited HN -1 activity by 
about 97.S% (Figure 6.S), the crude pregnancy plug mucus unlike the crude saliva 
(Section 6.2.2) but like the crude breast milk (Section 6.2.3) did not inhibit HN-l 
activity. Instead 100% viral infection of the CEM SS cells was measured by the p24 
antigen assay (Figure 6.S). The same result as in Sections 6.2.2 and 6.2.3 was 
obtained with both controls (Le. media and heat inactivated HN -1). 
As in Sections 6.2.2 and 6.2.3, the effect of time (incubation period) on the rate of 
inhibition of the HN -I activity or infection of the CEM SS cells as well as the highest 
dilution (lowest concentration) of these mucins which can cause HN-l inhibition was 
also determined. The results were similar to those previously obtained and there was 
no effect of time or length of incubation or the dilution of crude and purified samples 
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Figure 6.5 Inhibition of HIV-l activity by hnman pregnancy plug mucus and purified 
pregnancy plug mucins in an in lIitm assay. Crude pregnancy plug mucus and purified pregnancy 
plug mucins (SOO,.d or O.9mg each) were incubated with subtype D IHV-I for 60min and filtered 
through 0.4SJml pore size cellulose acetate filter. As controls IHV-I treated with media and heat 
inactivated HIV -1 were used. The unfiltered samples were then incubated with CEM SS cells at a 
concentration ofO.S x 106cellS/ml for 30min. Ih and 3h. After PBS wash cells were cultured and viral 
replication was measured by a qualitative p24 antigen assay. Letters A, B, C and D indicate the anti-
IHV-l activity of each sample in a serial tenfold dilution of 10-1, 10-2, 10-3 and 104 respectively. P. 
plug represents pregnancy plug. 
To detennine if the anti-HN -1 activity of pregnancy plug mucins is by viral 
aggregation, the mixtures of HN -1 with either crude pregnancy plug mucus or 
purified pregnancy plug mucins or with media only (control). incubating for an hour, 
were filtered through 0.45J.1.m pore size cellulose acetate filter. The filtrates were 
subsequently incubated with the CEM SS cells for 30min. While the filtrate from the 
HN -1 plus purified pregnancy plug mucins mixture caused approximately 2.5% viral 
replication or infection of the CEM SS cells (Figure 6.6), 100% HN -1 replication or 











1 plus crude pregnancy plug mucus and the control, HN -1 plus media were used 
(Figure 6.6). Once more there was no effect of time or length of incubation or the 
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Figure 6.6 Inhibition of HIV-l activity by human pregnancy plug mucus and purified 
pregnancy plug mudns in an in vitro assay. Crode pregnancy plug mucus and purified pregnancy 
plug mucins (500,11 or O.9mg each) were incubated with subtype D HIV-l for 60min and filtered 
through 0.45~m pore size cellulose acetate filter. As controls HIV-l treated with media and heat 
inactivated HIV -I were used. The filtrates of the mixtures were then incubated with CEM SS cells at a 
concentration ofO.S x 106cellslml for 30min, Ih and 3h. After PBS wash cells were cultured and viral 
replication was measured by a qualitative p24 antigen assay. Letters A, B, C and D indicate the anti-
HIV-l activity of each sample in a serial tenfold dilution of 10-1, lO-2, 10-3 and lO-4 respectively. P. 
plug represents pregnancy plug. 
6.2.S Inhibition of HIV -1 activity by blocking the putative viral binding sites 
(receptors) of the CEM SS cells using MUC7 
To determine whether MUC7 can inhibit HN -1 infection by blocking the putative 











different concentrations of purified salivary MUC7 (img, O.Smg, 0.2Smg and 
0.12Smg) prior to addition of the HIV-l. The result revealed that even at the highest 
con~entration (lmg), MUC7 did not inhibit HIV-l infection of the CEM SS cells 
(Figure 6.7). The results were very similar to that in the positive control where the 
CEM SS cells were incubated with PBS prior to addition of the HIV -I and 100% viral 
infection was detected. However, no viral infection was detected on the CEM SS cells 
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Figure 6.7 Inhibition of HIV-l activity by blocking the putative viral binding sites 
(reeepton) of the CEM SS cells using MUC7 In an in vitro auay. The CEM SS cells were incubated 
with different concentrations of salivary MUC7 (lmg, O.5mg, O.25mg and 0.125mg) for 6Omin. As 
controls CEM SS cells treated with PBS (positive) and CEM SS cells only (negative) were used. At the 
end of the incubation period HIV -1 was added to the mixtures except to the negative control. Cells 
were then cultured and viral replication was measured by a qualitative p24 antigen assay. 
6.3 Discussion 
In this Chapter the anti-HIV-I activity of crude human secretions in the form of 
saliva, breast milk and pregnancy plug mucus, together with purified mucin from 
saliva (MUCSB and MUC7), breast milk (MUCI) and from pregnancy plug mucus (a 
combination of MUCI, MUC2, MUC4, MUCSAC, MUCSB and MUC6) was 











and subsequently added to PHA stimulated CEM SS cells. The inhibition of HIV-l 
activity or infection of the CEM SS cells was then measured using the p24 antigen 
assay. 
The HIV -1 Subtype C virus is the most widely prevalent strain in the Southern 
African region whereas the Subtype D virus which was used in this study was found 
during the early HIV epidemic in South Africa and used to establish an in vitro 
inhibition assay. It is still prevalent in this region. albeit to a lesser extent. The 
Subtype D strain is perhaps the only available laboratory adapted strain used in an 
HIV assay in the entire country. As described in the Materials and Methods section 
(Chapter 2), the virus was first isolated from an AIDS patient by the Department of 
Medical Virology, Tygerberg Hospital, University of Stellenbosch, South Africa, in 
February 1988, and was fully characterised and sequenced (Treumicht et 01., 2002). 
The human T lymphoblastoid cell line (CEM-SS cells) which are used in this assay 
are known to produce a distinct and quantifiable syncytia formation in four to six days 
when infected with HIV-I (Nara et 01., 1987). This cell line is reported to express 
CD4, CXCR4, ICAM-3 and MHC class II molecules (Lallos et ai., 1999), thus 
making them suitable as host cells for use in an HIV infection assay. 
Guanidinium chloride (GuHCI) is a known denaturant (Francis and Bradford, 1976) 
and is commonly used, at a molar concentration of 6M. to prevent endogenous 
proteolysis in the extraction of mucin from a variety of tissue sources (Carlstedt et 01., 
1983; 1982). This chaotropic agent is also (expectedly) known to denature viral 
protein and has been reported to kin viruses such as molluscum contagiosum virus 
(MCV) which is a member of the poxvirus group by more than 99.9% (Francis and 
Bradford. 1976). It was therefore imperative that the GuHCl in the buffers used for 
sample collection, chromatography and caesium chloride isopycnic density gradient 
centrifugation was later removed from the salivary. milk and pregnancy plug mucins 
by extensive dialysis against distilled water. Mucins were then freeze dried and re-
suspended in 25% PBS buffer for use in the in vitro inhibition assay. In the case of 
crude salivary, breast milk and cervical secretion (pregnancy plug mucus) in which 
purification or dissociation of mucins from non-mucinous components was not 











PMSF pH 7.5. This buffer was also used as a control and found not to be toxic to the 
VIrus. 
Kennedy et al. (1998) and Malamud et al. (1993; 1997) have shown that human 
whole and submandibular saliva inhibit HN activity in an inhibition assay. However, 
the anti-HN activity of the whole and submandibular saliva was reported to be 
considerably reduced after filtration. It has been suggested that the macromolecular 
components, specifically the mucus components of the oral secretions (Bergey et al., 
1994; Bolscher et al., 2002) are the most likely candidates in the oral defence against 
HN infection. These observations coincide with the idea of Malamud et al. (1993) 
that saliva induces viral aggregation to clear viruses from the oral cavity and 
subsequently reduces transmission of HN through saliva. Although these researchers 
speculated that crude saliva (Fox et al., 1988; Fultz, 1986), MUC5B and MUC7 
(Bolscher et al., 2002), the two secreted salivary mucins (Thornton et al., 1999), are 
potentially involved in inhibition of HN infection by aggregating the viral particles, a 
defmitive attempt to purify, identify and test these and other purified mucins from 
sites where infection is known to occur, has not been done. Therefore the objective of 
this study was to purify, identify and determine the anti-HN-l activities of salivary 
MUC5B and MUC7 mucins in an in vitro inhibition assays separately, and compare 
these with the anti-HN -1 activities of the breast milk: and cervical mucus secretions 
from regions that are known routes of transmission of the virus. 
As shown in the results section crude saliva and purified salivary MUC5B and MUC7 
mucins inhibited HN-l activity by approximately 97.6%. Though the mechanism of 
inhibition is not clear, it is possible that carbohydrate moieties or side-chains of 
mucins, that constitute 50 to 85% of the glycoprotein (Klein et al., 1992, Leikauf et 
al., 2002) aggregate the virus particles physically upon incubation with them, a purely 
physical phenomenon, thus inhibiting the virus from entering the host cells (CEM SS 
cells). This hypothesis is in keeping with the findings of Bosch et al. (2000) and 
Prakobphol et al. (1999) that the carbohydrate moieties of salivary mucins serve as an 
attachment site for a range of bacteria and viruses and inhibit bacterial or viral entry 
by aggregating these pathogenic micro-organisms, (Klein et al., 1992, Prakobphol et 
al., 1998, Prakobphol et al., 2005; Yeh et al., 1992a). This was further supported by 











influenza virus and block the attachment of the virus to host cells (Levine et al., 1987; 
Tabak et al., 1982; Tabak. 1995). This phenomenon is diagrammatically represented 
in Figure 6.8. 
Despite contradictory reports that proline-rich proteins (Robinovitch et al., 1993) and 
secretory leukocyte protease inhibitors (SLPQ (McNeely et al., 1995 and 1997) 
inhibit HN activity. Turpin et al. (1996) demonstrated the failure of the secretory 
leukocyte protease inhibitor to inhibit or aggregate HN -1 particles. Bolscher et ai, 
(2002) also demonstrated the failure of HN -1 inhibition or aggregation by parotid 
secretion which is the source of proline-rich proteins, but which lack mucin. These 
findings made salivary mucins the ideal candidates to investigate in the inhibition of 
HN through saliva. Thus the focus of this study was only on crude material and 
purified mucins and their role in the inhibition of this virus. 
To confirm the hypothesis that mucins inhibit viral activity by aggregating the virus, 
the CEM SS cells were infected or incubated with filtrates from the mixtures, HN-l 
plus crude saliva, HN-l plus MUC5B and HN-l plus MUC7. However, very low or 
only 2.4% HN-l infection of the CEM SS cens was detected. This suggested that 
HN -1 may bind to the high-molecular weight salivary mutins which results in a 
macromolecular complex which is removable during filtration through 0.451J.Ill pore 
filter paper (Archibald and Cole, 1990; Ge et al., 2004; Nagashunmugam et al., 1997; 
Shugars and Wahl. 1998; Shugars et al., 1999). Thus there may not be enough viruses 
left un-aggregated by the mucins to pass through the filter paper and be present in the 
filtrates to bind and cause viral infection of the CEM SS cells. This finding agreed 
with that of Bobek and Situ (2003) that salivary mucins agglutinate or trap micro-
organisms, thus clearing them from the oral cavity. This hypothesis also strengthens 
the report by Situ et al. (2003) that salivary mucins do not directly kill micro-
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A, Ihe ,,"'oohydratc UIO,('l1CS "f ~ahvan. "'I"''''' sen.·c as an auachmcut ~t tc~ I'.r 
1"1(1<.'0 " 'In,i ,",n.,,,' .000J inluh,! h",1 li",o.! ': IIIIy br i\ggn:galinll lhc-.c rarh"~",,, c 
III i(."r<)~lOrg'H1 iSlll ~ (13<,,,'h , 'f ,,/ . ~ 1l00: Prak oIJ[lh< II <', ,d.. 1 <; ')<;). chali llc, ,'11 Ih~ paU,:m 
lIf g l\'wsyhtiorJ m .• y afrh'\ 111("1' ad i ," i l~ " gilll" t Ih~,~ p 'Jloog~n s . I'rakoul'h,,1 eJ ,,/. 
(20IlS) dcmnn~lr.l1".1 Iha\ ill frmal,," Ih.: glycv,yl;llIlIll p;H1cm of ~ah \'a r> Ul ucm, 
>tk'<',r"'"I1~ \ fIJC~B i~ sUullgl~ lIInU"'IL"t.\! by Ihe mem lrua l ,')'\'10: "" hl .. b IS 
h .... n"""II) rq;:ula!,·,!. A.:.-.m hng to Ih('c :lulll" "" lhc gtycosyl :u,,'n ,,"!ll<.'m IIr 
('xpre<;sioLl of /l.H iCSB "n" "h<)\\11 to be w:ry 1o", <>n !II~ (!a~ i, r'! il ft~r Illl::l1> t1"1kl tion 
bUl illCiebe, ,,"Hh Ih.: ,yck 1)]1 ti l a fev. (tly~ aft~r " vulalion TI", nll ~ ,,( g ly.-osyialioL1 
;~ h igh~t duril1)! I'r"j! II .Ulcy a"d L,,:t"!lO" : h,)\\cI'cr It ;~ ,(H",,,,,I III m:!le, IUIJ post 
IlltIlOp" II';al "0JJ1~1I. Accur<i ing \n t-."l'", hUlIlIlUgam ei ut ( IQ91). the .ml'"ir..1 
",'l i,·,ll "r ",Ii,"a ,.!;I.) ,~, rt,,~ 3mon~ IIIthVltlll .. k A, t~e efTc,'! of me.'~ln,al ,'y,'!': on 
the ,1111; -H IV "cli, iii • .,. df "dil'a and "'llh" ' f}' ntUClI1< . ' 1111\ \';no',",I. c(>lkcl ioll of <a ll Vd 
1\\ differe1H l' ha,~~ OJ I b~ ,,'c'hl.rual cydc '''ld ,kl!,'f1 nmulf!; thc' "" I;-H IV-! .,cti"1! ies of 
lhe , ,, Iivary mucin. ,'~pe .. . ~ lI )" ~llJC5H . ;, n:quir,' d. 
Tht: alllnl"l1 "r CQlI,'cnmu 10 .1 ,,1 lI "n~ U1 ..... I.var. rrtlKin;; i;; Rro""d 10 dcdlllt " .\11 ")!C 
(Uo I..c hl"r el <r/., 1'1'"19). [)t:ltny el oJ (!991 ) OCU1nn~lmlcd the e'RlL"I:"n\r.l1l01lS of 
.... 11" " ,1' ,,1UC5L1 ~ I IJ ,,10("7 mlle;n' in bUlh U!lst im ub tcd and lI.mubkd ",1"'<1 
'3mpb; [" dL..: li,.." "~Iljjk,mtly in the a~d gmup c "m)1ar~d I<J " }"ul 'llgcr group. 
'J abak ei at (I <J~ 2) :11"(, "~portcd the di ftcr~ll c~ HI , ugar c"nlcn l (If the ""livary 
'Illl.:in> in re latill·n h) ag~ II ilh the ".lldl group 1)(lssess ing t .... icc the am" "II I L~ll1')1,(f~d 
,,,III Il~ yU"II ~'" ~"O)llp . Alt hough Ihe frcqncill tlS~ " rm",licaIlUTl '" aged ;nd i"iuu;lI;; 
\<;" reported to be l"("j,["'On;, ible Ii" d"dine in Iho;) l)<)te l1 cy, am ount and IUIICl ion "f 
""1.",,. Denny ,'I ,)1 (I<)<)I! repon Ihat the 10~$ or" <;uhm.md.bular p .. "",,neh~mn ",ith a~e 
,h<.H, I{i be the pli T\1e I"I;';Ison. With Ihi" in mi mi, I h~ te" for <I nti- I II V - I :1<;11 Ilirks of lhe 
,'mJc sa liva and ,all\","")' ~ I UC5 rl 'lild MUC7 LlHlc im. of d irli: rt: rIt else g""'U)1' 1S 
~"wnliaJ 
Il um .. n hr'-"35t 'ml/.: t~ ~ I\"" n In prm"CI Ihe bl"l;';'~1 fL'(j in f.mt;; ag3J1t~1 bnCl~na. \ i ru~e~ 
~U1d toxins thns nl ll1ll1 l1 Zllig u.~ca ;,cs such ~I' <lmlThea. re:;pinltlllY disc-a;cs, J!lU ololis 
rl1~ (ha (\\'ieder,cll"m :U1 .J "e",burg. 200 II. LX~ll1pl~s i L1dud~ , nlll blllll" vf chulera 
tl)x iL1 and Escht'rj,,/ii,1 1:010 b~ human br~'1 ,t III il ~ glymlip id and iLl bibni ("1JI of rotav; 111, 











"im {Pekr~o n era/. . 1998. Vo lk~n d al .. 1~'l2). Th~ ccrvical ,end,o" which d~aTb 
millions (l f micro-orgi!nI ~ms J day is also considered to b~ thc fj rq hne or delcoce ill 
th~ f~male r~pmdL1"live tr.(e t (\-V iggins cr al .. 100 I). However. d~pi te Ih~, c dcfcl\si\"C 
"'edmmsm, and t h~ pr~,~nc~ of mUl'U~ and mUC·lns. breil>; l 111 i Ik and the C'en i~a l tracl 
,t ill remain ,ignlli" anl ruules ol"lran'mis.s ion for (he H1 \"inl~ . 
On~ 01" the LllIportalll que<' lion ~ mised by I hl~ slnd)" W,,", the ro k of mn,us lJl bre,,"~1 
milk and the cervix (pregnanl'y plug). ,,·h,eh ~karly ,~e1\1 ed nollo be ef'fl"diH: ,,"g,,"ins( 
the VLru ,. unlik~ ~TL1de sal iva. a worlhwhlle ~Oll"ider,ll i (Hl e~ pe"ially ~l"ulSe of the 
kno\~n high incidence of mothcr to child (raLl>1nl>, ion , ia !>rca, t fceding amI 
transm , s~ion hy ~exual intercourse through thc vagina lic"rvical rou les. Thll' il \~ a, 
d~ci(kd lo pUrify the br"'ilst m,lk mll~in ,,"nd cervKal mudn~ from breast milk and 
pr"gnancy plug mucu, and to detenl\i n~ and ~ompar~ lheir ant,- H!V- I aC tiv,ly to tInt 
of salivary mudn~ in an HIV inhibitioll assay. 
As deSl"rlbed in the !e;ult, ,eclion. wh,le the pUri fied m,lk mUC'Jn (11,IUC I) inhlblled 
H1V-1 act"i ty by aboul972%. lhe crooe breas l 111llk dId not inhihil H1V- 1 adi," ,t y. 
Though the mechanism or inhibi tion is not clear. Ih" carbohycirale moiclies 01" the 
.\lUCI mudn may playa role in aggregation oflhe \irus and inhihit host cells entry. 
Thi, hYl'o lhesi,,, m ab>reemenl wi lh Ihat of ":-.Iewburg (1999) th,,"l the human milk 
mu~in "arhohyJrale moielies. ,,·hKh ad as hosl ~el1 re~ep lor' . may aggregal~ the 
palhng"nl~ mi"m-organislll, and inhIbi t them from enlering and infecting (he hosl 
celk A'TordLllg lo ":-.I eI' burg {l9'l9) and Peterson d ill (19'lS) tl)..; rcmova l of Sialic 
acid from lhe milk mllC'ln hllldens lhe ,,"n l,-rotavlral adi~ily of the T\lu~,n, i ndl~ating 
that the carhohydrat~ ll1oie(i e~ ofmllcins plays a crucial role in the inhibit ion of viral 
,,"Cl i'· lli es. Tht> h )'polhe,i, i, repre,enled III a "'I)eluatil' jimn ,n F 'gurc 6.1 O. 
The abihty of \l1.:e I to Inhibit HI\q aClivi ty by aggrega ling the virus was confirmed 
as the filtrate from it, mixture wi lh H1V-I caused w ry low (~ .l\ ~"',) ml"el"lion 01' th" 
CFM SS c'ell, ~",npar~d lo the 100':'/0 inli.xlion by 1,Ilrate, Irom the mixtufCs, HIV·I 
pI llS cmde brea,t milk and IIIV-l plus media. As expla ined in the Lase or >ali,,, and 
~alivary mu~in~. the milk MUel m,,"y aggreg~le the ,",ruses and lhu, lh~r~ may not he 
enough free viruses in the filtraks to cau~e inl<:d ion of the CEM SS l·ells. SlIlce th~ 











CFM SS ce ll s. 
" f H 
r 'd ~ H , 
c nco 
'~ 




P "'0 S"llIblc rCl" qllor homology fWln m il k 
Fi~IJ" fdO SO h,",,,,,lir "'~IT"' n l", i,," (If inhihili(l" 01 p,uhog". hlllding lo '/lOil ' hOSl roll, 
~; lll,' lIIill, mod" t'~ rb"hyd,""k'. Tn bTt'. " h ,T i nfont' tI", .'"rl>.)hydt~k cC'rLJl'b.cs oj'11 .... , ",d. lllUCIn 
": '.J",' ~o'" t J~ · I''' J l.Og"" nu rHC'V"·.C[]l ly 1m J 'TO llI blllh,", iioll1 h 'l:d "'g .nd el:tering ;1><' 1",.<; , ,,11,. ,hu.' 
'nh ihitlng 'nfeeM'" ("I""Q <i '>cod )(0", "ndo"Jlg . 1 VV9 .. 
1\ ~\\'bu r~ U al (I ')<)2) aLld "Je" burg ( I 999) .,h.,w lhe ah1 llt, of t he 111 d k muci n to bi nti 
or hlock h,>s l ~~ II l ~cep t(\r' and >ubscyucnt ly 11111ihll thc hll](hn).' ()f the )1'l1h()g~ Lll C' 
111l crl'-orgQllislll' to th~ boot cdl rcc'cplor:< and C'a uSe i nl ~ e l i '\l1 . H'\W~V~r ill th is swd, 
n() '"ell 1ll1ll' lLl-ed l r~c'~p l "r act ivity was d ct~ cled a, Q mCQllS of prcvcnt ing HI\/ cnlry 
into hos t cdls.'" CLM SS eelb. Wc <;lLgg~~tcd thaI mllCll1 S physically aggregat.> the 
\ 1ms lh rough all i l1l~racti'\l1 wi th carbohydmlc <; j,k-chai lK TI,C ililCra Ll1()1l c'olIld h<: 
pW'cly a phy,ic'a l crl lan glell1 ~ Llt Ihn\ugh a charge intcrac tioll considering tha1 llllLC' l11, 
ha\'c a hig,h cknsilY of ncgmivc char)lc<; lhrougb "aile aC1d arid 'ulphal c residues 










tiltr~te froLlllhe nn, \lIre, HIV-l pili' ~lLCI. f;"lcd to ,an,,, 111 \' - 1 mticdiu,] or!h~ 
CLM SS celi, 
As , hown in tilC reslllt , section the pllrit i~d pregnan~y plug mUClllS inlllbited 1I1V-l 
activity by ap PIOximatcly 97.5%. Ho"'~ \'n, lih the n ude hreJst milk. the cn,eic 
pr~gnan,y phlg mucu, t'l iled 10 inhlbi l HIV-I a~!i,i! y. The "bliily oCthc pregnancy 
plug 11l1Kin' 10 inhibi t H1V- 1 ac ti, ity hy aggregaLing the vim, was "Iso confllUlcd .1, 
Ihe filLra!~ ii-om til<: l1ll\lllrc of HIV-I plu, pregnancy pllLg rIllLl'lfi' inl~d ~ ~u.';' oflhe 
hos l .'elk TI'I<;e fi llral e 1;-0m thc mixlur~ of III V- I pillS en,de p,.egnall ~y plug mll~l". 
on the oth.'rhaIlJ ~all,~d a lOO'/; Infection oftilc host cdls. Agalll, th" reason I(,r tlllS 
i, no! dear :m,1 If><, ~~p l;ma l1on gi\'en for >a livary' anci brea',t Lll ilk mlLcills should k 
appll.'able h"r". 
The inabil i!y o f lTL1(k breas t mi lk and ~nld c pr('gn.IIKY plug mw;ous to inhibit HIV-I 
is not knuwn. HowC\'er, iT \\o<-dd be wonhwhile 10 'pecu laTe why th i, wa, '0, ill th~ 
~a,c ufbrc'l,t milk, .'cIUCI was ~ndosed by fat globules (S~hro len ('/ aI., 1<)<)2), and 
h'I(J w i..;: extlad~d .Illd i s ol J1~d Pl'iOl'lO tcsllng for Lt'> ami-HIV-I adi,I1,' Tbere LIlay 
not Ix aLly phY'lC,iI ~onla('( octwccn th~ mlKin and HIV- l ill Vifni or hct\"~n the 
m""in aLld the ii"ee \lnj'~' and iLlfi:cled m0110LlIJdem kukoL)t~s prc,cnt in lhc br~'lst 
milk of HI V infec ted rnotll<.:r.i (Lepage ('/ a', I<)H 7: 'iaarJmg ('I at., 200S: Tlmy ('/ al.. 
19 ~5; VJn dc P~rlc e/ (J/" 10/)3), A, a Iemlt no aggregatioll ofthc \LrU' by MLTel 
l'olllJ "'TlLriLl nlLd~ brea,lmi lk 
F r~ ezing .Illd hcating ofl-U V -ln feckci h lLLIlan brea <,t LIlil k prior to feed ing the ch Lid has 
be~n reponed !o reduce II IV lraLlsmi"ion ii-om HIV positive m01hcls 10 infants 
(Baroll e/ ai., 1999), This phenomenon LIl lght j'lcliilate lll<.: rciea,e of the milk mucin 
(i\-IUC ij WhKh I, cnc losed by the milk f'l t globu les in brcast milk (Sdlw len i!I at., 
1992), a, It was done ill om pmlficmion mdhod. This would ellable the m\lcin to trap 
OI 'Iggrcgatc lh~ virus in th~ br~a ,t milk and I~Juce lllV trJnsmission, 'j ilus it may b~ 
wDrtimiuic tn heal l'rude brca'>t LIli lk before lC<;L ing 1[S ami-HIV-I adi"i ly. Perhap' 
thc d is,oeiation of r-..lUCI f['Om fat in hr~ a, t milL i, a nel'e><;ary , tel' to make cl1lcie 











It lS abo posSIble th ut Ibe COncenlrati()n of mll(:m, within the crude pl1::gnalLey plllg 
mucus and ,'rud~ breusl milk (whicb eOl"i sl~ of' w,ller, m!lcins, lipids, nlLddc ael(ls, 
1,I(:tofemn, lysozyme. se~rdal)" Icukl'(:y1e prolease iILllLbilors, Il-~aSeln, 
oligo,a~~ha ri dc" immunoglobul ins ami lOllS (Kaardmg e/ ,,/. , 2005; Wiggill' et "t.. 
20( 1), as fOlL",I '1l lne physiologl(:,iI situmirm, are maybe (()O I"" .' for to aggregute or 
be effective "gail lSI t ile \'lru~. For 111 \1 ilIKe muCin, constitUle ab()ul 0.5- I %, of lhe 10lal 
1l1lKliS (Creeth, 1',17)(; ( iipson eI (11,200 1: MOl;llc, eral .. I',IY3) , Therefore cotllpar~d 
to the our starting COllcen(ratlOlL ofO,9mg purified mucin. the atllount OfLlltLelll m (he 
O.'fmg (:Jude or toml mucu, (wh,eh "e'-l ui \~ l el1l to ,Ip proximately O.OOYmg) could be 
vcry ,ma ll to cause vira l inhihi!lOlL or ,lggl-ega!iOIl, However. quant ifi cation ()f tne 
amO\l lll of 'nu~ i n, in tile cmdc mlLCllS prior I() allY ,,,~ay should Ix consi(kr~d for 
I'LlILlTC sllidies (for exampic see Rayn.al d al" 2()0~). 
l his bowclcr d(),e~ Ilol C,'pbll ' \\'ny ~nLde saliva is effect ive as a total ,ccrction 
against the vims. It is possible Ihal (I) Ihe lllu,;in ~ollC'entra t ion is higil~r limn. in 
rci,ltion to Ihe total vo Ilimc of seerdum (2) (he hypOi()n i~ Il ~ture of " diva or (3) other 
<:ompOllent, of"dl\'a. as in [ile cas~ ofllllLell'l. may als() havc an li- \'lra l adi"ity or. all 
tn rec of the abo". 
The IOlllmy ofsaJ iva. hremct In, lk and (:crvkal secretion could also r ia) a role in HI\, 
transmiss ion or lIs inhlbllioll Fhnm et ill. ( 1999) dCHlollslnlted 1.n'11 human s~ l iva is 
ilypotonic in narn rc and can thcrdorc bUG( HIV inl"Cled mOIl()HLldear ICLlkoeytes 
wh Lch ,Ir~ eOlllinLla ll y shed mlo the oral ca\' ity during muco"iI and ginginllcsious or 
during dental tre atl1l~nt of liN · i nf~cted patients. Frec \';rusc, are thcn (ra pped by the 
sal ivary T\1lL(:ins. Since \ mIl illfeclion require, nossilLg of th~ mu~o'al ba'Tier 
(]\aa,-dlllg eI aI., 20(5), 'Iggrcgal.ion. by InU<;II, prevents vi ral multi pl ication and cell to 
cdl lransmisSLO il of HI\' , or the altachmeHI or HIV (0 the epilhdial c~ l h al the 
mll<:o,al s ur fi~~e, \\,hi(:h is n.~(:es,,~ry for penetmtion and transportution to Ihe sub· 
clwhchal C[)4 cell< IPh,] I,p' 1-'/ aI. , 1')')5), III "OJLtr~sll:>rea,t mil k, semin,IJ f1 111d ilIxl 
cervical secretions arc isotonic H' nalure and can llot d"rupl HIV illt",<:ted 
monolluclear l e Llk(),,'yte~. as sal iva does (ll ,Jron cl (1/" 1999)' j' here fur~ , IIn li k~ in Ihe 
oral cavlt} , lh~ v irus.:s lIllxcast mi lk and ll...: ICmale reproduct ive Iran are proleeted 











"olume of brea,l 'H,1k 'mu wmin~ 1 fluid can di'l1Ipl the hypolomc nal" n; of s"h"" 
(Uawn e/ a/., 1<1')'1) d"nllg hl1:,,,1 fccu 'ng "nu oral ,e\. respecll\dy. lh"reh~ 
overcomi Il)! the pf{\I~Cll \ ~ prop~r1 ic> of ,J[ IV", 'I ran,mi ,Si{\11 of Ihe \ irus II ,rmLgl, 
br~ast feeding maybe well dOu"Ht:nled (\la'ln il ng ('/ (1/" 2005) and oral se,,- may al'>" 
be 'Is>o~mted with a ,'enaill kvd " I' rl';k 
Ac~orJilig In Parke (l'In) lh,; "'~lll dil'{cre"t:e lX:N~(' 1l the clilll1ed ccrvic~1 mucu<. 
produccJ ullder the illtlucnce 01' {\~slrog~ns dunng th~ pmlifcrativc pha,e and the 
thick viscous cervical mlLClL, pL'ouuced un,kr th~ illllL1~nt:~ ofpwge,togcn, during the 
lutea l ph,N.' or under the inlluence of cOlllntceptive drug,> is ",amly ~ Uilr.:r~l1ce m 
siali~ at:Hi ~(\l1kllt. Thc dilutl."{l cervical IlllICU, of the oe,(rogm.< '" char~Cl~w,~d by 
the pre~eLlce ofa mlLch I()wn amOL1l11 ()ftl ,e sia lic iKcid than the vi,cous mucu" As the 
tennillal ,i~lic aciJ l-c,idu~,> {\fll1lL~in., 'Ir~ r~rortcd to interact with viruses such a, the 
influenza vims aLld pL'evelll the ho'>t cdl r~c~ptor altadlln~nt (r.~\'in{' et a/., 1987: 
Tabak el ,,1. _ 19~2; 'I abak , 1'195), Ille acce,s iblily Ol'lh~ HI VlrtlS and l!, lr,mS"'1'>S1()l1 
could difl"r bascd on thl." ,tage of the menstnml cycle. Thus collecti()n or cervical 
111 "t:u, al ,Ii 11hell1 slag~., of t h~ men.,t"J,1 1 cyclc and detcrmi Llatlon oflhcir anti-H I V -I 
ad l\ II Y I <; a 'lll~' li on 1(\ h~ ~ddrc'o;l."u, 
No difference in [Ill' rate of inhibi[ioLl or vi ral HIIi:clHlll dlL ~ In till1~ dill"r~l1c~ waS 
observed. This sugge,ts thai mucins may aggrega1t: tile vim'> i r\]m~dial ely ~"J 
p<:nn'IlX"11l1:-, Sl."ri:ll t~ l1f"ld fold di lutimjs (i,c, 10·', 10-". II)"' ~nd 10-4) of the samples 
were al>o dOlle to det('oniLlL' th,·Lr aLlli-H IV-1 aCli , ily althe highe'l dil\ll !On. Onc~ 
1110rt:. no Ji 1'tCrt:ncc HI l h~ ~nli-HrV - 1 ~d I VI l~· ()(' lh ~ mLlt:ills \V~<; J~kLl~d Jown In 
10--1, Mayhe the stmting ('OlKenllat imj which wa, (1,\JllIg wa, velY high thu, a IlOwcr 
U\nCeLllralion [han (Lolmg '" advi,ab1c 10 b.: u,cd ," a slariLlg m~l~ri al 
IH ~l l Ihc cx p~rill1~n!,> h~al lJ]a~li'al~d J-IlV-I was lI.s~d ao; a n~g'lli ,~ ~ol1lroL A,> 
,hO\\,Ll ill the re,ul! sect ioLl ~n approximalCly ]0',·" intCnioLl 0(' the CE'v1 SS cel l'> ", .. ~, 
ob'crveu. Heat inadi'a lion did 1101 ~(HnpIc1 ely destroy the \'in!s, 
In summa!)' u1Kk saliva and purified lvlLC5B and MUC7 inhihil ihe human 
immL.lI1(\delit:l~l1cy VlrIlS ill all JIJ I'irro a'S;I}" Crude mi lk anu crllde pregnancy plug 











C HAPTER 7 
ANTI-H IV" 1 ACTIVITY OF SA LI VA RY I\llT5 1l AND iIIUO -,we i NS 
FRO\! H IV PA T1El\TS \VIT'~ D' l'rF.R1<:NT CD.t COl l\ TS « 200, 200-.t00 anti 
>-1(0) 
7. 1 'nt rodudion 
The objel'live oflhis part ofthc study was to delennine ",helhn sal ivary J\.1UC5B and 
\1UC7 TUul'ins from HIV pos itive palienl, or palienb ",ilil HIV-/\ IDS inhihil HIV-I 
activity in an ill L·ilru assay. SlI livary lvIUC513 and J\.lL'C7 lIllleins from HIV patients 
with different CD4 ~OUIllS «200. 200-400 and >4(0) were incubilled with IIIV- I as 
pr~\")l"ly de,cribed imd ,lLb;equenl.ly added 10 Ihe (EM 55 ~el l s. (ell, were then 
~ ll ltll red and viral r~p l ication wa, measured hy a q'~1 I iLalive p24 ami!(cn a,say. The 
size. charge and immunoreaclivity of mucin, from HIV negative and positive 
individuals or mU('ins from Il l \' patients of diffcrent CD.t (·ounts. WilS anilly,cd by 
5D5-I'AGF. W~'len1 bIoI and El.lSA re;pedi,ely The paLienl'; with CD4 COlLnt 
<200 have lilll b lo" .. n A IDS Di Ilerellc~ 111 I hie' deg ree 11 r in I"'~liv it y Or vimlcnce of the 
virus in the s.aliva. breast milk, ccrvil'a i secrelion and plasma of I IIV positi\e 
ind i \ ,duals WliS also determin d by incubming these secre tioll s wi I h C~, \ t 5 S ~el l s, 
P,ior to th~ inhibi llO" as,,,y, lhe lmi~ily 01' salivary MUC5B and ML"C7 mucins from 
HI\, palien[s with CD4 count « :200. 2ooAOO :Illd >4(0) to the ('EM 5S ('el l, wa, 
determincd by toX l ~lly a\S"y. A, ~h"",..n ill Tabl~ 7.1, Lher~ wa, death of 5'!--" of the 
~el l s when m~ l,haLed wllh ML'C5B li'onl patienb with CD" coum 20iJ ·.tOO, Other 











\IUCSIl CD4 200-400 0, Slm!! 2, 5 )( 10"iml 5 95 
_\IUC51l CD4>400 O,'Im!! 2_5 )( 11I"irnl II 100 
\-1UCi CD4<200 0, 'Illig 2,5)( lO"iLll I II 100 
r. IU(7 CD4 200-400 O,'Img , " ... Id'/ml II 100 
MUC7 CD4 >400 IL9mg 2.5 x Io"'ml II 100 
Th o pc'<O"tog< ~fli"" «11 < "'os caiouLl r.,i a; ttl< numb" oCi",' ('db oYer total cell, (he pi ", dC<lJ:, , 
, (XI 
i .2:,1 The a uti-HI V- I ac( i >itie<, of sui i ,uQ i\I L C ~B an tI 1\ mei III uci,,~ from 
III V patient. with difl'rrem CD-I Cflun(~ (~200.2:00-400 und >4(0) 
To check "hdh~r the sa livary MUC5B and ~'iJ\.iC7 muCm, li-0111 HIV pall Cnl~ pos~c" 
th~ same inhibitol'y activity as !lH1S~ Ii-om HI\-' ncga(ivc Hldividuab (Chap(~r 6). the 
'Hlti -IllV·1 activities of the salivary MUC5B and ML,Ci mlLcin;; fmm the thrce 
j,.'TOLIpS of IllV pati ~nts (I.e, patients with CD COlLnt <200. 200-400 and >4(0) was 
(k lenmned 111 an iii vitro inh ihn ion ,,,say, The result dClllonst r,lkd Ihat IlTcspc(.,tive of 
l!Jeir CD-I coum helth Ml)C5B and MUC7 lU lLc-,ns rrorn H1V pali~nb ja il~d lO inh il1\! 
Ill\-' ·1 activit), ,lnd 100'>'0 vi!',11 infectielll elflhe CUM SS cells \n s measu!'~d by th~ 
1'24 anhgcn assay ancr a :<0111in 111(.'ub'\lioll I"-""xi (Figllrc i, IA. I'> and C), ThIS \\a, 
unl ike \IUC5B and r. ILT7 mucins iI'elm HI\-' nc!!.llivc indi viduals (Section 6,2.21. 
When HIV-I was Ir~a l ~d ",ilh Ihc mcdi,1 mstead OfI11LKtn' '" a nmtroL IIIO':h, HIV-I 
rLpl ical io n or tIlt<:clion or lh~ CE\l SS celb ",1:'< d~(~c(cd (Figllr~ 7,lA, Jl and C), 
Ilowc\'cr. no HIV -I in t,:c-lion w,,, s~en whcn hca( ma~liya l~d HIV -I w,,, m,~d I F'g lll-c 
7. IA, B and C), 
Thc clfecl elr lhc lclL~(h of (he inc lLbaLiem p~n()d em the rat~ elf mllib itlOn elf the I I I V- I 
mfection o ft h~ CFM SS cel l, "'itS (k(cnll;ncd hy inCLlb'llmg Ihc CFM SS L~lI~ '\I(h 
Ib~ 1111xILlr~, fpr I hand 2h_ Thcre IVa, no dilTcrcnLL du~ lo lh~ knglh o j lhe 
incuha(ion r~rjod ( Fi!!ur~ 7, I A. B aLld C,l, A, ill (h~ ca,,~ ell' the MUC5Jl and !l-lL'C7 
from IIlV ncg,l1Ive ind il'idu'l ls (Sc(,tionli,2,21. s~rj,11 tenfold d ilution. (Ir)' - to Ir)") 01' 
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...... "". M.o:;:'. _~. ... .. 
" 
H'I_' -to;. ...,. , 11\.;""""" 
~"'·1 
~ , • ~I' , ! ' , ~ , , 
","(i" I He"! 
HV" ,noc!r",ed 
Ir,' _, 
"I~"..., 1.1 \ ,";_111 \ '_ 1 . to;,;t in of 'Dli>'a~ Ml ('~ U ~, ... .\llC7 """ 'M (, .. ", III \ ~~!"'.b 
,,1110 ('1).1 ~ ... "" j<200. 1!ID-.I'/I' ~"d ;>.lUO). <,..,J""Y \t lJr~R .nd MIJC"l ,nu,,,,,,, (SflI)" l or lI.llmg 
t.),·h, ["' ''' pnlotn1. ""b ( I)t C'<>IIn) ("!OO. l{lo--~OO "n~ >~!)()} ,,,.,c I1Ic ~lwc.,J "," h "'~1\'1'" I) H)\ 1 
ror t>Omin.oo f ih .. <<.1 'hI'O II~h Q, ~~~m 1"''' .iL< c"llullNi .Nl ... nller ... , o""lml. HI\ _I "".trJ ""h 
moJ' ,l ,nd hoot ",".o(i,·".J lIlV· 1 wor. "..,d, Th" ,,"filt., t d !'",pl .; "Of< ,hon in,-"b.LTod wi1h CE\-{ 
~~ c<lI, "' a u~LContml\'''' co, fl .i ' Ifl'"cll ,.' ml tOl 'flo"" lh ""d 211, All.,. PJ:I" ".~1 , « il ! " or< 
,- " l l~rcJ ",oJ ,';ral CCr ILC" L~'" W;\' mo.",,-c<! h~ a ~ u,llinl l '" r2 ~ ,",ig<" '-',,~\ , T .1 .. ", ,\, R an<! C 
;"Jka,~ Uk: aLl(;-H ! \ ,·1 ""\I\U\ "I -..1"")- )"H I( ·-'R . M \1l 1('7 ,"" em, fi."n HT\' I',!I.",. ""h cn~ 
~"u"b ,2'JO. :~00--400;UW ·"-UX) r,·"''' ... ·';,cI)-,. 
To ooaminC' il 1 h~ ,oJI~.lry .\-1I)1'5B mod MI'('7 mu~ins limn HIV r"~ il l\c pali .:n!> 
t,';lp ur aggregate tnc \'l ru""S a5 th~ I\1U('513 'II1J .\ lUl'7 Illuci 'b fmlll HIV ,I(:.lIatlvc 











c(II LLlo,( aeelale I-, I,<:r ~! iill' ~"d of I h ~ ,ncubntion periIXI (60minJ, and ,II<.' t,Hraies 
were ,ub,,"quemly IIIc'lLb~i<;d "iih ih ~ CF\l SS (ell> fo r 30 min , L'nlike Ihe filtrate, 
from Ihe m ixlure' eli' HI V-] piLL > MLTC51l "" d Ml,C7 from] IIV negat ive ind i"ldu"is 
(S,'ction 62 _2 ), li lese filtrate, l'aus<:d l()fl',{, vIral IIIf,,<;I1(\1l of t he Cl:M SS cd I, 
(i'igur" 7,2A, B >1lld Cl_ E'(Ll l rth~,~ til lr"1c>wcr" i ll c ubat~d w ith the Cl:M SS cell" 
for III nlld 211. no ch"nge f['olll ih~ ~bOH' r~sLJ I ls mere oh S('n'~xl (I'Jgu re 7,2/\. U and 
C) 
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'., -' 1.-1)0 • I • ..-_, 
Modo, 1 It,t 
ft'.'-1 "-", I,,'M,,," 
c1'/_1 
..... -'1 ""'" h' ",-oc' 
""-' 
H~"rc 7 ,2 ,\1111-1 II\' -I acLi> iti,', "I' ,ali> "r), ~JlI(,58 .nd Ml' C7 ,"ud", fr"," Ill" p.ti.-nb 
";,h (,D~ mil"' «200. 2(111_~00 . lld :>40U.). '>ali,',,,} MU('.'R ,no ~tU('7 mu,i", (50011i nr 0,9m~ 
each 1 /;-nm pa:il11" with em enUll! «200, :'OO-~OO .,xl >~OO) we I'" i t"oCllh a:e,i with ,uht} 1,e [) HT\ · _ 1 
i'lr (>(Imin and fiit.'ITd :hrnugh O_~,; fLill pore ,i7~ C~lllll".e ac<tate tilter_ ih enn trol . HIV _I tr~"ed with 
media and hem <L,ac'j,alcu HIV_ I were used, TI", fi l trat~' "rtl", mixture, were thell iTlcuooted with 
( 'DI SS cdb.l a c'onceLlln\lion ,, [' 0 ,'; , I(i'c'd ls 1111 Ii" ,10mLn, Ih a11u :'h_ "\1\,, PBS wa, 1I cel ls were 
c"llur~d ,,,}(I ,i'!l1 re-piLeflli ,)ll wa, lnc1l.,ur~d hy a 4uali'alL'~ p24 .,,:is""' a"a)" Letten; A , H anu (" 
inJi,ale II", '1Ll1i -1 11 V -I He'li " il)' of ,,,Ii "!I')' M UC5B -1 L1<-1 \1 UC7 muc'in' fmOl H IV palienb "Llh CIJ.l 











7 .2.J G~adienl gel anu I ~ ses of sa il \'a ~y i\ lUes B and i\I UC7 muei 11 > f rom II r \' 
pfls il iH' in div idua ls " ilh d iffl"rcnt C Ll 4 connlS «200, 200-4110 nnd >400) 
To assess if the llIV inkct"," il1JCL~cd allY ~tnlCtu "a l or siz~ diJlcte'>c~ OIl th e: ,,,livary 
MUC5U and /v1 l C7 nlllc in" ,~livaTy 'vII TC5R aud vIUC'; lllucins from HI\, po,itilc 
individuals with difictcnt CD4 COHm, «1()O, ~()O-400 and >4(0), were disMlh'ed in a 
gel loadmg butTet ,Illd were subjccted to a 4-lm·;·, grau tenl gd ,lloIlg~ide tile saJivary 
vlLC5R and M1lC7 nFl,m~ from IIIV ncgative indiv](luab a, a contml (Ftg:ur~ 7.31. 
- -
\lCC7b 
H~\lr. 7.J Grolli",,1 gl'l a ll al~,h of .ali> M) ,\1 lC~B and Ml'C7 mudn, r,-uru HI\" n"gali" 
and p,,,ill," i udi, irluab. Fl"Cc,c_dricd ,"1l~1 'C' (.111,,!,) Ill' ML'C'SB frQ I11 HlV negot;" ;l1div-id,,, I 110". 
1)_ t.llC5B lium HIV p",iLL;e ind iv'i uu,ll, wllh c[H mun" <.200 (lane n. 11111_·1011 (:,,,,c 3 1. >11111 
(10". 4 i .. \HX7 from Ill\, ""gm,;e LlLui,iuual dalLc' ~J. MUC' frum HI\, f'U,ilhe i[lui,id",," ,,,[h 
CD,,) count; <:>0(, (lone (,), '_00--400 (Ion< n ,,,,1 ·400 (lone Si "ere prepared in a gel ,,,,,dillg buller 
an(1 ,epar.,.d L11 a 4_2 (" ~', !'"die"" g.l , F~:I~willg eleorwp l",resi, The ge l" os mi neel wiTb PAS, \, btle 
amlW' 111 re d m""o,", the :wo !,lycot;'Tln, ~f MCC7 ~11 rap ~f 11", running gel (MIX 7,', 'nd 'ligl~ II' 
cntcrllL!' [he runni[]g gel rMI;C7h). [lie om )w in hlac\; is ,It the "an ~f rU11"i11g gel 
lhc PAS ,;taincd gel sllowed tllat tile MLC5B from normals had slight ly morc 
ma{eri al m {oc 'tacking Sci and k,~ penetra{i()n m{o lh~ running gel (lane 1) {han Ih a{ 
from the IIIV patients w itll CD4 COUll! <200 (lane 2). 100-400 (lane 3) aml_~40() (lane 
4) " ,hlCh showed ics, llla{~rial m Ih~ ~lackmg gd ,ll1d high penetrall(ln jll{O Ih~ 
mnning gel. MUC'5U from paticnt, with CDel COlLll! <100 (lane 1) appeared as a 











IllOrt; mat~nal anu shmn:u k," p<'ndraTlnn "'luThe runn ing gd (laLll" 5) than that Irolll 
th~ IllV palil'n ts with CD-< "nunl < ~f)() {Ian" (iI, ~ ()()-41)0 (lall~ 7) anu >401) (IaLlL HI 
"hlel, slll,,,~d sliglllly k,., lIlakrial(,fMUC7a dllumOfC Illaleriai or'\ll.1C7b than thl' 
nOllllal Th,' r>.1I 1C7a frunl r"ti~lll.' WiTh C!)4 coul11 >4()() (1:1Ile: ill ,howed k , s 
llWlLnal lhall IhL r~.;L 
7.2.4 1","1U "m'cad;v;l y ana I) w s of saH v ar)' j\ It C511 ami j\ I UC7 lIlIlci tl <, fro m 
Hn' (los;!;, c ;" ti ; v; ti "a Is "ith d itll'rclIt C04 COUlIts «2UU, 2()U-4()U a nd 
>4(11 ) 
I 0 elcterminc il thcrc are any itlllllunGreacti, lly dllr.;r~ncl" hel" L~n ..a l i, ary '\ Il.IC5 Fl 
:111(1 r>.1UC7 ]l1 ucins from HI\' ncgativc ancl HIV positi\e ind i, idua l, Inwards Ih~ same: 
a11libodil's a, Ih~ result ul"lh~ HTV mfedi(ll1. ,ali\'in)' r..IUC5R and \lUC7 lnuc in, 
Irom HIV pmi[l\'L Lndi"uL1als "ilh d il"krenl CD-< count> «200, 201l-400 and >4(0) 
Wcrl' coawel in all ELISA plat~, al ong,iel~ Ihl' sahvary r.. 1UC5B allu MUC7 limn HIV 
llegative inell,icluals and probed "ith anli-\'f l T513 and anti -MUC7 polyclonal 
ant illlxlics (FiguTe' 7.4), 
A II hough lhl' di tTer~l1 <X in iml11UnOre,H;li \' ill' between lIlucm, from III \' ll~g,j li \ ~ :1 nd 
po,il]\'L salllpks i., \'cry ,mall, I>1UC5Fl (F igure: 74A) and Ml'C7 {FiglLT<' 74B) Imr\] 
HIV nc"gat ivc ind ividuals havc shoWJl the highest reactivity Inwards their rcspl'cti\c 
anllboJrc;; , il1\Clntingly. we ddccted illlillll110re~cllvily dilferelKc~ o<;tween th~ 
mllClIlS li'om HIV patil'lHs 01 difk rclll CD4 CXJLUIlS as \\d L Howc"\l'f non~ of th~sc 
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Concel1trBtioll of primary Ab (~g.l ml) 
Fi~ul-' 7.4 [LISA m'mit"rio~ il1lmun(II-.acti\'i~' ,,( ,alivar}' MIIC~ R and MI' C7 mucin, 
h -omlltV n<~otiw ond p" , jtjn iruli"id"ol,. I'lal~ IA) "''' c""ed "jlh l>l llUU [wm JJfV I ",~"·.;'~ 
i!:,l ividu,1 (* J. \f\X5A fr011l HI\, p<>, it i", il>j ividll,l , with CD4 C(llJllt, <200 ( 0 1, 20()-~1~) I "' ),,><l 
·,·4()O (» ,,><l pi". (81 wos """. d with MI)C'7 fr011l HI\, ''''g'' iv. i"<IiviJ,,,1 1* 1. \1\.:17 fr,'11l HI\, 
1~1Sii,'c inJ "'luuals ",ith (1)4 ""u"" <.2 1~) (0). 2t X)_4IX) ( "' ) and "41.) ( ). Plat'" "'~,.. i",uhal"J v,lth 
>~r' ~: two-lolJ MLLlio,,, ,,[ ~ua' anli -MlIC5B ( A ) and g(~" an:i-~1l ;C7 ([I) "" lyd(){w l a[L:tboch~, al 
cu[),:~n"",uJ:; be, w"e): SfLg.-'ml and 1I.25 ~l ~,-'jJd l ~uLLI aw :-MlCli) and l 2f L ~.-'ml "nd \I, n' pg. ml (~~" 
" nli-.\ll (7) , Amilxxly bindmg waS MI~l"ed lbln g "bbil allli-~ual ll]{I'O linkod s~("Gndary all[i bGdy 
"nd \'iSll' Ez~d w;,ll T\1U..-1I202 ;ub>1rale. Abs Grb'lll'e valeles """ road ot 4\1511111 in a T:tert.1: FUS.-\ 
r.ad",· Fach p<> int i, the ''''mgo ab",rh,"co 01' durli,". "mr:e s_ .-\, a l1eg"i", ,orlU'01 wells ",or. 










7.2.S W."leTn blo1ti nl! lln 3 l y~rs fi r ~a Ii \ ar~' '1 (J f:5 B "nd 'I U ("7 11111 dn~ from 
III \' I'",i Ii \'e i "di\'i du al s " it h difhn'n t {'04 co II nb «21111 , 2011-41111 and 
>4110) 
10 deterilline il- lhere are any charge dlfl"er",nces betw<Jen the <,alivory MlIC5R and 
J\·1l}C7 LH U~illS Ii-om HlV ncgal.l\'e and Tll V pos itive ind ividlLal, or among Ihe mIlL'lJ~ 
fro LH HIV palients ,, 1- diflerent CD4 <:01lnts. _\IUC5U and t>.WC7 Ilm.: im, Ii-om HIV 
pos itive imlivit.hmls ,,·,lh di llerenl CD4 \:OHntS « 200. 200-400 and >400) were run in 
an agarose gel along, ide the \H JC5 R ~nJ \1 \TC7 [rum IJIV negati"", ind ividua ls as a 
control. .\1U\'Jll~ " ·ere thell tram,.t','l'red I() niln ><:e ll ul(),e membrane, and probed with 
rahbil anti -MUC5R and mOHst" mll i-\ 1UC7 alllihoJies (Figure 7_5) 
lIw MUC5 U from HIV llegali"e mdi", dual (lane 4) dearly had more lIloteriQI and a 
,,·ide range llf chargt 31lcl' t 'lual loading_ lhan lhe \11}C5R ti-om the IIlV Pllsitive 
pal,en!> wllh CD4 CllHnt >400 (lmIt' 1), 200-400 (lane 2) and <~()() (lane 3) \\·h,d 
,h<lwed rdati, ely small range llf ('h~rge. The lllllbilities between group" hardly 
differed (Janes I- ~ ) . 
Dli ferenc~~ lD the chargt" w~s llbserved between the MUC7 from HIV negative and 
HIV p,,~i li ve mdlYidua l, and with in tht" group of HIV patient, of different CD4 
count~ (lanes. 7, N. 9 and 10)_ i\Il,;C7 li-oIll II IV nt"gati\·e indn·iduals (loot: 10) was of 
lower charge than the M l}C7 Ii-om HIV palients wnh CD4 count >4()() (lane 7), 2()(l-
400 (lane S) Qnd <200 (lane 9) As ,hown in Ihe Ji gure, while the PO~ l li\e conlrol> 
cmde ,aliva (lanes 5 and I j) readed \vith the anti"_\I1.;CSLl mId anll-M l}C7 
ant ibodies. QS expecte<l the ocgalive contro ls 'vIlI C7 (lane 6) and \1LC5B (laue I ~) 
<li d n()l rea~l wilh the anli- \ !l;e ~R and anti- \ t 1}C 7 anti I:>odie~ respect ively. 










fi~lIre7.~ II «'en' hlolli"g ""al),,', "I ,.Ih",') \ l lIf'~B ."d Ml le7 mlld", f..om 111\ 
I'",i[i,,' i"dhidu~ 1> lIi,h ,Iiffen-"I CiJ4 c,,'''lt , «200. !1)O-400 .",1 ·">4 001. Lan' L MUe.'I) liom 
1''',"c'''L, ",,10 ('1)4 >4IXI_ Ian" C. \t UCl A Ir"", I'mi o"" "ill, C LM 2()()-411U, lane J, MUC5lJ liom 
pa,"c'"'' wllh CI)4 ~I X I, la",' 4 , \11 ;C:iR fro", III \.' "eg" j" ",d j"d,",l, Ian" 5, c[ude ,ali", 11""i l,," 
c,,,"ro l), land) , MUC7 i negati' C cnntrnll- I,,," " \1lTC 7 ,'rOll1 1''';'''''' " illl C LM ~4l'U , hlnc ~ , \ IlT7 
ie()[1I p.l,enl, '\1111 ('1)4 cl~)_4(~( la" e 9, ~tCC 7 rrOl)l pm i, ,,,, " ill. CU4 <, 200. bll" II! , MlC7 (rom 
HIV n"gal1vc 1I \J iV1U,uk Ian" I. OMJ,: " Ii" 1I"',ili, . ""lUru)) "lid 1",>,: 1:2, \,tlJ C~U 11>.:g,,, ,,," 
"oulr01) we, " ,op"m:.-J b,' " 1' <, ,,~aroso g<: ""d t",,,(.,-ro<1 10 "i " " " II" I" .., ","",,,,,,,,<, 1 ' 01i0" ;n~ 
","nigb, ~I""king, Ih' [1I ", ,,h,,,,>.:' ",ore incubl.d for 2h wit h rahhi' a"ti-\!lIC~R ""Iyclonal (iano, 1-
6', a"d [lJ"'''" ,,,ni-\,tlJC7 ,j.ln,><'lonal (I an", 7_ 12 ) an'ihod ies dil" ted in 5% 1m,",) low fa: milk J", ,,,der 
in 'jjJS]'", I in 21)ijiJ (rabbll anli \IUC 5R) .IlU I in 1I~~llmou ')C 1lnti-MlT(7) Mom"r"'" were tb en 
"a,h<d J x 5' ''10 wilh TllSl "nu incuhaLed roo' 111 w':'h HRf'O linl:ed 1'001 "": -rot!:>! (Ialle> 1-6 ', a.ld 
gual anro-tln ,, " Ibne, 7- 121 , cconu .. ), allLihod i., di luteu in ~% (m .'\) low t;, t mil , pcmdor ill TRST '" 
uil lltion, "I' I in 5(~~) .IlU I in 151XI r.,pecti vely, Afl"r ",w lb"I' TUS j "",,10 U ' 5min l, band, we,e 
del,cI.d ",i"g an ECl deLe"," "" h 
7.2.6 Compariloll ofth,' lin' v i ru l ~ lI ce ill 'a li . 'a. h reast milk. ctn ical se~rel i () lI 
and plm.IlI'1 nr the HI \i i"r~~ t ~d i ndivid ual ' 
To cll~ck wh.;(hcr HIV m ,alna, br~a~l mrl k, ('~r\,l(:al s~Lr~lion and p la"na Lan mf~C I 
th~ CH.1 SS ce lls at the same or d lfrcl'cllI ratcs. CE\1 SS cclis wcre intCctcd or 
incuhatcd Wilh cruJc ,"-li,a, br~a'i nnlk. L~r.-iLal plug and 1'1(1,111" from HIV po,ill\'C 
inct ividu(li s and IJlV· 1 as a cOilIrnL Thc fC:,:ult ckrnorrslratcd thaI whik Ihc I(\'c v,ru, 
(pos,tivc Lonlrol) m i'cded lhc CEt>1 SS cel ls by ,limos! ItKl','a. the cmoc saliY(I. br~<lst 
milk, cervical plug m,d plasnm laried 10 LaLIS ~ \'wdl ](l i'ce l.,\(l of' the CE\l SS c~JJ s. As 

























" '<I'} _, 
. -igUl-.7.6 (" "' ~ " rh"" ,, ( !he HIV ,i ,-ulen{" in " lin . h r~", ! m ill'_ ce,,,;cal ,ecreU"n a nd 
pia,,,,., of {ile III \' iJlf~c{«1 imli\·id ua l,. Clu de sali 'd_ bTC,~ ! TIL1I'_ Ck-n lcal ,cen:! ion ,,,xl l'la, " C1 (4",1 
~ach ) fr"m jll\ p<,,"i,~ 1I1lhidu,1b wctc LllCu",' l<:d " ,!h ClM ~~ ccj[,; a! a "<)1x c"lral1"" ofO.~ ' 
lOocd l,/ ml fOT "iJ m l1. As C011l",ls CL\j S~ celi> wetc m"U"alcJ wllh liyc vim> or HI\, -j lP'-,",llvc-i '" 
[Jl'-<lia Inc~lLl ' v~) . A(kt Pjj~ ",,,h "db wc~e culluTed ,,"d " iral repli e.l ion wa> mc""-,,,,d by " 
c_ u"lilali, c 1'24 al1ligen a",,,,y_ 
7.3 Discussion 
Il ,,, .. , sh()wn lhal IlTespcCl ive nl- lheir CD4 COlLlll «2110, 2110-400 mal ::. 4(11) bOlh 
MPC5B ami MUC7 mll~im lrem] IITV palie,,!; did nOl lJllubil HIV - I aClIvlly; mst~Q~ 
IOO~'~ viml replication was d~t~ctcd by th~ p24 [111t ig~n as>'l)" SizO'. ~harge and 
mmllLnl)]'caclivilY dil'ic:rcnceii bel"cen lhe llllLCi", Ire11l1 HIV negalLye Q n ~ p,)sitJ\"~ 
indinduals and amOl1g lhe mL1~LllS from Illy' pahents of di fkr~llt CIl4 ~OUl1 t waS 
ob,crvcd by SDS-P,\(iE. \,'"eii tcrn blo l and ELlS,\. Th~ crude iiQ liYa, b r~ast milk. 
(-CI>'lcal plug and pla,ma from II IV pos i tiv~ Ll1di viduab did n()t Ll1 feel lh~ ('E\! SS 
cdl>_ 
Munn; of higher ~harg~ m i grat~ fuLth~r in to lhe gd lhaLl lh(\se of 1L "'~r charg" 
(ThomLLln "I a/., 19'1Lfl_ Th~ MI ,'C! I'mm Ll i ~ca,~ m lgraleu l'urlh,,1' Ihan lhal I'rom 











~harg~d lhan normal \-HJe7 II' lhlS i, dll~ l" an al l~r~d glyco>ylalion lhen onc C,1l1 
expcd , I ,,,ner silk chain, and an n pO>Llre " I' 11 'OIT clla rged groups "n th ~ III ucin, Wllh 
a l" On, ~quen! increa,~ in thc charge ]1<:r densily nllio of the lllucin l! wOLL ld also b~ 
cxp~cted that l'vIUC7 from paticnts Wilh a CD4 count -AOO Ilouid mi~ratc l"loscr 10 
whcre n<)rmal MUC7 is jXJsitioned, SUlpris inj:!ly (h i, wa, not to bc the ca,c because it 
seemed like the nwbi l, (y of/l.IUC7 fwm paticnts \vitll CD4 <200 (l'igurc 7,5. lane 9) 
migrated less t li an CD4 20() ·400 (lan~ 8) and CD4 >400 (lane 7), Also thc ~cb could 
be over loaded ,Illd thus we have not h ighl ight~d thc nwblliry of tile di ffer~m OlUCIllS 
adequatdy. 
In lh~ rrccedin~ Cimptn (Chapl~r 6) il was ,hown lhat sail,arl' Ml,C5B anll MLC7 
mucins frulll HIV negalive ind ividuals inhibiled HIV-l adivity by approximately 
'n .5%. , Here we invest igated whether ,alival}' MUC5B and ."vfCC7 mucin, fWOl HIV 
IX1>1I1\'e mdlvidUill> would h,l vc a Sll11 Ii Jr inllibilOry effect to thm frum HIV neg,lti\"e 
lnd ividUJls in <111 iii l'ilm illhlb llor)' iI>S'ly. We have shown that irres pect iw of their 
(,D4 cOlllll «~()O , ~()O-40() and ; 4(0) bolh M\JC5B and MLC7 mUcin, Ii-om HIV 
pat icm, lai led lO inhibit H1V-1 ac tiv ily, Ther~ was a I(){J~<, inkction orlhc CEM SS 
cdls JS ,kln"lcd by lh ~ p24 Jlll1gen ,""IY, .Although the rca,on is not cicJr. II IS 
p,,"ibl ~ lhal I IlV in l"c[ion indllces ch"nge~ 01' the s~li,arl' glands " Inch re,"lls in a 
dccline ill the a'"OUIll of,aliva anel a cha"j:!e in its c"Il',litucnts (Wagnere! ,,/ .. 19%). 
Th is in turn may afkct lI ,e glycosylal ion paacrn or ,ugar composition of the sa li vary 
l11l1cins. and If mhibitlon ofth~ villl> i> tlm>ugh ,jggr~gation bJ' the ('arbohydrilt~ ~ide 
chall's" a"eI Lf cI,anges iI, these ,u~aj' s id~ chaL"s OCClirs as a resull ol-infection (Lal CI 
aI.., 1';<)2).11 lS concci,able that IIns" the n.:ason li>r lb~ mab,l ity OrmUcillS IroTH HIV 
positive individuals to inh Ibit Tile vinls in ,ill in dlro assa y, I' unhelillOre II J V infection 
is a lso rrpmted to suppress the pmdllclion of ,al Lva inhibLlOl)' fadors, or elici t 
b locking mok('uks (Crombk e/ ai"~ 19')~J, \lucins ar~ ,1],0 repon ed to los~ lk'r 
c"rbohl'drate sille chains as a res ,dt "I' inkcllOns "hid, l"ould "fkl"tthLi r abil ity to 
adhere or j'~ coj:!niL~ anllj:!ens or micro-organ isms (Taylore/ ai., 1,)9Xj, Thus there is J 
higher possibil ity tim the IIIV in fection Induced chilngc in the glyco'yblion paltern 
01" the III LIcll1 '_ 
'10 chcck whclhcr the HIV in i'cn ioll ,likl" led I h~ "b1lily "I' Ih~ l11L1cin, to lrap or 











,dk rhc filt r~tes c~ ll\ ~d II K)%, lllkclion o r the CEM 55 C~ 1l 5. unlib." the fi l t [:n~, 
from the ml xtu ws of IIIV- I and nOL'llldI IllIICH". nl i~ .'"S1\~St., Iha l. hoth MlTC~B 'llld 
_\ 1 LT7 mUClns from III V posi ti ',c individlLJI.<. irrcspccll vc or I h~ir Cf)4 COUlU I'li I ~,l 
10 "gl:rcg~le Thc ViIlJ', Ik'KC thcrc \V~r~ free vinlses in thc tiltrate.s thaI cOlLld en l<:r 
the Cl.:M 5S cells "nd C<lnse infectIOn. A.s thc c,rbohydrale ll,oictie.' " I' .,,,hvary 
lnu,'l ns s~r. c ,IS at] ,nt;"hmcll1 sites for bacteria and Vlrll .Se.s (B", ch e/ 01.. 20f)O; 
Pr~ ~ ()b p ho l '" "I .. I')')'!). ~hange., in charge or g lyc o" yl~lion p"ncm as" result "r HI\, 
milTli,,,, ~oul d a ll~c t the abi II l Y of the mucins 10 'l ggr~g'lt~ I h~ vi rus. 
rhe PAS sta ined 4·20'y, gradient)!d deillonmatcd that there wa, a size difference 
bc1\veen the muci~s from II IV n~gmive and PO, ilivc individlLals a.s wcll a.s bc1\veen 
thc mu~tns from JIlV p'ltkll1' of d i fTer~nt CLl4 COllll1'. with the Illuci~s from HIV 
pO.,Jl IW in,lividU'lls showing sligh tly more ~x:n~tr'ltion or higher clcctrophor~tic 
llloblllly .. "'gam ~han 1\~' in Ihe glyco.,yia ll on p,lllem could b~ nnphcatcd. Fu rthcrmor~ 
as lhe degree of )! Iyco,ylalion aikc ls the ekclrorhor~l l c mohdily (Pallesen ('I 01., 
2001; P,nton N "/" 1\.19 5). the app~ar,mce of thc mucins from 11iV nc)!ative and 
po.,ith ~ indnnduab on the gradicnt gd W,IS diffen:~t. In summary as the strudura l 
,h lkr,·nce.' in ImICIl '" are rd~led l" phy",olog: Lc"lly ,lini:r~ll t I'UlIClloll.S (R"l.;ch~r cl 
al. . 1995), the ,i/e 01 stnLclLLral dLllcrencc 01' the salIvary mud", I'rom HIV (l~tienIS 
may ,lffect thei r ability to trap or ~)!gre)!ate the VIllIS. IIov,:e\,cr, the d iff~renc~, we 
dctlX'tcG 'vere too small to form ,Ill" condusion, 
LnzYl11~ linked i rl1lnU n osorb~nt as~;'y (I . USA) ""IS ~ I ,0 p~rfo rl11 (,,1 10 ,kknlllne If I he 
ill liliulloreactivil" 01' toc ,alivary Lllllc in, wa, altcred dllC 10 (he HIV infccTlon. As 
shown Ln th~ resu ll S('~t l () Jl immH~on"Kt J 1f i t y difkT't'n~c~ hd"'~~n mucin.< from IIIV 
ncs~li,e and p",ilive mdivlduals ",a.S ob,el'ved, WL(h lx' th rc.-IU('5U a nd r ... t l.'('7 
Il1ucins from ItTV neg~ti\'C mdividua ls shO Wing til(' h, g h~ ,1 1X, ,,cln,ity. If 1101 for lh~ 
.shorla)!e of ant ibody, heller immunore'lctivity diffe rence bctwc~~ 1'>1 UC7 mu~in, from 
IllV negati\'e a~d IXJsitive individuals could havc h e~Tl .,hown hy mcr~asin 1\ lh~ 
concelllral ion 01' (he primary an tihod y. Althou)!h the rea.lon is not clear. ,IS variat ion i ~ 
glyco.sylation can ark,-t 'lJllib<J dy bi nding (Patton er at., 1995). t h~ II IV infeCl lon may 
h'lv~ a llecled the glycmylation pall~L1l or I.h~ lllLLClTlS wl",:h ~ ollid result 111 epilOpc 
modification. Thi.s lindin)! ,eell!.S 10 ,trell)!then the outCOlllCS of th~ West~rn blot 











I'il~ role ,,1- <,alovary MlT5H ,,11(1 rvTUC7 in prolccllllg lh~ oral ,'avily Ii-om bJC1~riJ. 
"illlSC", ycasl" andlOXlI" i, wdl dll'cum~mcd (B"sch c/ ,11.,2000_ LHI ,'I (Ii" 1')00: 
l)rakobl'lHlI c/ aI., 2005: SHII ~n(1 Bob~k. 20001_ )hlWn~r, I,al el ul. (1902) reponed 
that cllmpilred 10 HIV ll~Saliw mdl\·iduals. sali,a li'om HIV ros l l.l\ ' ~ in<l ' \'Hlu:,ls 
I' llS'C>S considcr'lbly lo\\~r ant T- (llndicid~1 ~Cl"'ty Thi, Wil' sUl'rorl~d by thc 
finding, of (iLLnLraja e/ ai, (190'1) and :, ;t1l el a/ (2003) lhat limg,,1 ink,' uom 
sj1"cificall" C"",{ida "lbimfiS hilS 1 11Cr~"singly co)onl/,cd the mil) ,'avily of HIV 
1'0'-111' e pill.1enls_ Th" suSg~skd that th~ I I IV infcclIon 'flay hil' ~ 1lIdu~~d fllndiona I 
il ltcnuioTl OTl lh~ ,,!li.-ary m1l~ins which are VCl'y pOIC'111m nonllil1 ,'lI','um'l,m,'~', ['or 
in'-lallce VIlle"! tn 'l1lm LJTlO~Ol1lpromlscd individuals is reporled h, lo<,~ Ihe CXf"~S'IOTl 
of sugar rcccplor I' Le") h~lIcc milk iTl),': lh~ indivldllal morc su,ccpti hie 10 ora I (h sea ,~, 
(Pmkobphol el "I, 1 99~) I'lLlthennOle, as cO'iliellily l1l0difi~d SlUe"! is r~p01tcd to 
lo'~ it', pot~lI~y aga inst Pseudomonas aerugmosa, Slapliyi(){.'oc('lI.1' mll'CIIS aTld 
Candida aihi"w" (lnl eI af.. 1999). rhc idea that HI\, lniCuion Illighl induce 
slrlLcmral changc, 10 Ihe 111llci n~ l' I h~ most likely phenomcnon can be 1hink or In 
summary thc Sl)S-P,\(iE (gradicnt gel)_ ELISA illld W~'l~ll1 blot il11iIIY'IS strengthcns 
th~sc fin di ng;. 
h , thlS sludy (h~ diff~r~TK~ in rhc degrcc of in fectivity or virulencc Ol-lhc viru<,c<, Til 
Ill<.' sail,a. brea<,l milk. ccnic,,1 'CcretHlTl ""d plilSlllil or'nl\' posi1i,"~ indi'ldlials w~s 
also dctermincd by Incubating Ihes~ <'~crdHln, wnh ('F~r SS <:~1l8 . . A' ,h(,wn in lhe 
rcsu lls section none ofthcsc secrctions wcr~ ahle 10 in led Ihe (:FM SS c~ II" Though 
lhe rea<,on is llOt clear ma"he lh~ Vifill IOi,,1 ill lh~; e s~<:rd;on' w~s 1<){) low to ('aus~ 
ill[;;,~tioTl , Thus 8c<:rdiOTls with higher viral load arc r~quircd (0 tell whclher Ihere is 













HIE IWLr OF "UC71~ INHIBIT ING OR Rlm UCTi\"G VIRAL INFECTlOl\ 
OF Till: PERI I'll rRAL BLOOD \IONOl\"lJ CLE, \R CU ,I ,S AN n 
~ 11 ~ I \11/.11\(; TTn: SI'R L\O OF 111\ - I FROl\1 111\'-1 POSITIVE TO III V- I 
NI-:GA'[ I V I-: C~:LLS 
11.1 Inl roduction 
rhe :l ln1S of Thi s pan of the , Tudy wcrc to in "">t i g~tc whcther \RIC7 i) C<l ulu Hlilib it 
vir~1 inl-":CllOIl ('[" lilL pt;np lll'ra l blood mOlHmurlc'lr <:e ll; (!' lnICs) Ii) n,dll~" " lr,, 1 
1Ilf,Yl hlll oflh~ HIV- l Lllt,'cled PBII.IC, a]lu iul can1101111lnl/,t: lil" 'prc'ad of HIV- I 
from fIIV -1 pl),iti,'c PLl\IC> 10 III\' I neg~li'"C PUMC in an ill "ilm inhibition 
In i) 111\'- 1 negJtiw P13MC~ ''''ere incli bnted "ilh ui lrelent concclllmtion, of \ Il1('7 
prior to the addilion of HIV-I Sublypc C In ii) HI\-'-I [nfcded P8MC, " ,ere lrcmed 
with diffcrcnT con~cJ1trHliOJ1' of J\ \UC7 prio r 10 cd l culturc, In iii) thc II\V-I )X1>il i\'c 
PBJ\ICs were inclLbalcd wilh differcnt conccntml JO n, of M lT7 prior 1O the add Llion 
of Jj IV - I ncgatlvc P 13M Cs. '111<: mixtures wcrc then cultured and viml rcpliuiT ion wa> 
me"slIreu hy a '1ualitill lve p2.t anligen ,~"ay, 
N.l.1 Toxidty of :\ l l1C7 to while btood \:clt s 
Th~ loxicil" o l'sall"ary MI!C7 10 whi le hlood c~lIs l1a,ne l; lllon'><;ytc,_ lylllphoc;1CS 
anu granulocy1c, at ditferclll mlLcin concentL'miol1, (lmg. O.5mg and O,25mg) was 
dctcrmined u>ing thc lO\lcLty <J>say, ·rhc r~>uh (flow cytOl11~try reauing) r~v~aled lhal 
~\~n ,JI Ihe highe'l mucin concentration ( Img), \llTC7 wa, t'''Ll1U to he non-toxic 10 
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Fi ~IJF~K l I)~t~rmi .. tion of MI 'C7 to'irK}' to "bit~ bloo<t coil, ",in~ . tn<icitl . ".}. 
""'hi!" ~I",.I ce ll , (Uml or (,A· I,d' 10' «11» in RPM I m"'ailHn~ 10"/, Fetat Call"Semm and I'", 
Pen i,'i Il in'Strer" nm)," in "nlil~ "' i ,, Were mi"d with ~ifkre'" ".,n,,,n\r",.,n, "f ",I ivary MU(:7 (I m~, 
O. < mg ""I 0 .2.1mg) 01)(1 in<LJ1,",~d m " CO" i,,< ubiwor t"r 48h , A, " ,'on'ml, "dis "''' h (~Jt M lT7 ","" 
inmhak d in , CO, in,'LJha!n, tor 48h. At tho ond " I" tho in"ub",ion peri,,,t celh "or" wa, h<d and 
resuspe n(\e(i in PI)S, TI>er""fteL" ,'~ 1I 5 "'ere in''Uoo,"~ " ith 7-A Oli,,,, -,,,in,,,ny<in I) (7A,\I)) and ,o il 
"ia bi lity was moniTored b)' flo",' ")'tom01 r), , [lh",,! sampb /Yom two ,hl("" were u",d ,.., d a 
dc>eript ion is pIc>cnted r.,1"w .,ach ,,, ,)'_ t'-t3 '" the ""ults for lr., ~iifere,,' nlu< in "o""en,,-,t i,,,,,"re 
, ;",ilar: a "'p'e"' nt'lj,e which ;, 0 contmi ""d lhe """II • • l Illo highe" Inucin "oncentrat ion ( I mg) ~f 
"""h donor afe p",s.ente~. 
!!.2.2 Toxki~' of _\1 UC7 to red hlood cell, 
jhc toxicity of salh-ary !,1LC7 to rcd blood cdls at diff"rcnt mll~in cOllcent r,ltiuns 
(lmg, O.5mg ,md O.25mg) w~s ;Iisu d"lt:mlined using the 10xicil) 'L~S~y. The r~sul l 
rev",ll~d th~1 ~v~n "I th" high.:~l mucin cuncenlr~tioll (lmg). MU('7 w~s i(lUnd lu be 
nun-toxic wlhe ",d blood cel b and nO h;l~mol}'~is Oflhe red hlood c~ll s was observed 
(Figllre R_ 2). 
i 
I I 
fi~"r. 8.2 Ikt~n"in.(ioH or _'ILIC7 to,jd(~' to ro1 ~Iood ,,~tt, ~SjKg ~ to~idty a,," ~·. Red 
bk><,d (el i> we", w i,od wilh diife,ont conconlratiotl. ~f \ l UC7 (Img. O.~mg ",,,I O,2.1mg) and 
in< ubmed fOT &Om in 01 room temporat""., As a ""nlfol. ,'eli> wi,hou, \1UC7 w<e< irlCLJhaleu r,,, (,()rnin 
at 1'O<)n1 'emper"ure, A, 1he ""d ol"lhe in""ba lion p<,-.) d lhe hk",,,t WliS cenlrifLJg"d 11 000g. I.I<1Ii1l, 
4°0 and h"" tll<)ly, i, was vi,ua li 7e(1. Nfl. Tuh<, numh<r I, 2, 3 al)(14 12.'rnl each or to_ ~ _ 14.7 x 10" 











8.2.3 V it·lI l IOlld of the hlood ,a rill' le~ 1"1"<"" H I V po~lti\"f and n c~ath·c 
i "diviull al s 
The viral 10",1 llf 1l1C bl l""d .,ample' Ire"" hmh Ilw IIIV pO.'ltiw "nd n~galivl· 
indi\idua ls was dctooliocd prillf Ill t h~ HIV ",hihitlon "S"IY'.';', pre . ;cntcd in Tab l ~ 
)(.1 n".,q or lhe hlm,,1 "1111plcs from the HIY patient- "n~ 1'111]1(110 h~\·e higil vira l 
loads. As "pedcd no ' lral p:miclcs ,,~rc delcCkd 111 Ihe ,,"np les thllll th~ lilY 
T obk 8.1 Viral lood of i}lood ,alllple> rrm" H 1\· p",iti, ~ .nrl l1ogotiw indh·idual, 


















N.2.... I" hihitiotl or H I \ ·-1 acti,· iI, h ~ h It>("k i n!! Ih l· pllfatiH' ,irai hinding ,it<'s 
(receptor') of Illl' pI'rip linlll bloou monon u clear cell, u,ing :'11 ITC7 
I'he s~mc nperiment ~., in Sertion 6.2. 5 w~s done to dclcrmLll~ whdhn "'1I},7 Can 
inh ibit HIY-l Illfcctil)n of lbe PBM,s hy hlocklng lheir plLl ,Hi'e ,irill binding ,iles 
(re<:q'llm'). I he rC'SlLll showed that. as in tilc casc of CEJ\-l SS cells (Seclio" 62.5), 
eVCn at thc 1llshe~t c()lIcenlrali on (Img). \1 UC7 d"l nlll inh i bi t I II V-I Inlcctilln of thc 
Pl3.\ ICs (i'ib'ltfe ll.3). inslcad ~ high rerc~nlag~ or viral inicclillll "':IS dete~led 
Ho\\e\'er, n() Viral Infec tion WilS dctc<:ted when the Pl3MCs from H!V negali\e 




























Inu.ro1; on of I I ri -1 "Je f'6 ,\,1[;" v.i'11 """ 'P eo pri or 10 HI\! 
""Ui :, ,,,) 
HPJ-1-. ~ 
F'ef .. n 
FiglLreX,; J"hih i li"n "I HI\_I ~cti,'itr h! hlf),killg lht plI!olh'r ,iral Ilindin~ ,ite, 
(r,,",'p""') of tl", p" riphrral bloo~ mon"nude..- cell, .,i.~ \11 C7 in "n ill ";"0 ~"~)' . The 
rIl MC, from H IV_I '''' ~''';Ye :nd i"id"al, "CTC "KUb"Le<.i wiLil Ibn"TeilL C('I"'""""li",'I'; ,)t 'ali'ar" 
\11 ;('7 {lmg. O,5mg. O,25mg a"d O,:25mgl for DOmin. A, "(nllr,)I, PIlMC, ;" c"hated W;lh rns 
ip".,ili,'ol 1L11<l Pfl\lC" fr ,)m 11 1\'_. " "g"l ;.-. ",j i, id "oi> (ncgali,q WCle u<cd . A L the ""J "f the 
][)C uh "i()" ]lCTi(~l. 111\ '_1 SLlhtype C wa, odded 10 Ihe mi"HrC' ", "cpl Lo LI", ''''gali,," """" ',, 1 C"i l, 
wer< th"n cul",red aHlI vi, al r'plrc"\J0lL wa' " ,,,",,rrc'd by a '1'.",l il,,'i,," 1' 24 "nji ge l1 ,,~,ay 
8.2,5 rile ruk uf:\ IUl'7in reducing ,iraJ inrCd;,," "rLhe HIV-1 in fC ('lcd 
pcriphcral b lood mononuclear cell< 
T 0 ch~ck whclher :\ nrC7 wuld redLlce \ id , nfccti un of the III V _I inkctcd P 8.\1(,. 
l'll\ fC~ from IIIV-I in fefk~ in~i'ld\l~ls were t reall"d Or i"Cllb"tcd wl(h difli;rC11( 
COJlc~"tralioJls 01 \1\ 1("7 1, lm ~, O . <;m~, 0.25 111 ;; ,md Q,125mgl. T~c result 
demonstr,lted II"n Ii kc PBS (po>i l ivc wntwi) _\1 L:C7, ~v~n ~t it, highc,( cOJle~IIlratio" 

















" • ,~ e 
" IlJoJ  
SoJ 
0 
Ir<o UDatioo 011-11'.'-' .. ", PB~1C~ with " ~nlpll's 
figllrc~A I ht' "'''' "I \lllC7 in I"'rlucing ,';,"1 infoc{ioll of Ike 111 \'_1 illr. d.d "".-ij,hel'.t 
b~,od mono"""I""' <011, ill ~Il in \'ilr" a,,"), . The PIlML frOlll lIIV-l POSJ1j,' ind"',dual, wcre 
incuba1<d with dLII""" '(>{l,,-nl1lLl''''., or .,ali,'a,), MIT' (Img, O.5mg. O.25mg " nel U, 125mg:' I"r 
WOlin <llld cell< ""'. ;ll"n cuiturc-d <I[""j viral rOlli i"a !ioll ",.' nlC(l.,U 'oil b}' " quolitat"" I'M "mig,-n 
",,,,,y. ,\, " cOlltrol l'UMC. from III V-I pm ' Li vc iLldn·iduah W<I e ,""uho led w jeb PBS 
K2.6 Tilr role of .'llIe7 in rlIinirll i~jng the 'I)read of 111\-1 fromlllV-1 
IJO;itiw prripilerai blo()[] rIlononudcur cdh to IIIV_1IIcgati\'e periplH'rai 
hlotKl [JIonolludcm' ('ell, 
To (kt~rmmc "'hellIer MlT7 could fllLrlLllliLC (he <,pread or HTV-' i nf~Llion from 
HIV-! pnsiti 'T PBMC, 10 I-IIV-I l1~~ative l'R\fC\. Pl.n1Cs from patients with high 
vira l load rl nb le 8.1) wcrc treated nr lllcub~ted "ith dllr~rell l ~onLelltrali()",; of 
\llJC7 (Img. O.51llg, 0.25mg alld 0 125mg\ prior to th~ addition of lllV-l negative 
PB~1C~. A~ ,h()wn ill thc result scctam nn HIV- l inicCllOn or inhibilwll () r HTV-' 
actiYlly by \llJC7 al all ('on('el1lratl(m~ wn~ det~,tc d by thc p24 antigen assay after 
thr~e day, of Ldl cLlltur~ (Figure ~.5). Surprl_ingl) only TllImmal \' md mf~di,," ()r 
aelivily wa, dd~<:ted by the p2-1 nntigcn assay \vhen the H1V-l infected PBMC, "ere 










H g urr K5 
Wl rrut 
M ):7 
Inc Jb~t"'" or HIV _1 +v..' PBMCs with samples 
prior to addition 01 HIV-1 -'" PBM(">.; 
rho rote "r Ml 'C7 in Illinillli lin~ (hr ' pn,",1 of 111 \'- 1 !"cum 111\ _1 infected 
pt";pht'F"1 bh",d """'''nuclear <e ll, to 1I1\'_{ nr~"{ht pr";pheral blood "",n"nuclear ,' ell, in an 
;" '-;Iro '''"). l iLe P!Jh IL lTom HIV_ I I""it;v< ;llci;, id"ols were iJ:cub"leJ wllh JilkTcnL 
""J:("o"trotiom of ,"Ii"fll"y ~ll'U (lmg . O.5mg, {) . 25n~ "'xl O,:2:'mg) fm 60mm Al tile end or Ihe 
iocub"iotl perioo liLe mlxluTC' wcTt ",hied to HIV _ I ""I'oti"o rOMe, ,,:J celi, ''''e liLell cul:u"J moJ 
,i,.,1 repli("fll iGn wfl, me"'"Ted by" "_""iit"tive p2~ olltigoJ: '"""Y, As 0 ("OJ""": PU.\lC, fTOm HI \-- I 
po,i"". iliJi "llkLflls "ere dLTeclly ITk'Llhate,i witll HIV _ 1 neg",i "0 PlJI>IC" 
To delenninc whelher knglh)-' dur<ltion of cdl culturc could al fe et the olllcome llf Ihe 
above resu lt th~ mi., lu r<:' (HIV- l pllsi li ve PBlvlC, plus differclll concentrali()ll ' oj" 
r..1I. '(7) were ill('llb~!Cd wilh HI\, -I negall '" ~ PFl'v1Cs and ~u Iturcd fllr IllJ1ger lime (six 
J~ys) . Hr""e\'CT. knglhy in~ ub,lti(l ns (,dl cullUre) m~Je no dil ferellec to the ab()\'~ 
resnlts (data not shown), 
This sludy provcd lh~ ubi lily of salivary. breast milk and pregnnncy plug muGins to 
inhibn IIIV-I activity. The queSlion" whal can b~ don~ to ~xploil the ami-H!V-I 
a~ I1\ ' i ty llf th~s ~ mucin" Thus the focus of this Chapler waS III im~Sli g:a l~ whe{h~r 
sah\'ary MUC7 can b ~ used ,IS an ant i-IIlV-1 ~geni illlhc blood stream which is Olle 











The PU~ICs which were ll,cd m Ih" sLudy ,Ire known to cxpress all lh~ lhr~e 
dlell10kine rcceptors or co- recq110n; (CCR~. CXCR4. and CClU) and s~v~ral 
adhes ion tnolecuiL'~ ~uch ,t<, MHC II , IC.'\M-3. ICAM-I and LEA-I . in audiliolL to 
CD4 (Lallo, e/ al., 1949). The HIV- I SlIlJlype (' whi~h j, thc 1110't pl"C\'a lctll st r~LL I in 
Ihe S()llihern Aii'ic,lll ~()lllltries \\"'IS the vims <,traill u,cd ill lh" ap~nl11ell t . 
Thc llIucin (Ml)C7) did 1101 illh ibit infection ofthc PI3\K's by lhc Subtype C \ " nl' by 
blocking th~ p"lat,\"e \' lral bmdmg sites as mentioned in Chaplct' O. MLC7 i"ail<'<l lo 
[lliLibi l illt"ction orth~ CF.\1 SS cell, b; Ille Subtype 0 \'it1.I~. Agailllhc rea,OIl could 
either be that \IUC7 diu 11 01 block liw vira l bmdillg ,ites or the \'il1lses were quick to 
bllxlllr enler the l'UMCs beforc Iwillg trapf"'d Or ag!"'T~gal,,,1 by the mucin (lkrgey eI 
ai, 1994. Rols~h~r er a/" ::00::; Mal,lilllld e/ al. . 149.1). How~\"eL as pre"lou;ly 
mcntiolled, ~ I tc"Ctnm ml ~roscopy IS requi red to d~tcrminc cxactly the illleracliol' or th~ 
mucin alLd PB\IC,. 
r he otllct' POi lLl of ill lere'>l wa, lhal 11' IIllLc ins \\"~r~ added tll the <llre<ldy infected 
P13.\1Cs would (hey rcduce thc ilLtixlivity () j' th~ ,~ cdk To a(jJr~s, I h~se quesuons 
HIV- I p<l,ili\"c PB~ICs w~r~ mCLllml",1 or I r~,ltcd with different ~onccntr<ltions of 
MlT7 ,ll1d C1.llmrcd. Howe\'['I'. no rl'\luclion ill v,ral mi"dlOll a; a resu lt uf r.1UC7 
'r~almenl was obserl'ed.lI lV- 1 is an intmcL'ilu l<lr paLhogcn which inl~grmes with l h~ 
ho,t cdb nuclcl ~ aC1(ls. ,Illd the likel ihood or there bcing all Y physical cOlltact 
hClweclL the \' irus 111 th ~ HIV-I p<:lSlIi"~ T'B\lCs .Illd the mll~in. is unl ikely to occur 
(llergeyel "I .. i ')94: 130lscller i'I "/,, 2()02: Malamud ('I "/, 1993). 
/\. S ,IHl'.,'Tl in lb~ pr~\'ious Ch,lpter (Ch<lpter (,). s.lI iv'lI), (/l-IUCS 13 and \1 U Cn breast 
milk (MUCl) and pregnancy plug (MUCI , \l UC~ . \1LC4. r. ILC3 AC, MUC3Fl alld 
\'HJO'i) lll llcin, , nhibll~U H1V -1 acll \'iry by aggreg,lting the \ inls. lile question in our 
minds is whether mucins C,llL act as lhcrapelil ic llr aTlti -HIV-1 ag~nts in areas ;uch as 
bl()(,xl whIch IS not knuwn to be a rich ,ource oflllucills but onc orthe main [O lllc, of 
IIIV- I lrarl'>l[][ SS lon, As liN IS all Il1trac~llular p'ilh og~n WhiCb integrates ,vith the 
fl<.lSt ~ells nlld ~ i c 'I~ids. Ihe ide,1 of reducing lllV-1 inkction of inlL'clcd ~ dl , using 
llludn~ (,ce the pre\'1ous paragraph) Wh,Cb mblhil ll 1V-1 by aggregatmg or l"lpping 
the , irlls (Lkrgey c/ aI., IYY4: 1301~chct' e/ "I ~002; Malall lUd e/ al . 1943) is (lUt 01' 











\HlUld be 1( , h~p Ihc y irns ,,( thc IlN'csl Inc! fl'J"iblc or il> minimize the gener~li'lTl 
0]" llCW V1rlLS r~r1l<;ks by dcsl ruyiTlg the illl cClCd <:d ls '" CIlS' r ,el ls do (\Iet UTl<;, 
200 1: \1c\1 1dl a~1 and Rowlal1d Jones, lOnl). 
Al lh()ugh iJ\<: ", f(\rmallon "bom viral ,prcatJ ,,"mllg l "mpho<:)1~s is limitct! (Sol-
Foulo" e/ aI. , H)(l2) ,In ~tI.~mpt wa, made 10 ch<:ck if 111U<:IIlS fould minimize lhe 
,prcad o l'HIV- 1 from HIV I ]1 osit iye 10 HIV- I "~gall \'~ 1'F\\l Cs by aggfcgalinS the 
frec vimses which could be released b" Ihe infee-let! ce lls be l;\re Cl1tenllg Ihe 
lI'nl1fecied ones. In this sllLdy_ \,111C7. whi<:h IS the smallesl m lLciTl allt! Silllplc, l III 
sl rll c' lme Wi" used (llo lschcr CI 01., 1999: Lagow <.'1 al" 1m: Si tu and llobek, 2000; 
Thorl1 I"" fl a/., 19<)9), As It is only found in ,ahva (Thomss ol1 <'I ai"~ 20(2) its la,k 0 1' 
(o" 'elly 10 bolh wlnle ill1 d red bk~.1(1 ,ells "a, conJi nned pn(\]' lo lhc HIV ,!'Say, As 
shown in Ih~ r~sull se<:tio" il1 tereslingly enolLgh ML'C7, al all lll ucin con<:enl[,l\Ions, 
inh ibi tcd JJIV'-1 aClivity by I ()(la,,;', Th~orctim [jy lhc spread of HI V- I li'om lh~ HIV-l 
positive to the IJ]\,!-I n~gall ve PF\MC~ ~holl i d bc minimizcd by mlLcill lrapping Or 
aggregilltl1g free VIruses released by the illlCcled cel ls p,i (\]' 10 Iheir Cnl!)' w the 
Ull tllkc (L,<1 cells. 11 IS assumed Ihat vira l parlicle;; released Ii-()In the 1l1li:deu PH\1Cs 
shou ld be detectable. which did nol sc~m to 1H'l h ~ cas~ h~re, /\l s<' ' UTl'ri Stllgly, hard ly 
allY virus 'I',,,, dctccled WIKIl lh~ m"CIil Imlrcat~d HIV I jX' slllye p n\1 C', wCre 
(hr~ctlv ildded 10 til" IlIV- 1 negali,e PRMC,. r;l[slng Ihc quesTl ol1 of wheth~r Jny 
vi ra l cxchangc l>ccurred onweell lLlllnl'ccled and inJ(:cl<:d ~e1b 
All()l1wr qll cstion th aI aros~ li'om Ihese rcslLlt<, \\,,",, ", hl'lh ~r lh r~c un\'s of l'dJ <:,,!tu rl' 
'''ilS suffk ient tim" Ii))' the Vl,-u<,eS 10 ,prcnd from lh~ HIV-l I",,,t ivf I'Lf\1Cs to IIIV-
I llc'ga llvc PHMC, lo <::lIl SC il1fection. 1'0 addl'e<,,; til i, lhe e,~pLTtJllCllt. w,,, rcpeal<:d 
followed by a SIX daycc11 cuhun:. Howcn:r, ll"s did 1101 Jl l tlllel1c'~ (h~ above r~sult, In 
lill s assay (he OCCUrrel1f~ of any viral spread from HIV- I l ~"'ilive PBMCs 10 HIV-J 
ncg,nivc I'U\lCs rcmains ambiguous. TIm, I'un,her 'ILJ di ~s should 1l1C ILI(le thc 
e,tabh, hmell l of,lIl ,iSsay with ~ capadty w cunli nn vira l spread Ii-om HIV- I posil lve 
I'UMCs to IUV- l negati vc PBMC', alld all llldirl"(:l co-culturc HIV aSS;ly to exa,ti y 
deknnin~ th ~ role of Ml,C7 in minimizillg ~lC "pread o]"HIV-I Ii-om Ih ~ 11l f<."(: I ~d 10 











III summary MUC7 neither inhibited HIV infection of tile P13MCs by blocking the 
putative viral binding sites nor reduced vlraJ infection "fthe IllV-l infected PllMCs 
ill an in vitro assay. Although MUC7 ~eemed to inhibit or minimize the spread or 
IIlV_1 from JlJV-I positive PBMCs to HIV-I negative PBMC~ as mentiotlcd in the 
previous paragraph funher sUldy is required I"r the lilture \0 answer the questions 











CI 1 .. \ PTER 9 
Ai\TI- \ ',\CCIi\IA \ ' IKL S ACTIVITIES OF SALlV!\RY, BREAST I\IILK Al'm 
I'Kl:G"<k'KY PLl.I G _'\llJClNS IN A"< lA' VIlRO I"<IIIBITIO~ ASSA \' 
9.1 Introduction 
I he objcrtivc of the Palt of the study repl\n~"{l in this Chapter \Vas to ,'Iocck if ,all\'ilry, 
brCilst ll1il~ and pregnatKY plug m ucin, (' ,111 mill bi t the ,,,;ti\,ity of othcr cnvclopul 
\ ' lflL'CS b;;,,,k, IIIV-I, In thi s ,hldy the act i,ities () f' pUrified 'vIVeSll ~ nd r>nrC7 
from sa liva, 'vIUC! Ii-()m breds l rn tlk and prC!!nalKY plug illlLcin, agm nst a laboral()ry 
adaptcd cnveloped viru" vaccinia ""US (vCk-S 'train). which is a Illemocr or the 
11l\X\' lnlS family was dctermined by an ill h,biu()n il'Say, Va~(, i n ia \ lruS (\GK-5) was 
ll,,--ub,1L~d wllh Ml.C:;U. tvIUC7. MUCI all,l pregni111c'y pl ug mll~In' >;cparatcly and 
subs~"-llLclltly added tl\ Ihc Afri~an grecn Illollkc), kidney cel l> (RSC-Il_ Cell, were 
thell ell IllLr~d ,111d I h~ ;: tak () I' In fec'lil\n was monitored by Crystal Vi()1 et Dy~ s() lut l()n 
s\ninin!!, 
9.2 He,lllls 
9.2.1 Tuxkit~y a~say 
jhc wxkity of \1l;C513 and MUC7 Ir()", ,al1\'il. 'vIVC I i[om breilsl mllk and 
pregnancy plug llLueim Lo t h~ RSC-I was dctermincd by a toxicit), assay , Tloc rC>lLlt 












'I able 9.1 "I o'it"iL; or ~ 11'("SIl a",1 _\IIT7 frnm ,alin • . \1 tT I from Ii,'< ",{ milk "illi ~nW'""t"; 
Ill" 1II"<i", ,,,"{a; "ill' _\1 Lei, \1 1.'("2 •. ~ll1C4" \1 LC5AC ;\Il'C5B "",I M lI(6) {II {h . SSt . 1. 
Sample Con flSC-l % of dead cd], % orliv" c""lb 
\1OC58 U. lmg 3 x IO"/ L!LI 0 100 
\IUC7 0 1m g J x IO"/ml 0 100 
MlJCI 0 I"'g J ' 10
6 m! 0 100 
~egnaney piLig lllLicins o. I"'g 3 x 1 OO/{n! 0 100 
Th, p",,""~,~" ofli,'" "lis "'os ,"., lculokd '" tile nLL,"beT of I;,'c c"li.' ",'C'- h)tal ,'e ll, ( ~-"" r l" , <1,",1) x 
11111 
9.2.2 -\ntl-\ardula virus activjties ofs:lli':lr~' ruucim, 
The r~LLll de",onslL,Ll ed Ihal \flJCSH (illd ~1UC7 111uci", inhibited y(jK-S infectiv iry 
by "boul riO",';, and 70'}, r~sp eclivel y " Ilo\\'e\er no inh ibi tiOll (lUO')-';' infection) of the 
FlSC-l was r"port,d wh~n Ihe "Oll lm l, 1. L11Ir~(lled Vlnbe, (vGK-5 Wilhml1 Illuc ins) 
were add~d to the ElSC- l (Figur" 9_11_ 












1he mJxtu'es adeled to:he lJSC-1 cells 
Fi~u,-"~,I ,\,,(i·'acdnix ,i,-u, act ; vi(~' "r ,alh-ar~ Ml:C~R and MVC7 1II,,<in,. Sali\'a ry 
MlX~B "'-1<.1 MI:C7 W_I I"g "acill ,",eTC iOCLI"" LeJ with ,{;K _5 '''- 1.IIn'" at .17't" T he In,xtl,,-os were 
"'kbl to the USC- ! in til" .\liJlinll"n L"Cl~:" 1 Medium onJ cLLI{urcd"L ]7"C in a CO, ;"'"00010, (5% 
C(1e! for 48h to 0110\0/ til" forl1lo1ion of \'Ll'[ pin'l L>';>, A, 0 comrul un([cn"d \iiru"" ( ,. ( , K- ~ ",ilh()ul 
Inuci,,) we," .,d,led t" tile IlSC-1 h'<I ,""" of i" hi bcti otl w.o; then d'''XlI".;.rrJ1<cl b) ;t"inin~ oftl", ,"ell 











'1.2 . .1 An ti-, acci"i" viru, ""t ivitic \ of preglla lIey plug ,II uein, 
The ,~su![ rcvealed that at viral wnc~lllr"twns uf 3 mll liOl I P!aqllL' Forming Ullltiml 
(P] ' L'imi) and 2.4 million PFUiml. PI"Cb"'''Ill'Y plug mucins (cOlllaining \l lJCI. 
r. IUC2, MlJC4, l\IUC'iAC MUC5R alld MUC6) inhi bited yUK-5 activI ty by 55'.'" 
and 100% re<;p<.: ctiv~ l y . How~ver when the ' ame conccntmtions "I' lIntrca ted v!nests 
(vCiK-5 without rlllldn,) were ad'kd lO Ih ~ RSC-I nu inhibit ion (]OO% infec tion) ot 





" < c , 
" ~ 
x 
" .,a; . ., Cf!:J rr • . 'n 
P--LI m • CO"',,,,,, 
mJ' '''' 
I 
·,'a;·s @~.4 rr~ 
po,J,," """ " ' " 
O1.c, ,; 
Tile r Tlixtu rc~ added 10 :he ElSC-1 c el ls 
I 
-I 
t ' i~ur~9.1 
IO.ll11g) ""'e 
.\n1i ,"",cillia ,jn, "eli,it) ut" pnyMKC) ptug ,,,,,,ill,. Pn.' grumey p iug Ll",e in, 
;"""0""" w;,11 v(;f..·~ a\ " ]Ca: CO[lC,r;IMi"", UL .I [llLlli,,:\ Pt 'V",1 "n" 2.·1 lLL;lIion 
rf Ll,' 1111 ,.". I 'l11i" "' :n"C Tho In :" LJr", v. ere ad<kd To Th, HSC ·j H\ " ,. .\1 "OLlllLlJ]) b"",, :i,,: M"d",," 
"n<l cul lUr"d", .i"h: in" CO , ITx.'uh",,,," (" ,,', en,) fnr~8h '0 " lI ow ,he formaT ion nf \ iral 1"'''1Ll"" ,\, a 
conlrol u[a' .. ":",, "im"" ivGK·' w'Lh"U L nme ;n'l WCTC addcd ", "-...: B~'·I. F,·id.:n<o "I inhi hitioll 
we, lh" " d"LLun>l,.",,,,i by ,,"inin~ OL lhc "cll mOl~ " "ycT< wl lh Cry"o l Vi"lcL Dyo. 
9,2.4 Anti-yaednia virus adh·ity of breast milk mucin 
rhc act i\itv of ML'Cl (milk mllc in) against vUK-5 activity at different ,ira] 
WIKenlraiion, was Illso (ktl'nnined by an illl'il!"" inhibi lion assay. Thc assay rl'\calcd 
(hat at v1ra! concentrations of .' mlihon PFU/ml and 2.4 mllhon PFlJ/ml \lVCl 











RSC- I "ere III feded by rlw same cl>llcent L'3ti om, " r lLlIlr~alcd vinl~e,; (vCiK -5 wi tll{)llt 
rv 1 LTC I), ll () mh il->illlm (1 00% I nfe,llon) of the usc '_I ,,'3>, deL,:cted (F 1 gun; '1'1. 
I()~ __ 
v'_'K-G (f 3 , *", 
PFII'm + f .. t IC 
',' (;1;-" C:( 2 4 "kr 
I'!'I I m + 1'.1 £1 
l 
Figure 9,J . \nli-voeciniJ virus ~c! i , i!y "r hre", ! mil~ mucin. ,\1 i lk mUf in (\1 U_' I) (0, I mg) 
w'" i,,: uoaLed wil" ;-(; K 5 aL mal C'()[)C c'" "",,ion, n(' .1 m i:_ ion PFI ;/ml ,nd 2,~ mlilian PF1I.·ml til< 
15mi" " .17'"C Thc" m'",,,,,", weTe ,',JJed to ,he BSC_I in 'h e ~1 io imLJm F ~,ent i , I MeJi am ,od CLJiLlIrc d 
'" JT'C i:t" CO, i [ ~',,"ali:X- (5",;, COo) L(,r -I ~h h, " ]I n,,, rile limn,,"oll o r ;iml 1'1'4"<'" A,,, cnlL\Tnl 
unlrcalcd ,iru,e, hC ,, -5 ",ilhoU( MLJCn " CTt' .~-kjcd~, Ibe fl ~C I l\'idclLce oi'iLlhLoLlion w", IIlC Ll 
dC'rTlO ,,""'led ~y ,lai:\ing ,, [ Ilk.' cell rTxHlO l"yer> w ilh Cn'"al V inler Dye 
As sn li \'ary, breast nu]k 'lild pregnancy plug lllucins inh ibit HIV- ] activity. we tested 
Chapter we descnbe til,- aJlH-v.'lCcinia \ ' in!> activity of lhe\-C IllUCillS. 
r ile virus whic il was used In tJus study was a higil ly a1t~nu ated r~Cl\ll1bin~llt V~L~inia 
vin!, ,tmin (,(l K5) ()I" the , mci()ped p"",irus flulli ly ( 13 illillgs ('/ <11_ . 20(4) 
/\ cco L'd ing LO Billll1gs eI ill, (2004) vCiK5 is a oo LLIJk -stmnd"d D~A vi rus nnd ]1(5 
kb p in siz~, Like thc wi ld-type \,i~Slern Reserve strain ohaccillia "in!, it can grow in 
~ell ~l1 l lUr~ bUI l a~ks a n euro-"tnd en~e iador 10 repli ~a!C in the bralll which make, it 











Cp<lIl ShO WlI lg that salil·al}' M1JC5ll and .\llJC! m lJC in" illh ,hllc'd HIV- I aelll'll y 
(ChapIn ()) " ·c wOlld er~d \I·hdhcr thcse llluGins shrl\\"cd thc ,ame inillbilory actl\'lly 
agalll ,t oth~r ~11\clo rcd \lru s~s such ~s ,GK-5 \Vhe:1l th" v(jl-:-5 "a, Irl',ll cd wllh 
"al ,vJry MUC~ 1l ami .vllle7 lIll1~im PrlOI- to arklitionlO lh~ hO,l cei l, (IlSC- 1l Ihc 
Illfed"'il) 01 ' tlw '<TK-S was r~du~~d . Jt IS iikdy lilat, ~s III til<' c",c of HI\'- I 
I Chapler Ii), lh" c' arlx-,hydraIL tll(" d i ~ > o{' the , Cl I i \ary m ll cm, cou Id trap or aggregmc 
lhc vtiK-5 (Bosch ,,1 "I , ~()()O) and inhibit hl,,1 c~ll s ~l1try (Kl l' lll c/ ,,/ .. I'N2, 
Prako bpho l c/ <II" 1\19);, Prakllbpbol <'I ,,/.. 1'199, Pmkobp llOl el aI. , ~()() 5) _ HO\\e'l'-. 
10 coniinn [his hypothesi-, ocglycosylalioll 01 blllh .\lL(5B and r-.. l lI(,7 pr ior 10 Ih e 
Incubalion wi lh vGK-5 i, requi rcd. 
,\ , c'~plainLd LarlLcr the: mucin" ma) have lIlh ,hiled viral <ld l\'ll y by aggregilting the 
,lnL" Pfl ll ' tLl bo"t cdl ~lllry. Howc\cr the' rale of aggrcgal l()l1 or inhibili()n L~lL1ld be 
il1fluenced either by mucin conccntmtiom or , iral load. To pro,c' th i~ hYP01"""i, 
Inh ibl t.ion ilS~ <ly' at ditTcrent v·iral or mucin eOIlCelllrJtion, \\C I'C rcquired. 
A, wa> ,h()wn III Ihe resHl1 seclion, Ihe pTegn,mcy plug rnU ~ In' ,Illd \I CC I (rn i l~ 
mucin) inhihitcd ,·(jK-5 aC\LvllY In a d(),e: d~pe:mkn l nMnne:r up lO I(l() %_ Alth()LIj!h 
Ihe reason is not complcldy ck<l r, <1t high~r \-Ira l concentrat Io n (3 milii()ll l'I '\Jiml) , It 
"I"""ihk Ihat ""mc ,iru , ~" ,In; !cl't Hn-'jggreg: ll.~d h" the mH~1I1~ . Ii ~ I1 C~ Ij-ee 10 bnxl 
lLllh~ smfac e: Ol'lh~ BSC- I ami Cause: " ral mk'cll lm,_ This could h~ I h~ n:J~on why 
thcr.- Wal o" ly .5~'YO and 75% inh ibi lion 01 Ihe vCOK -5 ~cl i \,lt)- by pregndncy phL!! 
mUCIll' ,md \ ,t1: ( 1 r~,p ccliv~ l y_ On th~ conlrar\' wh~n fc\\c r v i ru se~ 12 ..t million 
PFL' iml) wcre used it is r Ll~'ib l e that ellOugh ~ p,l ce Oil tlw su rfacL of rh" mUcliiS 
, h"Hld he: available- I'lr all 11'1<' ,iruse:' l() bi lld '1l~1, a, a n:'LIlr. 110 li-.',' \ Imse:> are: kit 
10 bind and inj",ct rhe IISC-I (I--igHr~ 9.4). l 'l"" rcfo r~ 100"" ",hibiri,,,, (lfthe \·(11<.-5 










J n ~ IIl>"l illn 
1 ~ lI1jn al 37 '( 
, ( iK-5 .\ lud ll lll l'US ,\1 ucin aggr.:g:I1C I h~ , (;K · 5 
A dd,llon n I' Ihe mix LUre 
into the IJ~C· I colI, 
• 
Aller incuhalloll ul H"C 
• 
For 4Rh 
ll~( · l ,ells 
Due I" \il e I ~rp:l' nLlml ..... T n() C" " Hg/l 'PJ~~ in the 
IHuCIU "a, u':lIbblc Ii,!, all llll" nl1~C~ I" bmd Ih" , 
<;onl<:, 1I'11;.('j, " 'ere left h ee 10 b ind nild ut!CcI ,hc 













MUcin in PBS r.1U(:111 ilggrcgil1~ the \'GK-5 
Add ition of tile mixture 
lIlio the liSC-1 cells 
• 




Duc to the smullnumocr aillhe V1L'lLSe,; wcre 
bound to (ile lllucin llencc no free \ irus was 
(I\'(lilnble to bind and infect the USC-I cell s 
B 
Fi~un'~.4 ,\ ,kdtll I" n~Ja ill Ihe dTed of "i r " 1 do,e ill ""odilia ,iru, illhihili"" """). 
Voce'illi, , irlL' ("OK·51 at " "I C"'lC""1f"i~", of} millivn I' LLiml (AJ on" 24 milli"' L l' f C .. rnl (Bl 
\\'ere inc"lutod with muc in, I"," 1,lmil: or 37'(', The nll"u,.s w.,. adde d m the HSC· I in the 
Min imllm F,,,, ,"i al \ 1<<1iL1111 ""d O<J itmo(1 at }T'C itl 'CO, ' n.:"hatv, (I~'; COJ f", 4~h, F" i,lcn.: < ~r 











In conclusion the lack of effective and long lasting vaccines against: enveloped viruses 
makes humans very susceptible for the outbreak of any new virulent strains (Kotwal 
et al., 2005). Therefore more attention should also be given to the natural anti-viral 












CONCLUSIONS, DISCUSSION AND THE FUTURE 
Since its outbreak in 1981 in sub-Saharan Africa, about 25 million adults and children 
have been reported to live with HN I AIDS with approximately 2.2 million deaths in 
2003 alone (Losina et al., 2006). According to Shaikh et al. (2006) Southern African 
countries have the highest prevalence ofHNIAIDS with 25.7% compared to East and 
West Africa, which respectively have 11.4% and 4.3%. In South Africa alone, 
between 4.68 and 7.03 million people were living with HNIAIDS in 2004 (Strode et 
al., 2005), of whom 55% were females (Kagee et al., 2005) and which puts the 
country among the worst affected countries in the world (Shaikh et al., 2006). Jaspan 
et al. (2005) reported that of the 1 million annual births in South Africa, more than a 
quarter of the infants are born to HN -infected mothers. By the year of 2010 this 
epidemic is expected to cost South Africa approximately 17% of its GDP growth 
(Stevens et al., 2006). Furthermore the incidence of opportunistic diseases such as 
TB is also reported to increase with HN prevalence (Lawn and Wood, 2006; Soeters 
et al., 2005). Therefore the need for the development of a safe, natural and affordable 
vaccine is very urgent. 
This study raises questions of the possibility of novel compounds, in this case with 
mucus as a possible component, to prevent transmission of the virus or to reduce the 
load of free virus in bodily substances such as the blood. Obviously more work is 
required to develop these ideas further. 
The HN-l Subtype C (see Chapter 8) is currently the most prevalent Subtype in 
Southern African countries and has only recently become available to us. Thus our 
intention is to use it for future inhibition assays in conjunction with a range of 
different cell lines with appropriate dose response curves. The very high costs of the 
in vitro inhibition assays have been a huge limiting factor in this study. 
This study focused on the role of human salivary, breast milk and pregnancy plug 











compared to the anti-HIV -1 activity of the salivary mucins from HIV positive 
individuals in an in vitro inhibition assay. Furthermore we investigated the role of 
mucins in inhibiting HIV -I infection, reducing viral infection of the HIV -1 positive 
PBMCs and minimizing the spread of HIV-l from HIV-l positive PBMCs to HIV-I 
negative PBMCs. The role of mucus and mucins in the inhibition of other enveloped 
viruses such as poxvirus was also a part of this study. The possibility of mucus or 
mucins being eventually used as an anti-viral agent is a long term goal of our 
research. 
We have shown that normal saliva and its mucin component together with purified 
mucin from breast milk and the pregnancy plug inhibit the virus. Crude breast milk 
and pregnancy plug mucus from normals and salivary mucins from patients who are 
HIV positive have no effect on viral infectivity. Mucins failed to reduce viral 
infection of the HIV positive cells or prevent the infectivity of cells with which they 
were incubated. There is also an urgent need to test the effect of heated breast milk, 
which we think could release the MUC I and consequently have an effect on viral load 
and transmission. 
The lack of inhibition by infected salivary mucin component is of great interest. Very 
early indications, by agarose gel electrophoresis, are that these mucins have different 
charge properties, implying alte ed glycosylation of the mucins which could well 
result in altered viral binding properties of the mucins. More agarose gel 
electrophoresis data followed by HPLC sugar analysis, comparing the length of 
carbohydrate side-chains and monosaccharide composition of mucins in normal and 
infected states will contribute further to the understanding of our findings. The failure 
of HIV -1 positive secretions to infect cells in culture would be due to a low viral load, 
something to consider for the future. 
This study has been largely a qualitative one, the idea of which arose from an earlier 
finding that crude saliva and possibly its mucus component inhibited the HIV -1 virus 
in an in vitro assay. We were able to confirm this finding, together with isolating the 
purified mucins from saliva, breast milk and pregnancy plug mucus identifying them 
and further showing their anti-HIV -1 activity. Inhibition of the virus seemed 











their amount. However we were unable to establish a suitable dose-response curve 
down to the smallest amount of mucin that would show inhibitory activity. Also, our 
findings need to be verified statistically and we are designing a study to do this. We 
have found that salivary, breast milk and pregnancy plug samples had to be pooled to 
have enough of a mucin yield; also the cost of the inhibition assays was daunting to 
say the least and we are currently seeking funding to address the many questions this 
study has raised. Kirkham et al. (2002) has described a method of quantifying mucin 
in crude mucus and it will be worth our while to have this data in future studies. 
Another future consideration would be to use an indirect co-culture for mv inhibition 
assay to accurately determine the role of mucins in minimizing the spread of mv-l 
from mv -1 positive PBMCs to mv -1 negative PBMCs. In this method the mv-l 
positive PBMCs and mv -1 negative PBMCs can be cultured in a tissue culture plate 
with compartments separated by a membrane with the HIV -1 positive PBMCs in the 
lower and the HN -1 negative PBMCs in the upper compartment. Viruses and growth 
factors can pass through the membrane but not the PBMCs and mucins; therefore 
there should not be any physical contact between the PBMCs in the lower and the 
PBMCs in the upper compartments of the tissue culture plate. Thus the principle of 
the experiment is the HN -1 positive PBMCs in the lower compartment will be treated 
with different concentrations of mucins and their role in minimizing mv spread from 
the HIV-l positive PBMCs in the lower compartment to the mY-I negative PBMCs 
in the upper compartment will be determined by p24 antigen assay. That is, if the 
mucins trap or aggregate the free viruses which are released from the HIV -1 infected 
PBMCs, no viral infection of the HIV -1 negative PBMCs in the upper compartment 
should be recorded but if the mucins failed to trap or aggregate the free viruses, as the 
viruses are free to pass through the membrane to the upper compartment viral 
infection of the HIV -1 negative PBMCs in the upper compartment is expected. 
However, confirmation of viral spread from HIV -1 positive PBMCs to HN-l 
negative PBMCs is required prior to this assay. 
Furthermore we wish to examine whether there is any association between gastro-
intestinal mucin gene polymorphisms and susceptibility to infection with mY. Mucin 
genes are highly polymorphic due to the presence of long stretches of variable number 











association between disease and the length of the VNTR region, for example in 
asthma (Kirkbride et al., 2001; VinaH et al., 2000) or polymorphisms at the level of a 
single nucleotide, as in ulcerative colitis (Kyo et al., 2001), and an association 
between short alleles of MUCI and gastric cancer (Carvalho et al., 1997). The 
variation of alleles in subjects of different ancestry has also been reported (Kirkbride 
et al., 2001). 
MUC7 is of interest to us because of the reported association between a haplotype 
carrying a shorter MUC7 allele of five tandem repeats (MUC7*5) with higher Forced 
Expiratory Volume (FEVl) at 53 years, reduced age-related decline of FEV. and 
reduced incidence of wheeze has recently been reported. A 20mer MUC7 peptide has 
been shown to possess a broad-spectrum anti-microbial activity (Bobek and Situ 
2003). Situ et al. (2003) further showed that a 12-mer peptide of the original 20-mer 
retains potent anti-fungal activity against Candida albicans and Cryptococcus 
neoformans. 
Therefore one of our future projects is on the association of MUC7 and HIV 
susceptibility. 
Purified salivary MUC5B and MUC7, breast milk mucin (MUCI) and pregnancy plug 
mucins (MUC1, MUC2, MUC4, MUC5AC, MUC5B and MUC6) also inhibited the 
activity of vaccinia virus (vGK-5 strain) which is a family of the enveloped poxvirus 
(Billings et al., 2004) in a dose dependent manner up to 100%. This suggests that 
mucins may also possess a strong activity against other enveloped viruses. 
Finally this study has raised important questions that justify further investigation and 
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